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ABSTRACT  
Staphylococcus aureus (S. aureus) is a significant pathogen that causes a wide variety of 
disease in humans and animals. Methicillin resistant S. aureus (MRSA) isolates carrying 
mecC, the gene that confers resistance to the antibiotic, have been isolated from 
humans but also from diverse animal species covering livestock, domestic and wild 
animals throughout Europe. Many of the known MRSA mecC isolates have been whole-
genome sequenced by our group to gain insight into the evolution and epidemiology of 
these emerging lineages.  
For microbes and humans alike, iron is an essential cofactor in many biochemical 
reactions and S. aureus requires iron for colonisation and subsequent pathogenesis. The 
success of S. aureus is partly attributed to its ability to exploit the host iron pool. It does 
this through multiple iron uptake mechanisms, including at least two high-affinity iron 
scavenging siderophores (staphyloferrins A and B) and an iron-regulated surface 
determinant (Isd) pathway for haem-iron acquisition.  
Here I describe the identification of a novel locus encoding a siderophore-like non-
ribosomal peptide synthetase (NRPS), directly downstream of the SCCmec insertion site 
in mecC S. aureus isolates. A homologous region was identified in Streptococcus equi 
4047 (S. equi) which encodes a NRPS termed ‘equibactin’ that is involved in iron 
acquisition. I have therefore named the NRPS product ‘staphylobactin’ in MRSA, and the 
aim of this study was to determine the function of the staphylobactin biosynthesis 
cluster: is this region involved in iron acquisition and how might it be regulated?  
Analysis of the prevalence of isolates containing the staphylobactin locus showed it to 
be present in a large number of mecC strains in our collection but also identified 
homologues in other staphylococcus isolates. The region is highly conserved in all S. 
aureus isolates belonging to clonal complex (CC) 130 (broad host range lineage), 
suggesting that staphylobactin might impact on S. aureus’s ability to infect a broad range 
of host species. 
The staphylobactin gene cluster contains 14 coding sequences, stbB-F, F1, G-M and O. 
Bioinformatic analysis results in predictions of domain and gene functions associated 
with iron acquisition. I hypothesized that staphylobactin might have been acquired to 
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compensate for the lack of another siderophore, such as staphyloferrin B, but the 
staphyloferrin B biosynthesis cluster and transport is present in nearly all S. aureus 
strains, ruling out this model. Unlike the equibactin locus, however, the staphylobactin 
locus lacks a homolog for the iron-dependent regulator eqbA. Instead, expression of this 
locus appears to be regulated by MntR, a DtxR-like regulator. The staplylobactin gene 
cluster is flanked by direct repeats which suggest staphylobactin could have been gained 
by horizontal gene transfer.  
In order to study the role of the staphylobactin gene cluster, deletion mutants of MntR, 
the staphylobactin locus and staphyloferrins A and B,  were generated using the pIMAY 
two step gene deletion procedure in the previously un-manipulated mecC S. aureus 
CC130 strains – a challenging protocol that required significant optimization given the 
difficulties with manipulating this bacterium. Analysis of the MntR mutant suggests that 
the staphylobactin operon is regulated by MntR, acting as a positive regulator, in an iron-
dependent manner. By RT-PCR, I found that expression of the staphylobactin NRPS 
genes is increased when cultures are grown in the absence of iron, suggesting an 
involvement with iron acquisition. Genomic inactivation of the staphyloferrins resulted 
in a mutant severely incapacitated for growth in serum and transferrin as the sole iron 
source, and addition of iron reversed this phenotype. However, deletion of 
staphylobactin alone or in addition to the staphyloferrins, lacked an iron-dependent 
growth defect, and numerous assays failed to identify a clear role for staphylobactin in 
iron metabolism. Therefore, further experiments are needed to elucidate the function 
of this siderophore like NRPS.  
Analysis of the same sequenced CC130 mecC isolates from our strain collection in which 
the staphylobactin locus was found, led to the identification of a novel Von Willebrand 
(vwb) gene. In order to investigate possible reasons for these isolates to infect a wide 
range of host species, wild-type and vwb deletion mutant strains, along with the novel 
vwb expressed in lactococcus, were tested using a coagulation assay and were able to 
clot plasma from a broad range of host species. Thus the specificity of vWbp proteins 
can be used to infer the host specificity and evolutionary history of the S. aureus strains 
that harbour them.  
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Although I was unable to generate definitive evidence revealing the biological role for 
the staphylobactin locus this study has generated valuable tools for further studies and 
thoroughly tested a number of hypotheses concerning its role in cation metabolism. 
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1.1 Staphylococcus aureus 
1.1.1   Staphylococcus aureus infections 
Staphylococcus aureus (S. aureus) is a Gram-positive, non-motile coccal bacterial 
pathogen. A common human commensal, it is often found as a part of the human skin 
microbiota and on mucous membranes. It colonises the nares of nearly a third of the 
world’s population (1-4). Most S. aureus infections cause skin and soft tissue infections, 
including furunculosis (5), impetigo (6), cellulitis (7), mastitis (8) and flesh eating disease 
(9, 10). It is the most common cause of hospital infections affecting the treatment of 
patients, especially in individuals suffering from chronic illness, traumatic injury, burns 
or immunosuppression (11, 12).  Breach of skin and mucosal membranes can cause 
bacteraemia, toxic shock (13), pneumonia (14), deep abscesses and septic shock (15) 
and sepsis, which can lead to osteomyelitis (16), septic arthritis (17), and endocarditis 
(18, 19). S. aureus is also a common cause of infections associated with indwelling 
devices such as joint prostheses, cardiovascular devices and artificial heart valves. 
Invasive S. aureus infections are a source of considerable morbidity and mortality (20). 
S. aureus colonises and sometimes causes infections in a wide variety of animals, 
including household pets, farm animals and wild animal species, and can be transmitted 
among diverse species. However, in general isolates obtained from different species 
differ at the genome level, suggesting the existence of specific host genotypes (21). Since 
S. aureus possesses a highly conserved core genome, host specific adaptions are likely 
to be carried by mobile genetic elements (MGEs). This implies that the organism may 
switch host specificity the acquisition (or loss) of one or more such elements. In dairy 
farms, S. aureus is among the most common causes of clinical and subclinical mastitis, 
which is a disease of considerable economic importance (22).  
1.1.2 Antibiotic resistance 
When Penicillin was introduced in 1941, over 94% of S. aureus isolates were susceptible 
to it (23). However, penicillin resistant strains were soon reported and an alternative 
therapy was required (23). Although initially prevalent only in hospitals, penicillin 
resistance is now present in over 90% of community isolates.  
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1.1.2.1 Penicillin resistance 
Initial S. aureus resistance to penicillin was mediated by a plasmid-encoded penicillinase 
(β-lactamase) that cleaves the β-lactam ring of penicillin, rendering the antibiotic 
ineffective. This led to the search for β-lactamase-resistant agents, which resulted in the 
synthesis of the semisynthetic antistaphylococcal penicillins, beginning with methicillin 
and subsequently with methicillin derivatives such as oxacillin, cloxacillin, dicloxacillin, 
flucloxacillin and nafcillin. 
1.1.2.2 Methicillin resistance 
Methicillin, a penicillinase stable β-lactam, was first used clinically in 1959. However, 
only 2 years later, Jevons et al. first described methicillin-resistant S. aureus (MRSA) (24). 
Resistance to methicillin and other β-lactam antibiotics is conferred by the mecA gene 
(25). mecA encodes an alternative penicillin-binding protein, PBP2a or PBP2', that differs 
from other penicillin-binding proteins by an active site having a decreased affinity for 
binding β-lactams such as penicillins, cephalosporins, and carbapenems (26-28). As such, 
PBP2a can continue to catalyse the transpeptidation reaction required for peptidoglycan 
cross-linking, enabling cell wall synthesis in the presence of penicillins (29). Therefore, 
acquisition of mecA allows for resistance to all β-lactam antibiotics, and obviates their 
clinical value for treating MRSA infections (30).  
1.1.3 Staphylococcal Cassette Chromosome (SCCmec) 
The mecA gene is carried on a mobile genetic element called the staphylococcal cassette 
chromosome (SCC) that is a member of a broader SCC family of elements. SCCmec also 
contains the genes ccrA and ccrB, which encode the recombinases that mediate the site-
specific integration and excision of the SCCmec element from the S. aureus chromosome 
(31, 32). There are 11 variants of SCCmec (types I to XI) currently defined, ranging in size 
from 21-67 kb and distinguished by variation in mec and ccr gene complexes (33). 
Chromosomal insertion is at the same position in all strains, the integration site 
sequence (ISS) within an open reading frame (ORF) designated orfX  in the S. aureus 
chromosome (34). Different SCCmec types confer different phenotypic characteristics, 
such as antimicrobial resistance rates (35). Different SCCmec types are also associated 
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with strains causing different epidemiological patterns of infections. Typically, hospital 
acquired MRSA (HA-MRSA) carry SCCmec types I-III, which are large elements including 
multiple resistance determinants. Community-associated MRSA (CA-MRSA) is 
associated with SCCmec types IV and V, which are smaller and carry fewer resistance 
elements than those seen in hospital-associated MRSA strains. The smaller size of 
SCCmec type IV has been suggested to promote its mobility; in support of this proposal, 
SCCmecIV has been inserted into multiple lineages of S. aureus whereas SCCmecII and 
SCCmecIII have only been found in three and two lineages, respectively (36).  
1.1.4 Detection and molecular typing of MRSA 
Most isolates of MRSA in the UK that have been cultured from blood, infected wound 
sites and body fluids, are identified by antimicrobial susceptibility testing, by measuring 
zones of growth inhibition around antibiotic-impregnated discs on agar plates, or 
through measurement of minimum inhibitory concentrations (MIC). Detection of the 
mecA gene by PCR (37, 38) or of PBP2a in a slide agglutination assay (39) can be used to 
confirm MRSA when phenotypic results are borderline. These two assays are regarded 
as the gold standard for the detection of MRSA. In a clinical setting, the use of automated 
antibiotic susceptibility testing, such as Vitek (40), are becoming more commonly used 
than MIC. 
In S. aureus, commonly used molecular typing methods include pulsed-field gel 
electrophoresis (PFGE) (41), spa typing (42) and multilocus sequence typing (MLST) (43). 
For MRSA, Staphylococcal Cassette Chromosome mec (SCCmec) analysis is also widely 
being carried out. MLST is a highly discriminatory method of characterising isolates on 
the basis of the nucleotide sequence of internal fragments of seven housekeeping genes 
(44). The sequences of each gene fragment are assigned as distinct alleles, and the 
sequence type (ST) or allelic profile of each isolate is defined by the alleles at each of the 
seven housekeeping loci.  Isolates with the same allelic profile for five or six out of seven 
genes are assigned as members of the same clonal complex (CC) (45). MLST can be used 
to study the evolution and population biology of S. aureus. 
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1.1.5 Discovery of a novel mecA homologue mecC  
In 2011, Garcia-Alvarez et al. discovered MRSA with a novel mecA homologue in human 
and bovine populations in the United Kingdom and Denmark (46). The original strain 
(LGA251) was isolated from bulk milk in England and was phenotypically resistant to β-
lactams but tested negative by PCR for the mecA gene and by PBP2a slide agglutination 
tests. This isolate was genome sequenced to find the genetic basis of the methicillin 
resistance. A divergent mecA homologue: mecC (previously known as mecALGA251 (47)) 
was discovered in a novel SCCmec element, designated SCCmec type XI. Published at the 
same time, work in the Republic of Ireland independently described mecC in human 
MRSA strains isolated in 2010 (48). mecC exhibits 69% nucleotide identity with the 
conventional mecA gene. The PBP2a protein encoded by mecC has distinct biochemical 
properties in comparison to mecA-PBP2a, showing a higher relative affinity for oxacillin 
compared to cefoxitin and being unstable at 37 ᵒC (49). Since the initial discovery of this 
mecC, it has been reported in several European countries (50) including Denmark (51-
53), France (54), Spain (55-57), Sweden (58), Austria (59), Finland (60), The Netherlands, 
Ireland, Germany (61-63), Belgium (64), Slovenia (65), Switzerland (66), Norway and the 
United Kingdom (67, 68), showing a wide geographical spread of these isolates. MRSA 
harbouring mecC has been reported from humans but also from diverse animal species 
including livestock, domestic, and wild animals (69). Host species include dogs, cats (70, 
71), rat, rabbit, seal (72), wood mice (57), cattle (73-77),  hedgehogs (78), small 
ruminants (53, 79), guinea pig and chaffinch (72, 80, 81) hares, otters, fox, deer (82, 83) 
and mara (84). mecC isolates have been found belonging to clonal complexes (CCs) 49, 
130, 425, 599 and 1943, with the majority belonging to CC130.  This is interesting as 
different S. aureus lineages normally show selective affinity towards specific animal 
hosts. However, the broad host spectrum, including a list of wild species supports the 
idea that mecC MRSA is a generalist lineage. The initial discovery and subsequent studies 
have demonstrated that mecC MRSA is frequently found in dairy cattle, suggesting that 
cows might provide a reservoir of infection (67). Evidence of transmission of mecC MRSA 
from livestock to humans has been provided by whole genome sequencing (WGS) in two 
cases in Denmark, showing that mecC-MRSA has the potential for zoonotic transmission 
(51, 85, 86). Gomez et al. (82) found mecC-MRSA in red deer in Southern Spain, 
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suggesting that red deer could be acting as mecC-MRSA hosts and could share these 
genes with other animals when they coexist in the same habitat. In Sweden, Unnerstad 
et al. (58) reported mecC-MRSA in domestic animals suggesting them as potential 
reservoirs with associated risks to humans. When wildlife and livestock share the same 
habitat, interspecies transmission can occur, either directly or indirectly. A mara in 
Copenhagen zoo was found to be carrying mecC-MRSA; it was suggested that the 
possible transmission route is likely to have involved either zoo personnel or wildlife 
such as birds and small rodents, both of which have been shown to carry mecC-MRSA 
(57, 72). In humans, mecC-MRSA prevalence is uncommon. It has been mostly found in 
skin and soft tissue infections (73), but has been responsible for fatal bacteraemia (55) 
and osteomyelitis (87). In Denmark, the number of mecC-positive MRSA cases in humans 
(including colonisation and infection) increased from 9 in 2009 to 24 in 2012. However, 
none of the 24 human cases registered reported any contact with livestock (81), 
supporting previous evidence that this lineage is able to transmit between humans (55). 
In Germany, only two mecC-MRSA isolates were found among 3207 MRSA isolates and 
there was no change in prevalence between 2004-2011 (61, 62). In the UK, 0.45% of 
human MRSA isolates were found to carry mecC in 2011 (88). Meta-analysis carried out 
in 2016 showed that the overall pooled prevalence of mecC was 0.009% (89). The 
estimated prevalence in the human subgroup was 0.004%, as compared to 0.10% in the 
animal subgroup. Studies have also reported isolation of mecC-MRSA from river water 
and urban waste water (56, 90). These findings highlight the potential role of 
environmental dissemination of mecC-MRSA in surface water but the origin, 
epidemiology and impact of mecC is still unclear. Recently, a Staphylococcus xylosus 
isolate was found to harbour a new allotype of the mecC gene, mecC1. The mecC1 gene 
has 93.5% nucleotide identity to the mecC gene in S. aureus LGA251. WGS revealed that 
mecC1 forms part of a class E mec complex (mecI-mecR1-mecC1-blaZ) located at the orfX 
locus as part of a likely SCCmec remnant, which also contains a number of other genes 
present on the type XI SCCmec (91). Also recently, mecC genes have been found in other 
coagulase-negative Staphylococcus species (92) including Staphylococcus stepanovicii 
(83), Staphylococcus sciuri (93) and Staphylococcus saprophyticus (94, 95) isolates 
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suggesting that coagulase-negative staphylococci (CoNS) may have provided the original 
source of mecC in S. aureus. 
1.1.6 Host cell interactions of S. aureus 
Following infection with S. aureus, a large inflammatory response occurs. The host’s 
innate immune response is the recruitment and activation of neutrophils through 
induction of cytokines, chemokines, and chemokine receptors (96, 97). These 
neutrophils can phagocytose opsonised bacteria and trigger oxidative killing and other 
antimicrobial mechanisms such as NETs (neutrophil extracellular traps) (98, 99). To 
counter neutrophil attack, S. aureus produces factors to subvert the immune system, via 
the secretion of staphylococcal superantigen-like 5 and 10 (SSL5 and SL10), extracellular 
adherence protein (Eap) (100) and the chemotaxis inhibitory protein of S. aureus (CHIPS) 
(101-103). S. aureus secretes nuclease to degrade NETs, allowing it to escape 
entrapment, but also to cause death of immune cells (104). 
Neutrophil phagocytosis and bacterial clearance are enabled when microbes are 
opsonised by components of the complement system or immunoglobulins (Igs) (105). 
Compliment can quickly recognise and opsonise bacteria directly or kill bacteria by the 
formation of membrane attack complexes (106). S. aureus reduces or delays 
opsonisation by targeting complement activation via staphylococcal complement 
inhibitor (SCIN) and extracellular complement binding protein (105). S. aureus secretes 
aureolysin which recruits complement inhibitory factors and clumping factor A (ClfA) 
(107). To prevent opsonisation by Ig, S. aureus evolved Ig-binding factors, such as 
staphylococcal protein A (SpA) and staphylococcal binder of Ig (108). 
S. aureus produces cytolytic toxins, including Panton-Valentine leukocidin (PVL) (109), 
α-haemolysin (110) and phenol-soluble modulins (PSMs) (111). These are pore-forming 
toxins that can lyse host cells (103), converting local host tissue into nutrients required 
for bacterial growth (112) or destroying immune cells. S. aureus uses α-haemolysin to 
lyse erythrocytes and release haemoproteins that are a source of iron. This allows 
staphylococcal iron acquisition systems, such as siderophores and haem transports, to 
overcome the host attempts to starve it of this essential nutrients.  
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Once phagocytosed by neutrophils, monocytes and macrophages, S. aureus are able to 
survive and proliferate before lysing the cell and escaping back into surrounding tissue 
(113). To survive within neutrophils, S. aureus produces factors such as staphyloxanthin 
(114) and superoxide dismutase that inhibit reactive oxygen species (ROS)-mediated 
killing. 
1.1.6.1 Aggregation and coagulation mechanisms 
Following entry into the blood stream of infected hosts, S. aureus disseminates into 
tissues and seeds abscesses. Staphylococci replicate as a bacterial community at the 
centre of these abscesses, protected by an inner pseudocapsule and an extended outer 
dense microcolony-associated meshwork (MAM) containing fibrin. The bacteria produce 
a number of factors that target coagulation as an immune evasive strategy. They do this 
by secreting two proteins that promote coagulation, coagulase (Coa) and von 
Willebrand factor-binding protein (vWbp) (115). Both Coa and vWbp interact with 
prothrombin, causing the conversion of fibrinogen to fibrin promoting the clotting of 
plasma (116, 117) (Figure 1.1). Both Coa and vWbp are required for the formation of 
abscesses and bacterial persistence in host tissues (118). Coa is involved in formation of 
pseudocapsule whereas MAM formation depends on vWbp. This clotting may help 
protect invading S. aureus from the host immune defenses, such as opsonisation or 
phagocytosis (119). 
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Figure 1.1 S. aureus produces coagulase (Coa) and von Willebrand factor-binding 
protein (vWbp) to clot blood. 
vWbp binds to prothrombin causing its activation and leading to the conversion of fibrinogen to 
fibrin, causing the clotting of blood, which probably help protect the invading S. aureus from 
phagocytosis. Image adapted from Crosby et al. Adv Appl Microbiol. 2016 (120). 
 
 
Coagulase is secreted by nearly all S. aureus strains and coagulates blood and plasma 
from various animals (121). S. aureus also produces clumping factor A (ClfA), which binds 
fibrinogen and contributes to platelet aggregation via a fibrinogen or complement 
dependent mechanism (122). In addition, vWbp binds von Willebrand factor (vWf) (123), 
a blood glycoprotein that is upregulated on host platelets and endothelial cells during 
haemostasis to promote blood coagulation (124). The ability of vWbp to bind this 
glycoprotein may have a role in localising prothrombin activation and therefore clot 
formation in the vicinity of the bacterium. The interaction between vWbp and vWf is 
highly specific and is mediated by a region of 26 amino acid residues in the C-terminal 
part of vWbp (123). When establishing endovascular infections, S. aureus adheres to the 
vessel wall under shear forces of flowing blood by vWbp-mediated binding to vWf (125, 
126). The secreted vWbp interacts with vWf and ClfA (a Sortase A-dependent 
staphylococcal surface protein) to form a complex that anchors S. aureus to vascular 
endothelium under shear stress (127).  
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In order to disseminate to organ tissue and seed abscess lesions, S. aureus needs to leave 
the bloodstream. S. aureus induces its uptake by non-phagocytic cells, such as epithelial 
and endothelial cells (128) by the production of adhesins that enable the attachment to 
the host cell surface. The major adhesins are fibronectin-binding proteins (Fnbps), 
collagen-binding protein, and fibrinogen binding proteins (ClfA and ClfB) (129). These 
factors belong to a major class of S. aureus adhesins, termed MSCRAMMs (microbial 
surface component recognising adhesive matrix molecules), which are covalently 
anchored to cell peptidoglycans and recognise the most prominent components of the 
extracellular matrix or blood plasma, including fibrinogen, fibronectin, and collagens 
(12).  
1.1.6.2 Regulation of virulence factors 
The ability of S. aureus to cause a variety of infections and its dynamic adaption to 
extracellular and intracellular host niches is dependent on the timely and coordinated 
expression of virulence factors by the pathogen. S. aureus coordinates expression of 
virulence genes mainly by two regulatory mechanisms, dependent on genes encoded 
within the agr (accessory gene regulator) locus and on the sarA (staphylococcal 
accessory regulator) gene (130-132). Additional mechanisms also fine tune expression 
of virulence factors. The two component regulator SaeRS is responsive to stimuli 
associated with phagocytic immune cells, such as hydrogen peroxide (133), leading to 
expression of secreted toxins and capsule (134).  
Iron limitation is also a key sensory trigger for the expression of staphylococcal virulence 
factors. Ferric uptake regulator (Fur) bound Fe2+ indirectly contributes to coordinated 
repression of secreted hemolysins and cytotoxins, and under sustained conditions of 
iron limitation upregulation of these factors occurs. On the other hand, Fur-Fe2+ 
contributes to positive regulation of immunomodulatory proteins, including 
superantigens, protein A, complement inhibitory protein, and chemotaxis inhibitor 
(135). A fur inactivated mutant was shown to be less virulent in a murine pneumonia 
model of infection (135), suggesting that in the absence of this key regulatory protein, 
virulence is compromised due to improved clearance by immune cells despite the 
enhanced cytotoxicity of the mutant.  
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1.2 Iron 
Iron is an essential nutrient for all microbial pathogens, with the exception of Borrelia 
burgdorferi and Treponema pallidum. In S. aureus, metal ions, such as iron, participate 
in diverse biochemical processes such as DNA synthesis, regulation of virulence factor 
expression, and defence against oxidative stress.  
The utility of iron in biological processes is due to its ability to participate in single 
electron transfers to interconvert between ferrous (Fe3+) and ferric (Fe2+) redox states. 
However, through this activity, excess or ‘free’ iron is capable of generating highly toxic 
reactive oxygen species (ROS) that can compromise cellular integrity through damage to 
lipids, proteins, and nucleic acids. Therefore, a delicate balance exists in S. aureus 
between the acquisition of iron for essential cellular processes and the sequestration of 
iron to avoid toxicity. The ability to acquire iron is required in S. aureus for colonization 
and disease pathogenesis. 
1.2.1 Nutritional Immunity 
As part of their innate immune response to bacterial infection, vertebrates have evolved 
sophisticated systems that sequester excess iron intracellularly to restrict the amount 
of free iron available for invading pathogens. This process is referred to as nutritional 
immunity (136) and extends to other transition metals, including zinc and manganese 
(137).  
1.2.1.1 Transferrin and Lactoferrin 
Extracellular iron is rapidly sequestered by high affinity iron binding proteins such as 
transferrin in serum which binds free iron (136). In addition to binding free iron, 
transferrin functions as an iron transport protein, moving iron to peripheral tissues 
through receptor-mediated endocytosis of transferrin receptor 1 (TfR1) upon 
complexation with holo-transferrin (138). Iron levels are also limited in lymph and 
mucosal secretions through lactoferrin, which quickly binds all free iron. Additionally, 
lactoferrin is a major antimicrobial constituent of lysosomes within phagocytes, 
ensuring that engulfed pathogens have limited access to intracellular iron.  
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1.2.1.2 Haem and Haem carrier proteins 
The majority of iron within vertebrates is complexed into the tetrapyrrole ring of haem, 
and is bound within haemoproteins such as haemoglobin, which contains around two-
thirds of the total body reservoir (69). To further prevent pathogen access to iron, 
haemoglobin is sequestered intracellularly within erythrocytes. More than 90% of iron 
within the human body is located intracellularly making it inaccessible to extracellular 
pathogens unless mechanisms are employed to liberate these rich sources of nutrient 
iron (139). S. aureus and many other bacterial pathogens lyse erythrocytes to release 
haemoglobin; however the host mitigates this through the action of the high-affinity 
haemoglobin binding protein haptoglobin (88). Haptoglobin is abundant in serum and 
this is increased during inflammation (140). The haemoglobin-haptoglobin interaction is 
one of the strongest noncovalent interactions reported in serum, ensuring that the 
complex does not dissociate until the proteins and haem are recycled in the liver (141). 
Lysed erythrocytes also release free haem which is then bound by haemopexin with high 
affinity and taken to the liver where it is endocytosed by hepatocytes and cleared from 
the serum (142). 
1.2.1.3 Ferritin 
Ferritin is an important component of iron homeostasis in the body, specifically in 
regards to storage of surplus iron in a soluble and nontoxic form inside cells (143, 144). 
In animals, ferritin is most abundant in liver hepatocytes, which act as the body’s primary 
iron reserve (145). Release of ferritin into serum may aid in iron delivery from the liver 
to other tissues (146, 147). More importantly, elevated serum ferritin serves to reduce 
iron overload caused by hemochromatosis or some cancers (148). 
1.2.2 Iron homeostasis 
Iron homeostasis in the host is strictly regulated to make sure that iron is available for 
essential biochemical reactions while preventing iron-associated toxicity and bacterial 
growth. Iron toxicity results from the accumulation of excess iron that surpasses the 
binding capacity of transferrin causing non-bound iron to catalyse the production of 
highly reactive oxygen species (ROS). This leads to damage of the liver, heart and 
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endocrine organs as well as potentially providing invading pathogens with a growth-
essential nutrient. The importance of iron homeostasis in health and disease is made 
clear when it is disrupted. For example, disruption of iron homeostasis can lead to 
increased severity of S. aureus infections (149). Iron overload, as manifested in 
haemochromatosis (caused by a mutation within the HFE gene leading to excessive iron 
in the liver and tissues) (150) or β-thalassaemia (caused by a mutation in the β globin 
gene that affects haemoglobin synthesis (151)), results in tissue damage and organ 
dysfunction such as liver failure and cardiovascular disease, causing increased risk of 
bacterial and viral infections (152, 153). Liver transplantations can also result in iron 
overload (139). The mortality rate in liver transplant patients that suffer from S. aureus 
bacteraemia is over 80% (154). Iron deficiency, encountered in patients with chronic 
inflammation or inadequate dietary intake, results in ineffective erythropoiesis (155). 
In order to overcome nutritional immunity, S. aureus has evolved specialised systems 
for the acquisition, processing and detoxification of iron and iron containing host 
molecules and proteins.  
1.3 Bacterial strategies for acquisition of host iron 
1.3.1 S. aureus response to iron starvation 
Iron is a cofactor of numerous proteins involved in central metabolism and respiration. 
S. aureus responds to iron limitation by reduced expression of non-essential iron-
containing pathways, including the tricarboxylic acid (TCA) cycle, while also upregulating 
glycolytic and fermentative metabolism (156). 
1.3.2 The ferric uptake regulator response to iron limitation 
S. aureus responds to the iron-restricted environment of the host by dramatically 
altering its genetic expression of iron uptake mechanisms and virulence factors that play 
roles in liberating host iron stores or circumventing host immune strategies. This change 
is mediated, in large part, by the iron-dependent Fur (156). Fur is an iron-dependent 
transcriptional regulator that is conserved among Gram-positive and Gram-negative 
bacteria (157).  The genes involved in both siderophore-mediated iron scavenging and 
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the haem-iron acquisition systems are under the control of this transcriptional 
repressor. In the presence of iron, Fur binds a consensus DNA sequence known as the 
Fur box, upstream of Fur regulated genes. This blocks RNA polymerase, leading to 
transcriptional repression.  
In iron-deplete conditions, Fe2+ dissociates from Fur-Fe complexes, Fur is released from 
Fur boxes, and transcription of Fur regulated genes can proceed (158). In this way, S. 
aureus can initiate a transcriptional program based on the amount of iron available in 
the environment (159).  Fur also regulates the expression of virulence factors involved 
in attachment to host cells, biofilm formation, and manipulation of host wound healing 
(160-162). It additionally controls the expression of secreted cytolytic and 
immunomodulatory toxins such as haemolysins that increase erythrocyte lysis, and 
regulates hydrolases (for example cytolysins and proteases) that modulate the host 
immune response such as chemotaxis inhibitory protein (CHIP). This plays an important 
role in decreasing the host immune response and promoting bacterial survival (163). 
Inactivation of fur and the peroxide stress regulator  (perR),  a homologue of fur, leads 
to a reduction in virulence in a mouse model of S. aureus infection (164) thus 
emphasising the importance of Fur in S. aureus pathogenesis.  
1.3.3 Alternate examples of regulatory mechanisms contributing to iron 
homeostasis 
Some organisms contain multiple fur homologues, including Bacillus subtilis that 
encodes three fur homologues (fur, perR and zur) (165) and a homologue of the 
Corynebacterium diphtheriae iron-regulator dtxR (mntR). B. subtilis Fur binds Fe2+ and 
regulates the expression of iron-uptake genes (166). PerR regulates the peroxide 
regulon and binds to Mn2+ or Fe2+ (166), while Zur down-regulates two Zn2+ uptake 
pathways in the presence of Zn2+ (167). MntR binds Mn2+ and regulates Mn2+ transport 
(168). The MntABC system competes with calprotectin for manganese. The 
transcriptional repressors MntR and Zur allow S. aureus to respond to manganese-
deplete and zinc-deplete environments, and regulate the expression of high affinity 
metal transporters. Like iron, free Zn2+ is found in low concentrations in vivo. S. aureus 
has ORFs corresponding to fur, perR, zur and dtxR which are predicted to be involved in 
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the regulation of these iron responses, and in the regulation responses to other metal 
ions (169-171).  
1.3.4 Direct uptake of Fe3+ from transferrin 
Some bacteria secure transferrin and lactoferrin iron through direct binding and 
manipulation of these serum proteins using cell surface receptors. 
1.3.5 Indirect uptake of Fe3+ from glycoproteins: siderophores 
Siderophores are small, high affinity, ferric iron-scavenging molecules produced and 
secreted by numerous bacteria, fungi, and plants in response to iron deprivation. The 
affinity of siderophores for ferric iron affords them the capacity to scavenge residual 
free iron from the environment, as well as steal it from host glycoproteins, such as 
transferrin and lactoferrin. Broadly, siderophores are classified based on functional 
groups involved in iron coordination, and include catecholate, hydroxamate and α-
hydroxycarboxylate types, as well as ‘mixed type’ siderophores when more than one 
type of coordinating moiety is employed.  
1.3.6 Indirect uptake of Fe3+ from transferrin: catecholamine stress 
hormones 
The low affinity of transferrin and lactoferrin for Fe2+ means their function may be 
compromised by interaction with agents that reduce Fe3+. Studies have shown that the 
catecholamine stress hormones, including adrenaline (epinephrine), noradrenaline 
(norepinephrine), dopamine, and L-3,4-dihydroxyphenylalanine (L-DOPA), are capable 
of forming direct complexes with holotransferrin and hololactoferrin, and reductively 
liberating iron as Fe2+ (172, 173). Catecholamine stress hormones may also act as 
biological chelators that compete with transferrin. 
1.3.7 Uptake of Fe2+ 
Bacteria also have mechanisms to transport the low levels of ferrous (Fe2+) iron that may 
be available in their environments.  Transport of Fe2+ is an iron uptake strategy for many 
bacteria, which involves the Feo (ferrous iron) transport system. First characterised in E. 
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coli (174, 175), this comprises of two or three proteins: FeoB (175, 176), FeoA and FeoC 
(177). FeoB-mediated iron uptake from the gastrointestinal tract contributes to 
colonization by and pathogenesis of Campylobacter jejuni (178) and Helicobacter pylori 
(179). FeoB also contributes to intracellular growth of Legionella pneumophila (180). 
1.4 Siderophores 
1.4.1 Biosynthesis of siderophores 
Siderophores are assembled from amino acids, organic acids, and other small organic 
metabolites, and their biosynthesis usually occurs through one of two modes of 
assembly, characterised by the requirement, or lack thereof, for large multifunctional 
enzyme assembly lines known as nonribosomal peptide synthetases (NRPS) (181). 
1.4.1.1 Nonribosomal peptide synthetase assembly 
The majority of siderophores classes are synthesised by NRPS-based siderophore 
synthesis. This involves the activation and incorporation of non-proteinogenic amino 
acids into an elongating chain, in the absence of an RNA template (182). Independently 
of a ribosome, NRPS siderophores are condensed and modified stepwise on a 
multimodular enzyme, the NRP synthetase, for which the roles of functional domains 
can be summarized as follows (183):  
1) Activation of an amino acid or growing intermediate aminoacyl-AMP by adenylation 
(A) domains;  
2) Transfer to peptidyl carrier protein (PCP) domains;  
3) Condensation of PCP-bound amino acids by condensation domains;  
4) Amino acid modifications, for example by epimerization domains;  
5) Transesterification (TE) of the peptide chain from the terminal PCP onto the TE 
domain, with subsequent liberation of the mature metabolite through hydrolysis or 
macrocyclization.  
The modular arrangement of the NRPS synthetase essentially creates a protein assembly 
line, allowing metabolite assembly and modification to occur in a progressive, stepwise 
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fashion. The coordinated biosynthesis of NRPSs (involved with siderophore synthesis) is 
activated by promoters which are sensitive to iron depletion. The NRPS genes for a 
certain peptide are usually organised in one operon. 
In addition to the synthesis of numerous macrocyclic, or ‘aryl capped’, peptide 
siderophores (206), including enterobactin (184), yersiniabactin (185), and vibriobactin 
(186), NRPS enzymes also produce antimicrobial peptides (187) and peptide-based 
antibiotics such as penicillin (188), daptomycin (189), and vancomycin (190).  
1.4.1.2 Nonribosomal peptide synthetase independent assembly 
In contrast, NRPS-independent siderophore (NIS) occurs through condensation of 
alternating amino alcohols, alcohols, dicarboxylic acids, and diamines through 
synthetase enzymes that catalyse  amide and ester bond formation between these 
siderophore subunits (191). The majority of carboxylate and α-hydroxycarboxylate type 
siderophores are synthesised using NIS-type pathways, including alcaligin (192), 
rhizobactin (193) and vibrioferrin (194). Notably, petrobactin, which is produced by 
pathogenic Bacillus spp., is synthesized via a NIS/NRPS hybrid system (195, 196). 
S. aureus is known to produce two α-hydroxycarboxylate-type siderophores; 
staphyloferrin A (197), and staphyloferrin B (198). They scavenge soluble ferric iron or 
compete for extracellular iron with host iron-binding proteins such as transferrin and 
lactoferrin.  Both siderophores are synthesised by the nonribosomal peptide synthetase 
independent pathway (NIS).  Biosynthesis and import of staphyloferrin A and 
staphyloferrin B are regulated by Fur in response to environmental iron concentrations 
(199, 200).  An additional putative S. aureus siderophore, aureochelin, has been found 
to be produced in iron-restricted medium, but has not been fully characterised  (201). 
Studies of culture collections have so far demonstrated that staphylococcal isolates do 
not produce two other classes of siderophore molecules, namely hydroxamates and 
catecholates (201-203). Bioinformatic analysis uncovered a NRPS pathway (gene aus) 
encoded within all sequenced genomes. The NRPS synthetase has been characterised 
and does not produce an iron-binding metabolite or antibiotics, but functions as 
regulators of virulence factor expression and are necessary for productive infections 
(204, 205). 
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In S. aureus, inactivation of staphyloferrin B biosynthesis but not staphyloferrin A 
biosynthesis leads to impaired growth in iron-restricted media. Double mutants of both 
staphyloferrins are severely growth attenuated in iron-deplete media and are 
resuscitated to wild-type levels only if the growth media is replete with iron  (199) 
suggesting that staphyloferrin B plays the more prominent role in staphylococcal growth 
during iron limitation, at least under the conditions tested. However, both staphyloferrin 
A and B can remove iron from human holo-transferrin to support S. aureus growth in 
iron-deplete conditions (206).   
1.4.2 S. aureus siderophores: Staphyloferrin A 
Staphyloferrin A has been identified in supernatants from both S. aureus and CoNS (197, 
207, 208). It is a 479 Da molecule, encoded by the sfaABCD operon (209-211), that is 
composed of a molecule of D-ornithine linked with two molecules of citrate via amide 
bonds (212). The staphyloferrin A encoding locus lacks a dedicated citrate synthase and 
citrate for staphyloferrin A production is derived from the TCA cycle citrate synthase, 
CitZ (213). Following the binding of iron by staphyloferrin A, transport across the 
bacterial cell membrane is mediated by the ABC transporter HtsABC in a process 
powered by a separate ATPase, FhuC (Figure 1.2A) (214). The staphyloferrin A operon 
encodes two NIS synthetases: SfaB and SfaD and is chromosomally adjacent to the 
HtsABC operon. The name of the htsABC operon is derived from its initial 
characterisation as a haem transport system (215). Crystallographic studies of HtsA 
demonstrate that it binds staphyloferrin A (216). Thus HtsABC is involved in the 
transport of multiple iron sources into the S. aureus cell.  
1.4.3 S. aureus siderophores: Staphyloferrin B 
Staphyloferrin B was first purified from supernatant extracts of Stapylococcus hyicus 
(CoNS) (198). It is a 448 Da molecule composed of a L-2,3-diaminopropionic acid (Dap), 
1,2-diaminoethane (Dae), and α-ketoglutaric acid (217). Staphyloferrin B production is 
encoded by the sbnABCDEFGHI operon (202, 218, 219). Only the NIS synthetases SbnC, 
SbnE, SbnF, and the decarboxylase SbnH are required for in vitro synthesis of 
staphyloferrin B (220). Import of staphyloferrin B into the bacterial cell is mediated by 
the staphylococcal iron-regulated transporter SirABC system (Figure 1.2B). The sirABC 
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operon is located next to the sbn operon on the S. aureus chromosome. The upstream 
DNA sequence encodes a consensus Fur box, and the sirABC operon is upregulated 
under conditions of iron limitation (221). SirBC is predicted to be a membrane permease 
that is involved in the transport of staphyloferrin B into the cytoplasm. SirA is the 
lipoprotein receptor component of the staphyloferrin B import system (222). sbn genes 
and SB production have also been described for two proteobacteria: the plant pathogen 
Ralstonia solanacearum (223), and the heavy metal tolerant saprotroph Cupriavidus 
metallidurans (224). 
1.4.4 Transport of siderophores across the membrane 
In Gram-negative bacteria, siderophore import to the periplasm is mediated by outer 
membrane receptors and the Ton system. In Gram-positive bacteria, transport of 
molecules across the cytoplasmic membrane requires energy, therefore ABC 
transporters are normally associated with an ATPase. However, neither the sirABC or 
htsABC operon encodes a putative ATPase (214). The ferric hydroxymate uptake system, 
Fhu, is comprised of two permease units (FhuBG), an ATPase (FhuC), and two substrate-
binding proteins, FhuD1 and FhuD2 (214, 225-228). The ATPase, FhuC, is necessary for 
the transport of staphyloferrin A and staphyloferrin B (214).  
 
 
 
Figure 1.2. A model of the S. aureus iron acquisition pathways. 
S. aureus produces two α-hydroxycarboxylate-type siderophores. Staphyloferrin A and 
Staphyloferrin B are taken up by HtsABC (A) and SirABC (B) respectively. Xenosiderophores 
produced by other bacteria are taken up by the FhuCBG and SstABCD systems (C). The energy 
required for siderophore transport is provided by the FhuC or the SstC ATPase. Haem acquisition 
is mediated by the Isd system (D). IsdB binds haemoglobin and IsdH binds haemoglobin-
haptoglobin. Haem is passed through the near iron transporter (NEAT) domains of IsdB, IsdC, 
IsdA and IsdH. Haem transport across the membrane occurs through IsdDEF. Degredation of 
haem leads to the release of iron. Figure adapted from Hammer & Skaar, Annu Rev, Microbiol 
2011 (229). 
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1.4.5 Xenosiderophores 
In addition to endogenous siderophore production and utilisation, some bacteria are 
able to import siderophores produced by other bacteria as a source of iron, these are 
known as ‘xenosiderophores’ (230) (Figure 1.2C). Acquisition of xenosiderophores often 
occurs through uptake pathways with broad specificity for iron-loaded hydroxamate, 
catechol or α-hydroxycarboxylate-type siderophores, rather than any one specific 
siderophore. Bacteria capable of acquiring exogenous siderophores may have a 
competitive advantage within heterogeneous bacterial populations, where they are able 
to exploit multiple iron-chelating molecules as an iron source without the energetic 
demands involved in their synthesis and secretion (231-233). S. aureus imports 
xenosiderophores through the binding activity of FhuD1 and FhuD2 receptor 
lipoproteins and the FhuBG permease (230) (Figure 1.2C). Unlike SirA and HtsA, FhuD1 
and FhuD2 undergo only modest conformational change upon siderophore binding (226, 
234) which probably facilitates the binding of a broad spectrum of xenosiderophores. S. 
aureus is unable to synthesise endogenous-hydroxamate siderophores and FhuD2 
facilitates the uptake of a wide variety of hydroxamate-type siderophores, including 
ferrichrome, desferrioxamine B, aerobactin and coprogen (214, 225, 227, 228, 235), 
whereas FhuD1 appears to accommodate a restricted subset of these siderophores (e.g. 
ferrichrome and desferrioxamine B). S. aureus is also known to use catecholate 
siderophores, such as enterobactin, for growth under iron restriction (225, 228). 
Bioinformatic analysis of the S. aureus genome uncovered the sstABCD operon, which 
includes genes for a dimeric permease (SstAB), an ATPase (SstC), and a lipoprotein 
sharing sequence identity with bacterial transport systems for iron ligands (SstD) such 
as Bacillus subtilis petrobactin receptor YclQ (236) (Figure 1.2C). This operon was shown 
to be iron regulated in vitro and in vivo (237) and is a broad specificity transporter of 
catecholate iron-coordination ligands. Catecholamine-mediated acquisition of serum 
iron is secondary to staphyloferrin-mediated iron uptake in vitro and can only be 
observed in the absence of siderophore production using sfa/sbn mutants. Genomic 
inactivation of sstABCD enhanced the attenuation phenotype of siderophore 
biosynthesis and transporter mutants in the mouse systemic model of infection, 
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suggesting the ability of S. aureus to acquire iron from host serum is the sum of multiple 
mechanisms and not exclusively limited to staphyloferrin-mediated uptake (238). 
1.4.6 Contributions to virulence 
A number of studies have demonstrated the impact of siderophore-mediated iron 
uptake on virulence, even among organisms capable of extracting host haem iron (Table 
1.1). 
Bacteria may also produce siderophores for survival outside a host niche, and rely on 
other iron uptake strategies in vivo. For example, production of a catecholate 
siderophore is important for survival of the veterinary pathogen Rhodococcus equi as an 
environmental saprotroph, while having no significant impact on virulence in a murine 
infection model (239). 
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Table 1.1: Siderophores contributing to the virulence of bacteria in animal models of 
colonisation or infection. 
Species Siderophore Animal model Ref 
Acinetobacter baumannii Acinetobactin 
Mouse, Wax 
moth larvae, 
Human epithelial 
cells 
(240) 
Actinobacillus 
pleuropneumoniae 
Tbp Pig (241) 
Bacillus anthracis Petrobactin Mouse  (195) 
Bordetella bronchiseptica Alcaligin Pig (242) 
Bordetella pertussis Alcaligin Mouse (243) 
Burkholderia cenocepacia Ornibactin Rat  (244) 
Campylobacter jejuni Enterobactin Chick (245) 
Dickeya dadantii Chrysobactin African violet (246) 
Escherichia coli 
Aerobactin 
Salmochelin 
Mouse  
Mouse  
(247) 
(248) 
Klebsiella pneumoniae 
Aerobactin, 
Yersiniabactin 
Mouse  
Mouse 
(249) 
(250) 
Legionella pneumophila Legiobactin Mouse  (251) 
Mycobacterium tuberculosis Mycobactin Mouse (252) 
Neisseria gonorrhoeae 
Gonobactin 
Tbp 
Chicken embryo  
Human  
(253) 
(254) 
Pantoea stewartii Aerobactin Sweet corn (255) 
Pseudomonas aeruginosa 
Pyoverdin 
Pyoverdin/Pyochelin 
Mouse  
(256) 
(257) 
Salmonella typhimurium 
Enterobactin 
Salmochelin 
Mouse  
 
(258) 
(259) 
Salmonella enterica Salmochelin Mouse  (260) 
Staphylococcus aureus  
Staphyloferrin B 
Staphyloferrin A 
Mouse  
 
(202) 
(238, 261)  
Vibrio cholera Vibriobactin Mouse  (262) 
Vibrio vulnificus Vulnibactin Mouse  (263) 
Yersinia pestis Yersiniabactin Mouse  (264, 265) 
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1.4.7 Siderocalin and stealth siderophores 
Part of the human host response to siderophores is to tightly sequester iron in proteins 
such as transferrin; however, the mammalian host also produces siderocalin, a molecule 
that binds bacterial siderophores, rendering them inaccessible to bacteria as iron-
scavenging agents [220]. Siderocalin is secreted by macrophages and neutrophils during 
the inflammatory response to bacterial antigens such as lipopolysaccharide, leading to 
rapid rises in serum levels (266). It is known to sequester a variety of bacterial 
siderophores, primarily those with catecholic or phenolic moieties and has been shown 
to bind enterobactin (267), bacillibactin, carboxymycobactin, and parabactin (268, 269). 
Siderocalin-deficient mice are more susceptible to sepsis and pneumonia caused by E. 
coli strains that rely on enterobactin for siderophore-mediated iron uptake (266, 270). 
Siderocalin is also capable of binding catecholamine stress hormones (271), further 
enhancing bacteriostasis through iron sequestration. Bacteria have evolved ways of 
avoiding this innate immune response, either by producing alternate, unrecognisable 
siderophores, or by incorporating structural modifications or substitutions within pre-
existing siderophore molecular templates. For example, bacteria including S. aureus 
(staphyloferrin A and staphyloferrin B), C. diphtheria and B. anthracis (petrobactin and 
bacillibactin) produce one or more siderophores that cannot be bound by siderocalin 
(267, 268, 272). These siderophores have been termed ‘stealth siderophores’. 
Mycobacteria usually colonize intracellular compartments of macrophages, which 
protects their siderophores and allows them to exploit iron-transferrin uptake inside 
phagosomes (273). Some bacteria that produce siderophores that can be bound by 
siderocalin occupy niches such as intestinal sites where they avoid siderocalin in plasma.  
1.5 Haem 
1.5.1 Haem uptake 
In addition to siderophore-mediated iron acquisition, S. aureus has the ability to acquire 
iron through the extraction of haem from host erythrocytes and serum haemoproteins 
by haem acquisition systems. Haem is the primary reservoir of iron in vertebrates. S. 
aureus preferentially imports and utilises haem-iron when grown in the presence of 
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both haem and haemoglobin (215). S. aureus lyses erythrocytes through the secretion 
of haemolysins, such as α-hemolysin, to release haemoglobin.  The iron-regulated 
surface determinant (Isd) system mediates the binding of haemoglobin and the 
transport of haem across the cell wall and plasma membrane (Figure 1.2D). The Isd 
system consists of a membrane transporter (IsdEF), cell wall anchored haem-binding 
proteins (IsdA and IsdC), haem/haptoglobin receptors (IsdB and IsdH), two haem 
oxygenases (IsdG and IsdI), and sortase B (SrtB), a transpeptidase that anchors specific 
substrate proteins to the cell wall (274). A consensus Fur box is located upstream of each 
of these operons, and these are therefore iron regulated (275). IsdA, IsdB and IsdH are 
covalently anchored to the cell wall by sortase A (SrtA) while IsdC is anchored by SrtB 
(274, 276). The current model for import of haem across the membrane and into the 
cytoplasm is: haem extracted from haemoproteins by IsdB and IsdH at the cell surface 
is relayed through the cell wall by IsdA and IsdC. IsdC then channels haem to the IsdDEF 
ABC transporter system (277, 278), which transports haem through the membrane, 
powered by an undefined ATPase (Figure 1.2D). Once internalised, haem is degraded by 
one of two haem oxygenases, IsdG or IsdI, releasing free iron from the tetrapyrrole ring 
for use by S. aureus (279). Haem degradation catalysed by the haem oxygenases results 
in the production of a chromophore unique to the IsdG family of haem oxygenases called 
staphylobilin (280). The binding of haemoproteins, extraction of haem and subsequent 
shuttling of haem through the cell wall by Isd proteins is facilitated by near 
iron transporter (NEAT) domains. IsdB and IsdH possess two and three NEAT domains, 
whereas IsdA and IsdC each possess one (281). These NEAT domains bind haemoglobin 
and haemoglobin-haptoglobin (282-284). 
1.5.2 Haem uptake by haemophores 
Haemophores are secreted proteins that extract haem from solution or from haem 
carrier proteins and deliver it to the bacterial cell. Haemophore production by Gram-
positive bacteria has been documented for Bacillus anthracis and Listeria  
monocytogenes, which secretes soluble proteins with haem-binding motifs homologous 
to those found in its Isd system (285, 286). 
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1.5.3 Haem toxicity 
Haem is used as a cofactor in many biological systems due to the redox potential of the 
iron atom. However, this redox-active molecule that can be toxic in high levels. S. aureus 
prevents haem toxicity through the activation of an ABC-type transporter called haem-
regulated transporter (hrt) composed of a permease (HrtB) and an ATPase (HrtA) (Figure 
1.3). The ATPase activity of HrtA is influenced by various physiochemical conditions 
including ATP concentration, temperature, pH, and metal cofactors (287). It is thought 
that HrtAB acts as an efflux pump that expels excess toxic haem. The upregulation of 
HrtA in response to haem is dependent on a two-component regulatory system, HssSR, 
composed of a intracellular haem accumulation sensor (HssS) and a transcriptional 
regulator (HssR) that function to activate expression of the hrt operon. Haem exposure 
results in the autophosphorylation of HssS which is followed by transphosphorylation of 
HssR. Phosphorylated HssR binds to a direct repeat sequence within the hrtAB promoter 
in order to induce transcription of hrtAB (Figure 1.3) (288).  
 
Figure 1.3. A model for sensing and alleviating Haem toxicity. 
HssR senses exposure to haem resulting in the expression on hrtAB. HrtA and HrtB transport 
haem across the cell membrane to alleviate haem mediated toxicity. Adapted from Hammer & 
Skaar, Annu Rev, Microbiol 2011 (229). 
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1.6 Transition metals 
Metal-ion homeostasis is important for bacterial life. The transition metals manganese 
and zinc, along with iron, play key roles in the metabolism of bacteria. While copper 
serves as a cofactor in some proteins, bacteria also possess transporters to avoid copper 
toxicity. In addition to restricting iron availability, the host also sequesters other 
transition metals. The host protein calprotectin inhibits the growth of S. aureus by 
sequestering manganese and zinc. Calprotectin is a major protein constituent of the 
neutrophil cytoplasm. 
1.6.1 Manganese 
Bacteria must acquire and regulate their intracellular concentration of manganese. It is 
necessary for a variety of processes including carbohydrate and amino acid metabolism 
and defence against oxidative stress (289). S. aureus encodes mntR, a manganese-
modulated transcriptional regulator, along with mntABC and mntH, manganese 
transporters. The transcriptional regulator MntR affects expression of both mntABC and 
mntH. In manganese-replete conditions, transcription of mntABC is repressed by MntR. 
In contrast, mntH transcription is reduced in the absence of MntR, suggesting that MntR 
may be a bifunctional regulator of S. aureus, as previously described for B. subtilis (168). 
In addition to MntR, mntABC is negatively regulated by PerR, a manganese and iron-
dependent Fur homologue that controls responses to oxidative stress (171, 290). 
1.6.2 Copper 
Copper is an important cofactor for a number of bacterial enzymes, but is toxic if 
concentrations are not carefully regulated. The mechanism by which copper 
homeostasis is achieved in S. aureus has not been fully elucidated. CopA has been shown 
to be involved in copper efflux (291) and its regulation has been shown to be regulated 
by the copper-sensitive operon repressor (CsoR) (292). 
1.6.3 Zinc 
Zinc is an essential element that participates in diverse processes such as regulation of 
virulence factors, metabolism, and inactivation of antibiotics. Zinc concentrations must 
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be carefully regulated and homeostasis is achieved through coordinated regulation of 
import and export. S. aureus possesses two zinc importers, AdcABC and CntABCDF, 
which are induced in response to zinc limitation (293). The crzC gene encodes zinc 
resistance and is genetically located within the type V SCCmec elements. The crzC gene 
is widespread among CC398 LA-MRSA isolates and might have contributed to the 
emergence of CC398 MRSA (294). 
A promising strategy to combat bacterial infections is to inhibit the procurement of the 
nutrients necessary for growth. The decreasing efficacy of available antibiotics 
underscores the need to increase our understanding of the fundamental processes that 
promote S. aureus pathogenesis, as these processes represent targets for novel 
therapeutics. 
1.7 Thesis overview 
1.7.1 Identification of a novel ICE encoding a siderophore-like NRPS in S. 
aureus 
Comparison of the S. aureus mecC strain LGA251, the first mecC isolate discovered by 
García-Álvarez et al. (67), and newly sequenced mecC S. aureus genomes from our strain 
collection using the Artemis Comparison Tool (295) led to the identification of a 23 kb 
region in all CC130 strains that was absent from the LGA251 genome (Data not 
published). Analysis of the locus showed that it contained coding regions with similarity 
and conserved gene order to coding sequences (CDs) of a non-ribosomal peptide 
synthetase (NRPS) siderophore system called equibactin from Streptococcus equi 4047 
(296). 
1.7.2 Streptococcus equi and equibactin 
Streptococcus equi (S. equi) is a host-restricted pathogen that causes a highly contagious 
equine disease called strangles. The disease is characterised by abscessation of the 
lymph nodes in the head and neck, causing swelling and restriction of the airway, leading 
to significant economic and welfare cost (297, 298). S. equi establishes persistent 
infections within the guttural pouches of apparently healthy horses that can result in 
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direct transmission to naïve horses or via indirect transmission due to contamination of 
human attendants, objects or the environment. S. equi is thought to have evolved 
recently from an ancestral strain of Streptococcus zooepidemicus (299), which is an 
opportunistic pathogen causing a wide variety of diseases in horses and other animals.  
Comparison of the genomes of S. equi strain 4047 with those of S. zooepidemicus strain 
H70 identified gene loss due to nonsense mutations and deletions, and gene gain 
through the acquisition of mobile genetic elements (MGEs), including four prophages 
and two novel integrative conjugative element (ICE).  One of the ICEs, ICESe2, encodes 
a NRPS (non-ribosomal peptide synthetase) that produces a putative siderophore, 
named equibactin. Equibactin has been shown to enhance the ability of S. equi to 
acquire iron in vitro (296) (Figure 1.4) and is the first example of a streptococcal 
siderophore (300).  The encoded NRPS system of S. equi shows homology to other 
systems found in Clostridium kluyveri and Yersinia spp. that produce an unnamed 
siderophore (301) and the ferric iron-binding siderophore yersiniabactin (302). 
Siderophore biosynthesis plays an important role in the virulence of many important 
pathogens (303), including Yersiniabactin by Yersinia pestis, the causative agent of 
bubonic plague (304). The equibactin locus is absent from all S. zooepidemicus strains 
examined to date, and the acquisition of this locus is thought to represent the main 
speciation event in the evolution of S. equi, as a host-restricted pathogen of horses, from 
an ancestral S. zooepidemicus strain (305). The acquisition of virulence genes carried on 
ICESe2 in S. equi may have contributed significantly to the survival fitness and influence 
niche adaption due to more efficient acquisition of iron that could enhance survival 
within the lymph nodes. This is critical to the establishment of long term carriage and 
vital to the success of this bacterium (305). Deletion of the equibactin locus occurs solely 
in isolates from persistently infected horses and stops these isolates from being able to 
cause severe disease and therefore transmitted to other horses. The S. equi genome 
encodes other metal acquisition systems, including a haem-binding system (306), a 
putative Mn2+ and Fe3+ metal transport system and a putative Fe3+ ferrichrome transport 
system. 
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Figure 1.4. The ICESe2 locus in S. equi produces a siderophore, named equibactin, 
which improves iron acquisition.  
The S. equi NRPS system carried on the ICESe2 locus produces a secreted siderophore, named 
equibactin, which enhances the ability of S. equi to acquire iron in vitro (296). The genes eqbH, 
eqbI and eqbJ encode a putative ABC transporter, which transport iron bound equibactin into 
the S. equi cell. Figure adapted from Waller et al. Journal of Medical Microbiology 2011 (307).  
 
 
 
 
1.7.3 Thesis objectives and summary 
This thesis focusses on the S. aureus homologue of the equibactin cluster identified 
through sequencing of the mecC S. aureus genomes in our strain collection. 
This project will address the research questions: 
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What is the role of the homologous equibactin biosynthesis cluster found in mecC S. 
aureus CC130 isolates? 
Is this region involved in iron acquisition and how might it be regulated? 
Does this region contribute to growth of S. aureus and to virulence? 
What is the advantage for CC130 isolates that contain this region and how has it 
contributed to its ability to infect a broad range of host species across Europe? 
Chapter 2, I describe computational analysis of the mecC strains in our collection, looking 
at the host and geographical range of these isolates specifically from CC130. I also looks 
at the prevalence of this ‘equibactin’ locus in S. aureus and other bacterial strains. I 
discuss predicted functions of the gene cluster by sequence analysis, as well as how this 
region might be regulated and substrate specificity of the binding pockets of the A 
domains in the NRPS. 
In Chapter 3, I describe the process of genetic manipulation of mecC S. aureus. In order 
to study the function of genes, genetic manipulation is required and this is the first time 
it has been carried out in mecC strains. This chapter includes discussion of how I 
overcame barriers encountered when creating deletion mutants in extremely difficult 
bacteria to manipulate, to create the optimal protocol. 
In Chapter 4, characterisation of the ‘equibactin’ locus was carried out. S. aureus is 
already known to produce two siderophores, staphyloferrin A and staphyloferrin B. 
Mutagenesis was performed to eliminate the iron acquisition loci from the S. aureus 
chromosome to dissect their individual and combined contributions toward growth in 
iron-restricted media, and to assess their roles in virulence. I determined whether mecC 
S. aureus produce siderophores and which siderophores they produce. I also analysed 
whether the ‘equibactin’ genes are expressed under iron-limited conditions and how 
this NRPS might be regulated and transported across the bacterial membrane. 
In Chapter 5, I describe a von Willebrand factor-binding protein (vWbp) that is produced 
by mecC S. aureus with the ability to clot plasma from a broad range of host species.  
Finally, Chapter 6 summarises the main findings and conclusions drawn from this 
project, including future investigative foci.
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2 SEQUENCE ANALYSIS OF 
STAPHYLOBACTIN 
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2.1 Introduction 
2.1.1 Identification and prevalence of a novel ICE encoding a siderophore-
like NRPS in S. aureus 
The following text in this introduction section describes unpublished work that was 
carried out by researchers, Dr Ewan Harrison and Dr Gavin Paterson, in our group prior 
to my PhD studies. Comparison of the mecC S. aureus LGA251 and newly sequenced 
mecC S. aureus genomes from our strain collection using the Artemis Comparison Tool 
(ACT) (295) led to the identification of a 23 kb region in all CC130 strains that was absent 
from the LGA251 genome (CC425) (Figure 2.1). The region was found downstream of 
the SCCmec (Type XI) insertion site and is highly conserved in all CC130 isolates in our 
collection. The CC130 strains have been isolated from diverse host species including 
bovine, human, cat and deer, and from a broad geographical area. Basic Local Alignment 
Search Tool (BLAST) analysis of all the sequenced isolates in our collection (~1200) 
identified one other mecC S. aureus isolate with the same region, strain 8572, with 
approximately 130 single nucleotide polymorphisms (SNPs) over 23 kb. Strain 8572 
belongs to CC350 and was isolated in the UK from a horse tracheal wash.   
Figure 2.1. Comparison of strain LGA251 (CC425) and strain C03 363 (CC130) genomes 
using ACT and showing the 23 kb region (orange) present in all CC130 genomes.  
The SCCmec Type XI element highlighted in green. 
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TBLASTX and FASTA (308) analysis against UniProt determined that the 23 kb locus 
contained coding regions with similarity to (43% aa identity) and gene order conserved 
with the Streptococcus equi 4047 (S. equi) equibactin locus. Equibactin is a non-
ribosomal peptide synthetase (NRPS) siderophore system contained within a integrative 
conjugative element (ICE) ICESe2 in the S. equi genome (296). We therefore named this 
locus in S. aureus: staphylobactin (stb). Note that the name staphylobactin had 
previously been used for staphyloferrin B before its identity was confirmed by mass 
spectrometry (202).  
A closer homologues region (54% aa identity) was also found to be present in the 
genome of Staphylococcus lugdunensis (S. lugdunensis) strain N920143 but this region 
is currently uncharacterised (Figure 2.2).  
Figure 2.2. TBLASTX comparison of the ‘equibactin’ region in Streptococcus equi, S. 
aureus and S. lugdunensis (Displayed using ACT).  
Red and blue lines between the elements represent protein similarity. The genes involved in 
equibactin biosynthesis are underlined in dark blue and those encoding the ABC transporters 
associated with the equibactin locus are underlined in light blue. 
  
S. lugdunensis 
N920143 
S. aureus  
(CC130) 
Streptococcus 
equi 
Equibactin biosynthesis ABC transporter  
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The stb gene cluster contains 14 coding sequences stbB-F, F1, G-M, O (Figure 2.3). 
Comparison of the stb gene cluster and the eqb gene cluster shows that the 
staphylobactin locus is lacking homologues of eqbA, which encodes a DtxR-like 
repressor, and eqbN, an α/β hydrolase (Table 2.1). However, the stb gene cluster 
contains two additional genes that are not present in the eqb cluster, stbF1 and stbO. 
BLASTp and FASTA analysis of these genes predict the function of stbF1 as a glyoxalase-
like domain protein, with its closest homologue found in S. lugdunensis VCU148 (62% 
identity). stbO is predicted to be a putative salicylate synthase and its closest homologue 
was found in Staphylococcus hyicus (71% identity). 
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Table 2.1. Comparison of the protein sequences contained within the staphylobactin 
cluster with the equibactin proteins.  
Their percentage amino acid identity and predicted functions using BLASTp. The organism 
showing identity and the length of amino acids for that protein.  
Protein 
Amino acid 
% identity 
Function Organism 
Length 
(a.a) 
StbB 54% 
Putative non-ribosomal peptide 
synthesis thioesterase 
Streptococcus equi 255 
StbC 35% 
Putative 4’-phosphopantetheinyl 
transferase superfamily protein 
Streptococcus equi 227 
StbD 54% Putative salicylate-AMP-ligase Streptococcus equi 535 
StbE 43% 
Equibactin nonribosomal peptide 
synthase protein 
Streptococcus equi 2005 
StbF 38% Thiazoline reductase Streptococcus equi 704 
StbF1 62% Glyoxalase-like domain protein 
Staphylococcus 
lugdunensis 
230 
StbG 44% 
Equibactin nonribosomal peptide 
synthase protein 
Streptococcus equi 874 
StbH 28% ABC transporter permease Streptococcus equi 192 
StbI 25% ABC transporter permease Streptococcus equi 225 
StbJ 39% ABC transporter ATP-binding protein Streptococcus equi 495 
StbK 55% ABC transporter ATP-binding protein Streptococcus equi 584 
StbL 56% ABC transporter ATP-binding protein Streptococcus equi 577 
StbM 32% Putative oxidoreductase Streptococcus equi 350 
StbO 71% Putative salicylate synthase 
Staphylococcus 
hyicus 
445 
 
 
The staphylobactin region is flanked by direct repeats (Figure 2.3). The left and right 
repeats show almost complete identity over 56bp, with just a single base pair difference. 
The direct repeats also have a 50 bp identity with a single base pair difference with the 
LGA251 chromosome (Figure 2.3). LGA251 is a mecC positive S. aureus strain that does 
not contain the staphylobactin locus. These direct repeats flanking staphylobactin are 
not identical to the region flanking equibactin.  
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Figure 2.3. The staphylobactin locus containing genes stbB-stbO bordered by direct 
repeats, DR-L and DR-R.  
Below shows the direct repeat left and right sequence homology and the direct repeat left 
matching the sequence from the strain LGA251.  
 
 
 
 
 
2.2 Bioinformatic analysis 
Illumina library preparation and Hi-Seq sequencing were carried out by the core 
sequencing and informatics team at the Wellcome Trust Sanger Institute. Maximum 
likelihood phylogenetic trees were constructed from a core genome alignment 
produced by Roary (309) using Randomised ‘Axelerated’ Maximum Likelihood MLST 
(RAxML) (310), and displayed and annotated using Interactive tree of life (iTOL) (311). 
BLAST and FASTA was used to find regions of similarity between biological sequences 
(312), and along with the UniProt Knowledgebase (UniProtKB) (313), was used to predict 
functions of proteins. Amino acid sequence alignment was carried out using SeaView 
applying the Clustal method (314). Identification of adenylation domains with their 
known substrates was carried out with: Non-Ribosomal Peptide Synthase Substrate 
Predictor (NRPSsp) (315), Latent Semantic Indexing (LSI) based A-domain function 
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predictor (316), PKS/NRPS Analysis (317). NRPSpredictor2 (318, 319), Genes encoding 
NRPS and modular PKS assembly lines, predictive sequence analysis tools (320-326) and 
Pfam (327). Comparison of genomes were displayed using ACT (295). Sequences were 
downloaded from the UniProt website. Staphylobactin gene sequences were extracted 
using Artemis (328) Genome browser and annotation. The sequences of A domains were 
retrieved from publicly accessible databases (NCBI, Swiss-Prot etc). 
 
2.3 Results 
2.3.1 Identification of staphylobactin locus in our strain collection 
Over the course of this project and during the initial identification of this region, many 
genomes have been sequenced by our group. These genomes are predominantly S. 
aureus but include other staphylococcal species. In order to investigate the prevalence 
in our current strain collection, I repeated this search for the genes in the staphylobactin 
locus, using 90% sequence similarity as the cut-off, in all our S. aureus isolates (2434 
genomes). 
In our entire strain collection there are a total of 226 sequence types, the largest number 
of strains belonging to ST130 (407 isolates), followed by ST22 (241 isolates), ST133 (232 
isolates), ST425 (200 isolates) and ST398 (122 isolates).  
The staphylobactin locus was found to be present in 582 genomes, of which 565 isolates 
belonged to clonal complex (CC) 130, 409 belonging to ST130 and 156 belonging to 40 
other different sequence types, including ST521 and ST1944. These isolates are all the 
CC130 that have been sequenced by my group and contained the whole gene cluster 
and were highly conserved within ST.  
The S. aureus CC130 isolates are interesting as they are from a diverse host species 
including: bovine, human, cat and deer, and from a broad geographical area: mainly the 
UK and Denmark, but also Germany, Norway and Spain. There are a number of isolates, 
inside and outside of the CC130 clade, containing the staphylobactin locus that do not 
contain the mecC gene. The mecC gene in the CC130 isolates was acquired once, and 
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has been lost in a small number of isolates, mainly from wild animals such as rat, squirrel 
and seal (E. M. Harrison, unpublished data).  
2.3.1.1 Staphylobactin in other sequence types 
The staphylobactin locus was found in other sequence types as follows: 
 ST177: the mecC positive S. aureus ST177 isolate (8572, 9061_8#79) came from 
a horse tracheal wash in the UK in 2005. This strain was the single locus variant 
of ST350 originally identified in the initial discovery of this locus in S. aureus. 
 ST2639: isolate ST2639 (DICM09/00289-9 HAS 12162_2#48) came from a nasal 
swab from an Iberian ibex, in 2009, Spain. 
 ST136: the ST136 isolate (178_B09 12448_6#83) came from a goat nasal swab in 
the Netherlands.  
 ST479: there are 14 isolates belonging to ST479 that contain the entire locus, 
these are all the ST479 isolates in our collection, they are all bovine isolates from 
the Netherlands provided by Ruth Zadoks. 
 ST425: there are 200 isolates belonging to ST425 in our collection, and a single 
ST425 isolate contains the entire staphylobactin locus (H091100226 7092_7#55). 
This was isolated from a human skin swab, in the UK during 2009.  
All the strains that contain the staphylobactin locus have it in its entirety.  
2.3.1.2 Identification of other genomic features 
Isolates were also investigated for the presence of the eqbA homologue, which encodes 
a DtxR-like repressor, but none of the strains contained this gene. The staphylobactin 
locus was found in either strains containing mecC or related MSSA strains, but no strains 
carrying the mecA gene. The presence of the staphyloferrin B biosynthesis cluster and 
transport was also searched for and found to be present in nearly all S. aureus strains 
except three ST that did not contain the sbnA-I genes and one ST that did not contain 
either sbnA-I and sirABC; however, none of these four STs contained the staphylobactin 
locus. This suggests that the presence of staphylobactin has not been acquired to 
compensate for the lack of the staphyloferrin siderophore. The direct repeats either side 
of the staphylobactin locus were searched for in all the strains and was found to be 
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present in all the CC130 isolates, along with the single ST425. ST479 was found to have 
one of the repeat regions missing. A maximum likelihood phylogenetic tree based on 
concatenated MLST allele sequences was constructed using RAxML illustrating the 
presence of this gene cluster within our sequenced S. aureus collection to show the 
population structure context of the five staphylobactin lineages (Figure 2.4)  
 
 
 
Figure 2.4: Maximum likelihood phylogenetic tree representing all the sequence types 
of S. aureus in our strain collection.  
An alignment of the core genome for all the sequence types of S. aureus in our strain collection 
was produced using Roary and MAFFT (309) using default settings. RaxML (310) was used to 
generate a maximum likelihood tree which was annotated using iTOL (311). The presence of 
methicillin resistance encoding genes mecA and mecC, staphyloferrin B biosynthesis and 
transport genes sbnA-I, sirABC, the equibactin DtxR-like repressor, eqbA and the individual genes 
of the staphylobactin locus stbB-O were searched for using 90% sequence identity in the whole 
of our strain collection. Sequence types in bold highlight the presence of the staphylobactin 
locus. Empty boxes show the absence of that gene in the genome. To the right of each sequence 
type, I give the number of strains containing the staphylobactin locus followed by the total 
number of strains belonging to that sequence type. 
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Although our strain collection predominantly comprises S. aureus isolates, we have 
sequenced a large number of other staphylococci, mainly coagulase negative isolates. 
These isolates (~200) were searched for the presence of all the staphylobactin genes, 
equibactin genes, and lugZ (predicted to encode an NADH dehydrogenase) using a 50% 
similarity threshold. This revealed 35 isolates of interest. The presence of the mecA and 
mecC genes was also determined, along with the staphyloferrin B biosynthesis and 
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transport cluster, sbnAI and sirABC. These strains were speciated using Kraken (329), 
however this proved unsuccessful for a large number of isolates, therefore 16s 
ribosomal RNA gene sequence analysis (16s) was carried out. All the strains searched 
contain lugZ, 70 strains contain mecA, and one S. xylosus isolate contains mecC. The 
remaining strains in this collection do not contain either gene and are therefore 
assumed to be methicillin susceptible. One S. schweitzeri isolate contains sbnA-I 
encoding staphyloferrin B biosynthesis and 40 strains contain the staphyloferrin B 
transporter, sirABC, including S. hyicus, S. schleiferi and S. agnetis. Four S. lugdunensis 
contain the entire homologous staphylobactin region, along with one S. hyicus strain 
that contains all staphylobactin genes (stbB-stbL) except stbM. There are many isolates 
with just one or two of the genes present in the following species: A S. agnetis and a S. 
auricularis strain contains stbH-L, predicted to encode an ABC transporter. Strains that 
contain individual staphylobactin genes include, six strains containing the stbH gene 
with 77% similarity from S. haemolyticus, stbI and stbJ (S. xylosus) and stbL (S. 
pettenkoferi) homologues. Isolates that contained two homologues include five strains 
containing stbH and stbJ with 52-56% similarity from S. saprophyticus, stbK and stbL (S. 
argentus and S. shweitzerei) and, stbI and stbJ (S. cohnii and S. gallinarum) homologues. 
The strains with two or more of the staphylobactin genes present are co-located in the 
genome. The non S. aureus isolates in our collection come from broad host species, 
including sheep, goat and cows, and from a large geographical area in Europe, including 
Turkey, Belgium and France.  
A maximum likelihood phylogenetic tree of the staphylococcal strains in our collection 
containing genes of the staphylobactin locus was constructed from a core genome 
alignment produced by Roary using RAxML and is shown in Figure 2.5. 
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Figure 2.5 Phylogenetic analysis of the staphylobactin biosynthetic cluster in non-S. 
aureus staphylococcal species in our strain collection. 
An alignment of the core genome for all the sequence types of S. aureus in our strain collection 
was produced using Roary and MAFFT (309) using default settings. RaxML (310) was used to 
generate a maximum likelihood tree which was annotated using iTOL (311). Searches were 
performed for the presence of methicillin resistance encoding genes mecA and mecC, all genes 
in the equibactin, staphylobactin and lugdunbactin (see section 2.3.2) loci plus the staphyloferrin 
B biosynthesis and transport genes sbnA-I and sirABC and the lugZ gene with 50% sequence 
identity.  The tree is based on core genome and lists the sequence ID of that isolate or 
staphylococcal species if known (strains were speciated using Kraken (329) and 16s analysis). 
Sequence types in bold highlight the presence of the staphylobactin or lugdunbactin genes. eqbA 
and stbO was not found to be present in any of the genomes searched. Empty boxes show the 
absence of that gene in the genome. 
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2.3.2 Further analysis of the homologous staphylobactin region in S. 
lugdunensis 
Our strain collection contains one sequenced S. lugdunensis isolate, H042360302, which 
was isolated from a human skin swab in England, in 2004. Two isolates that have been 
sequenced  are available in the public domain; N920143, a human breast isolate (330) 
(NCBI reference sequence NC_017353.1) and HKU-09 (331) (NCBI Reference 
Sequence: NC_013893.1). These strains are probably the most well studied sequenced 
S. lugdunensis strains (332-334). Other S. lugdunensis genomes currently available in the 
public domain are; VCU150, VCU148, M23590 and ACS-027-V-Sch2. 
BLASTn of the whole staphylobactin region from S. aureus strain 71277 (CC130, mecC) 
against the S. lugdunensis genome N920143 showed that it had 71% sequence identity, 
whereas BLASTn of the equibactin region from S. equi had 72% sequence identity. All of 
the S. lugdunensis genomes available including the one from our strain collection were 
searched for the presence of all the equibactin genes, including eqbA, the staphylobactin 
genes along with the staphyloferrin B biosynthesis and transport genes (sbnA-I and 
sirABC). These S. lugdunensis strains contained the whole staphylobactin gene cluster, 
in the same order, except for the presence of stbO, and had sequence identity ranging 
from 37% for stbM to 76% for stbL (Table 2.2). The homologous staphylobactin locus in 
S. lugdunensis was termed lugdunbactin and the genes labelled lugB-lugZ.  
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Table 2.2. Comparison of the protein sequences contained within the lugdunbactin 
cluster with the staphylobactin proteins.  
Their percentage amino acid identity and predicted functions using BLASTp. The organism 
showing identity and the length of amino acids for that protein. 
 
 
 
 
Protein 
Amino acid 
% identity 
Function Organism 
Length 
(a.a) 
LugB 62% Thioesterase  S. aureus  250 
LugC 41% 4’-phosphopantetheinyl transferase S. aureus 232 
LugD 63% 2,3-dihydroxybenzoate-AMP ligase S. aureus 527 
LugE 54% non-ribosomal peptide synthetase S. aureus 2007 
LugF 52% Polyketide synthase S. aureus 702 
LugF1 57% Hypothetical protein S. aureus 230 
LugG 53% Polyketide synthase S. aureus 920 
LugH 75% Membrane protein S. aureus  192 
LugI 68% 
Energy-coupling factor transporter 
transmembrane protein EcfT 
S. aureus 243 
LugJ 58% ABC transporter S. aureus 486 
LugK 74% ABC transporter ATP-binding protein S. aureus 583 
LugL 76% ABC transporter ATP-binding protein S. aureus 577 
LugM 37% Saccharopine dehydrogenase S. aureus 345 
LugZ 89% NADH dehydrogenase 
S. haemolyticus/ 
S. aureus 
402 
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Comparison of lugB shows that it is well conserved both at the nucleotide and protein 
level, 62% aa identity with StbB and 57% aa identity with EqbB, and is predicted to 
encode a thioesterase. lugC is predicted to encode a 4’phosphopantetheinyl 
transferase. BLASTn with stbC and eqbC show this gene is less well conserved, 67% 
nucelotide identity and only 39% coverage with stbC and BLASTp 41% aa identity, 99% 
coverage. lugC was found to be highly divergent from the staphylobactin and equibactin 
homologues, and so was not originally identified when searching the genome, however, 
I was able to identify the genes by looking for the ORF in this region and searching with 
a 50% identity limit. Using this search method, lugE-L were identified. lugD is predicted 
to encode a 527 amino acid 2,3-dihydroxybenzoate-AMP ligase; BLASTn with stbD shows 
71% nucleotide identity and BLASTp with StbD 63% aa identity. The largest gene in the 
locus, lugE (6021bp) has 66% identity at a nucleotide level with stbE, and 54% amino 
acid identity (43% with EqbE) and is predicted to encode a non-ribosomal peptide 
synthetase. lugF (68%), lugF1 (73%) and lugG (69%) have varying nucleotide identity and 
are predicted to encode polyketide synthase proteins. Like stbH-L, lugH-L are predicted 
to encode an ABC transporter with similarity ranging from 67-76%. lugM is not highly 
conserved with either stbM or eqbM, sharing only 37% amino acid identity. The next 
ORF after lugM is a completely different gene to stbO, which encodes a 402 amino acid 
protein predicted to be a NADH dehydrogenase, which I termed lugZ. This gene is not 
exactly in the same location in the genome as stbO, but was included in the searches 
with other staphylococcal species and was found to be a highly conserved gene that is 
present in all staphylococcal species investigated. Despite the low percentage identity 
between some genes in this cluster, they are all predicted to produce a protein with the 
same function as the homologous gene in staphylobactin and equibactin (Table 2.1 and 
Table 2.2) Searching this region I could not find direct repeats identified in S. aureus, 
either side of this locus in either S. lugdunensis or S. equi. sirABC, but not sbnA-I were 
identified in S. lugdunensis, as previously reported (334) and shared 77% sequence 
identity. 
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2.3.3 Functions of the staphylobactin gene cluster as predicted by 
sequence analysis. 
BLASTp was used to find sequence similarity and predict functions of the staphylobactin 
gene cluster by comparing the amino acid sequence of the individual genes in the 
staphylobactin cluster to sequence databases (Table 2.3). Amino acid sequences for 
each staphylobactin gene was taken from the genome of mecC CC130 strain 71277 
isolated from human blood in Denmark, and were used for the predicted function 
sequence analysis. 
 
 
Table 2.3. BLASTp and FASTA analysis of the amino acid sequence of the individual 
genes of the staphylobactin cluster  
S. aureus  
Amino 
acid % 
identity  
Function Organism 
 
 
 
StbB 
100 
 
68 
63 
 
55 
 
54 
54 
Iron acquisition yersiniabactin 
synthesis enzyme (thioesterase) 
Thioesterase 
Thioesterase 
 
Thioesterase 
 
Thioesterase 
Putative non-ribosomal peptide 
synthesis thioesterase type II 
Staphylococcus aureus 
O11 
Staphylococcus hyicus 
Staphylococcus 
lugdunensis 
Anaerococcus 
lactolyticus 
Peptoniphilus harei 
Streptococcus equi 
 
 
 
StbC 
100 
 
50 
41 
 
38 
 
41 
4'-phosphopantetheinyl 
transferase 
Hypothetical protein 
4'-phosphopantetheinyl 
transferase 
4'-phosphopantetheinyl 
transferase 
Hypothetical protein 
Staphylococcus aureus 
O11/O46 
Staphylococcus hyicus 
Staphylococcus 
lugdunensis 
Streptococcus 
anginosus 
Clostridium difficile 
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StbD 
100 
 
70 
64 
 
58 
57 
2,3-dihydroxybenzoate-AMP ligase 
 
2,3-dihydroxybenzoate-AMP ligase 
2,3-dihydroxybenzoate-AMP ligase 
 
2,3-dihydroxybenzoate-AMP ligase 
2,3-dihydroxybenzoate-AMP ligase 
Staphylococcus aureus 
O11/O46 
Staphylococcus hyicus 
Staphylococcus 
lugdunensis 
Clostridiodes difficile 
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The stbB gene is predicted to encode a type II thioesterase similar to the thioesterase, 
YbtT, from the yersiniabactin synthesis cluster. StbB shared 68% and 63% amino acid 
identity with other staphylococcal species (hyicus and lugdunensis) and 55% aa identity 
with a predicted thioesterase in Anaerococcus lactolyticus. StbC is predicted to function 
as a 4'-phosphopantetheinyl transferase, the same as EqbC in S. equi. Similar to EqbC, 
StbC is lacking sequence homology to the 4'-phosphopantetheinyl transferase, YbtD, of 
the yersiniabactin locus (24% identity, 38% coverage). StbC shows 50% and 41% aa 
identity with S. hyicus and S. lugdunensis, and 38% aa identity with Streptococcus 
anginosus. StbD shares 70% aa identity with S. hyicus and 64% aa identity with S. 
lugdunensis and is predicted to encode a 2,3-dihydroxybenzoate (DHB) AMP ligase. StbD 
shares sequence identity (39% identity, 94% coverage) with the characterised YbtE 
salicylate-AMP ligase from Y. pestis (335) and 38% sequence identity and 95% coverage 
with DHB AMP ligase, DhbE from B. subtilis (336). StbE, encoded by the largest gene in 
the staphylobactin cluster (6018bp), is predicted to encode a non-ribosomal peptide 
synthetase (NRPS) with 61% and 54% aa sequence identity with S. hyicus and S. 
lugdunensis, and 45% with Anaerococcus lactolyticus. StbF and StbG show 62% and 61% 
aa identity with polyketide synthase. stbF1 shows identity with other staphylococcal 
species, as well as Lysinibacillus macroides and Streptomyces spp. The sequence encodes 
a small protein made of 230 aa but currently has no predicted function using BLASTp. 
StbH, StbI, StbJ, StbK and StbL are predicted to be involved in transport. All five proteins 
show high sequence identity with S. aureus O11/O46, S. hyicus and S. lugdunensis 
species. StbH is predicted to encode a membrane protein, the same predicted function 
as EqbH, with sequence identity to Clostridium beijerinckii. StbI is predicted to encode a 
protein of energizing module of ECF transporter or a cobalt uptake/transporter protein. 
StbJ shows 69% aa identity with ABC transporters. StbK shared 80% aa identity with a 
multidrug ABC transporter permease from five different staphylococcal species; S.  
aureus, S. hyicus, S. agnetis, S. lugdunensis and S. pettenkoferi. StbL shared aa identity 
with the same staphylococcal species with 100 - 67% aa identity and is predicted to 
encode multidrug ABC transporter ATP-binding protein. StbM is predicted to encode an 
oxidoreductase, sharing 32% and 31% aa identity with EqbM of the equibactin gene 
cluster from Streptococcus equi and an oxidoreductase in Anaerococcus lactolyticus, 
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respectively. The staphylobactin gene cluster is missing EqbN, predicted to encode an 
α/β hydrolase, but encodes an extra gene, stbO. StbO is predicted to encode a salicylate 
synthase.  
2.3.3.1 Identification of the staphylobactin locus in publicly available bacterial genome 
databases 
S. aureus from many different lineages along with other bacterial genomes have been 
sequenced and are available in the public domain. BLASTp analysis of the whole 
staphylobactin region was carried out and found to be highly conserved in the S. aureus 
strains O11 and O46 (337). These two ovine strains induce severe (O11) and mild (O46) 
mastitis (338). Sequence analysis of the genomes showed that the two strains are closely 
related and cluster with isolates from the bovine CC130 lineage (339). The amino acid 
sequence of the staphylobactin locus shared the highest percentage sequence identity 
with coagulase-negative staphylococci (CoNS), S. hyicus (61% aa identity), S. lugdunensis 
(54% aa identity) and S. sciuri. The staphylobactin locus shared 45% aa identity with 
Anaerococcus lactolyticus and 43% aa identity with the equibactin region of S. equi. 
BLASTn of the whole staphylobactin region from strain 71277 was carried out. S. hyicus 
strain ATCC 11249, had the highest sequence identity of 77% but only 46% coverage. All 
the other top hits were S. aureus strains with 78% identity but only 14% coverage. After 
taking a closer look at this region, two genes adjacent on the chromosome outside the 
staphylobactin locus had showed sequence homology with stbL and stbK. 
2.3.4 Analysis of protein sequences of StbE and StbG, which are predicted 
to be a non-ribosomal peptide synthetase 
BLASTp analysis of the staphylobactin locus predicts that StbE and StbG encode a NRPS. 
The number of NRPS modules and their domain organisation within the enzymes 
determine the structure of the final peptide product. Using analyses of the NRPS genes, 
these conserved features within the NRPS machinery allow prediction of the type, and 
sometimes the structure, of the synthesized polypeptide. It is therefore possible to 
investigate the biosynthetic potential of a given bacterium by analysis of the 
architecture of its NRPS gene clusters. A basic module of nonribosomal peptides and 
polyketides (PK) contains an initiation module consisting of adenylation (A) responsible 
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for amino acid activation, and peptidyl carrier protein (PCP) domains for 
thioesterification of the activated amino acid. This is followed by an elongation module 
consisting of a condensation (C) domain, which performs transpeptidation between the 
upstream and downstream peptidyl and amino acyl thioesters to elongate the growing 
peptide chain.  Finally there is a chain-terminating thioesterase (TE) domain that is 
responsible for detachment of the mature polypeptide (181, 340, 341).  
While carrying out BLASTp analysis on StbE, putative conserved domains were identified 
and classified as a NRPS, condensation and phosphopantetheine (PP)-binding domains. 
Using PKS/NRPS and Pfam analysis, StbE is predicted to be a protein of 2005 amino acids, 
containing one adenylation domain within a total of seven domains. The eight residues 
lining the A-domain binding pocket are DLYNFSLI. Further analysis using NRPSsp and LSI 
based A-domain function indicated that the StbE A-domain starts at position 572 and 
ends at position 971 in the protein, and its predicted substrate is cysteine. Sequences 
yielding significant alignments for the A-domain prediction included myxothiazol 
synthetase, epothilone synthetase, bacitracin synthetase, pyochelin synthetase (a 
siderophore produced by P. aeruginosa) and syringomycin synthetase. The seven 
domains are predicted to be phosphopantheine (PP), Cyclization (Cy), A, unknown, PP, 
Cy, PP (Figure 2.6). There may be one extra domain between the A and T domains at 
position 902 and 1381.  
 
Figure 2.6. Organisation of modules and domains of StbE.  
StbE is comprised of three phosphopantetheine (PP) attachment sites (Green), two 
condensation (C) domains (Red) and a AMP-binding enzyme (Blue). 
 
 
 
 
In the equibactin locus, EqbE is predicted to comprise of four carrier domains, three 
cyclization domains, an epimerisation domain, a single adenylation domain, a 
methyltransferase domain and a type I thioesterase domain.  
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StbG is 922 amino acids in length and is also predicted to have a Cy domain and a 
thioesterase domain (Figure 2.7). Using the NRPSpredictor2, the StbG A-domain is 
located between 702-847, with its binding pocket signature being DLYNFSLIWK and 
predicted substrate also being cysteine. This analysis shows similar domain order and 
structure to that found in equibactin NRPS.  
 
Figure 2.7. Organisation of modules and domains in StbG. 
StbG protein is comprised of a condensation domain (Green) and a thioesterase domain (Red).  
 
 
 
2.3.5 Prediction of substrate specificity and conservation of the substrate 
binding pockets of A-domains in StbD and StbE 
At the core of each module is an adenylation domain that recognises and activates the 
substrate by reaction with ATP. Critical residues in all known NRPS A-domains have been 
identified that align with eight binding-pocket residues in the gramicidin S synthetase 
(GrsA) A-domain, from Bacillus brevis, and define sets of highly conserved recognition 
templates. Prediction of the substrate specificity of A-domains of unknown function can 
therefore be predicted by analysing a set of 8–10 critical residues in the binding-pocket 
of the A domain (321, 342). In the equibactin and yersiniabactin biosynthetic clusters, 
the single A-domain in HMWP2/EqbE is probably responsible for the aminoacylation of 
all three different PCP domains (two in HMWP2/EqbE and one in HMWP1/EqbG) (296, 
343). The sequences of 20 A-domains were retrieved from publicly accessible databases 
and aligned using the program SeaView (314) (Figure 2.8) and an update of the table 
from the Heather et al. (296) paper describing equibactin, including the staphylobactin 
proteins, StbD and StbE, for comparison (Table 2.4). Based on the structural data of DhbE 
and GrsA, residues conferring substrate specificity were identified (321, 336). 
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StbD 
StbD shares 39% aa identity to the YbtE salicylate-AMP ligase (335), 38% sequence 
identity with 2,3-dihydroxybenzoate (DHB) AMP ligase, DhbE from B. subtilis (336), and 
51% aa identity with the uncharacterised CKL_1504 of C. kluyveri (301).  38% aa identity 
with the pyochelin biosynthesis protein, PchD of P. aeruginosa, 36% aa identity with the 
enterobactin synthase component E, EntE from E. coli and 63% aa identity with LugD of 
S. lugdunensis. Based on the alignment of staphylobactin D (StbD) against these other 
A-domain containing proteins, StbD is predicted to activate salicylate as it shares the 
conserved cysteine (C) at residue 239, present in other NRPS systems that utilises 
salicylate. The conserved alanine (A) is also present at position 278 in StbD, which is 
changed to glycine in EqbD. At positions 322,330 and seen in EqbD, both residues are 
isoleucine (I) (Figure 2.8A and Table 2.4). These residues are conserved in StbD. 
StbE 
By comparison to the GrsA APhe prototype, StbE is predicted to mediate cysteine 
recognition, as it shares the critical residues lining the substrate-binding pocket of the 
A-domain with other A-domains that utilise cysteine, including the yersiniabactin 
synthetase; Irp2, bacitracin synthetase BacA, anguibactin synthetase AngR and 
pyochelin synthetases, PchE and PchF (321, 342, 343). Unlike EqbE, StbE has the 
conserved asparagine (N) at position 278, which is changed to aspartate in EqbE and 
LugE. The universally conserved Asn278 is presumably involved in substrate selection 
through interaction with the cysteine thiol. Other than a single change to phenylalanine 
from either leucine or methionine at position 299, StbE is conserved in all other residues 
in respect to other critical residues lining the A-domain binding pocket (Figure 2.8B and 
Table 2.4). 
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Figure 2.8: Alignment of staphylobactin homologues: (A) StbD in comparison to EqbD, 
DhbE, PchD, YbtE, EntE and LugD. (B) StbE in comparison to EqbE, AngR, PchE, BlmIV 
and LugE.   
The predicted amino acid sequences of the StbD and StbE A-domains were aligned, using clustal 
method in SeaView, to A-domains or aryl-AMP ligase homologues with > 30% sequence identity 
to StbD or StbE (321). The key amino acids residues lining the substrate binding pockets of A-
domains conferring substrate specificity are indicated with arrows and correspond to the same 
numbered residues in Table 2.4 (321, 336). StbD and StbE of S. aureus, EqbD and EqbE of S. equi, 
LugD and LugE of S. lugdunensis, DhbE of B. subtilis, PchD and PchE of P. aeruginosa, YbtE of 
Yersinia spp., BlmIV from Streptomyces verticillus and EntE from E. coli. 
 
A 
 
B 
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Table 2.4: Prediction of StbD and StbE A-domain substrate specificity 
a. Protein name: Irp2 (HMWP2), yersiniabactin NRPS, Y. pestis (343); BacA, bacitracin NRPS, 
Bacillus licheniformis (344); AngR, anguibactin NRPS, Vibrio anguillarum (345); PchE and PchF, 
pyochelin NRPSs, Pseudomonas aeruginosa (346); CtaC, cystothiazole A NRPS, Cystobacter 
fuscus (347); MtaC, myxothiazol NRPS, Stigmatella aurantiaca (348); BlmIV, bleomycin NRPS, 
Streptomyces verticillus (349); DhbE, bacillibactin DHB-AMP ligase, Bacillus subtilis (336); EntE, 
enterobactin synthetase, Escherichia coli (350); MxcE, myxochelin DHB-AMP ligase, S. 
aurantiaca (351); VibE, vibriobactin DHB-AMP ligase, Vibrio cholerae (352); AngE, anguibactin 
DHB-AMP ligase, V. anguillarum (353); YbtE, yersiniabactin salicyl-AMP ligase, Y. pestis (343); 
PchD, pyochelin salicyl-AMP ligase, P. aeruginosa (346); SnbA, pristinamycin I 3-hydroxy-
picolinic acid-AMP ligase, Streptomyces pristinaespiralis (354). LugE and LugD, Staphylococcus 
lugdunensis (331). Substrate: Activated amino acid by adenylation domain. 
b. Amino acids at positions 239, 330 discriminate salicylate (Sal) from 2,3 –dihydroxy benzoic 
acid (DHB) (336). S. equi residues defined in bold differ from the consensus code of characterised 
substrate-activating proteins. 
Accession number for the protein sequence from UniProtKB. EqbE predicted substrate is 
cysteine, however there is a change from asparagine to aspartate at residue 278. The critical 
residues lining the A-domain of StbE and StbD are highlighted in yellow. 
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A-
domaina Substrate 
Residue (according to APhe numbering) Accession 
number 235 236 239b 278 299 301 322 330b 
Irp2  Cys D L Y N M S M I Q9Z399 
BacA  Cys D L Y N L S L I O68006 
AngR Cys D L Y N M S M I P19828 
PchE  Cys D L F N L S L I Q9RFM8 
PchF Cys D L Y N L S L I Q9RFM7 
CtaC    Cys D L Y N M S L V Q5MD35 
MtaC Cys D L Y N M S L I Q9RFK9 
BlmIV Cys D L Y N L S L I Q9FB18 
LugE Cys D L Y D L S M I RS09450 
EqbE Cys? D L Y D M S M I C0M6N2 
StbE Cys D L Y N F * S L I  
DhbE    DHB N Y S A Q G V V P40871 
EntE   DHB N Y S A Q G V V P10378 
MxcE DHB N F S A Q G V V Q9F638 
VibE DHB N F S A Q G V V O07899 
AngE DHB N F S A Q G V V Q5DK17 
YbtE Sal N F C A Q G V L Q56950 
PchD Sal N F C A Q G V I Q9RFM9 
LugD Sal N F C A Q G V I EFU84524 
EqbD Sal? N F C G Q G I I C0M6N3 
StbD Sal N F C A Q G I I  
SnbA 
 
3-Hydroxy-
picolinic acid 
N F C S Q G V L P95819 
 * Phenylalanine present at position 299 in cyclosporin synthetase (CssA) in (321) 
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2.3.6 Proposed mechanism of staphylobactin biosynthesis 
Greg Challis and Lijiang Song from the University of Warwick attempted to identify the 
metabolic product of the equibactin biosynthetic gene cluster in S. equi, but without 
success (296). Although the biological data indicated that the genetic locus predicted to 
produce equibactin appears to be involved in iron uptake, they were not able to show 
evidence of the action of a specific iron-chelating siderophore molecule. They attributed 
this to the fact that a key catalytic serine residue within the thioesterase domain of EqbG 
is mutated to alanine in S. equi, strongly suggesting the NRPS assemble line is impaired 
or even non-functional. So I addressed the question of whether the TE domain in the 
MRSA ortholog of EqbG carries the same serine to alanine mutation.  
The biosynthesis of NRPs shares characteristics with the polyketide and fatty 
acid biosynthesis. Biosynthesis of a NRPs starts by the activation of the first amino acid 
with ATP by the A-domain and loaded onto the serine-attached 4'-phospho-
pantethine (4'PP) sidechain of the PCP-domain, catalysed by the PCP-domain. The 
elongation is followed by the C domain catalysing the amide bond formation between 
the thioester group of the growing peptide chain from the previous module with the 
amino group of the current module. The extended peptide is then attached to the 
current PCP-domain. This cycle is repeated for each elongation module. Finally 
termination occurs by the release of the polypeptide chain from the PCP-domain 
through the activity of a terminal thioesterase (type I) (355), forming cyclic amides or 
cyclic esters. The final peptide is often modified by glycosylation, acylation, etc. The 
enzymes responsible are usually associated with the synthetase complex and their genes 
are organised in an operon or gene cluster. 
In equibactin, the C-terminal domain of EqbG has similarity with type I thioesterases. 
However, sequence alignment of this domain to thioesterases in Pfam showed a serine 
to alanine mutation in the critical serine residue (GXSXG motif) of the predicted serine, 
histidine, aspartate catalytic triad essential for function (302, 356). Sequence alignment 
of the StbG, EqbG and LugG amino acid sequences was performed to see if StbG 
contained the same serine to alanine mutation as in EqbG which showed that StbG 
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possessed the critical serine residue (Figure 2.9). This suggests that the NRPS assembly 
line or staphylobactin is not impaired and should be functional. 
 
Figure 2.9. Amino acid sequence alignment of StbG, EqbG and LugG.  
The GXSXG motif circled with red circle. Black arrow points to serine (green) to alanine (blue) 
mutation in EqbG of the serine, histidine, aspartate catalytic triad. The predicted amino acid 
sequences of StbG, EqbG and LugG were aligned using clustal method in SeaView. 
 
 
2.3.7 Other iron acquisition genes 
S. aureus possesses several key iron acquisition loci that are well-characterised. It 
expresses an effective haem and haemoglobin acquisition system (Isd system),  
produces two carboxylate-type siderophores, staphyloferrin A and staphyloferrin B, and 
expresses transporters for many other siderophores that it itself does not synthesize 
(229, 357). The staphyloferrin A locus is conserved across all sequenced staphylococcal 
genomes, as is the htsABC operon encoding its ABC transport. The staphyloferrin B locus 
(sirABC and sbnA-I) was shown to be conserved in all the S. aureus isolates in our 
sequenced strain collection, regardless of the isolate having the staphylobactin locus 
(Figure 2.4). This suggests that the staphylobactin locus is not present to compensate 
for lack of other siderophores expressed by S. aureus, but may compliment their activity 
or be more beneficial in different niches or during the infection process. In contrast to 
S. aureus, S. lugdunensis makes neither staphyloferrin A nor staphyloferrin B, due to the 
absence of the SB gene cluster, and a large deletion in the SA biosynthetic gene cluster. 
This was confirmed when the staphyloferrin B biosynthesis and transport was included 
in the search of the CoNS in our strain collection. S. lugdunensis and S. hyicus which are 
the only two species to contain the staphylobactin locus in its entirety, were found to 
contain the homologous staphyloferrin B transport locus (sirABC) but not its biosynthetic 
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gene cluster (Figure 2.5). Other CoNS that did not contain the staphylobactin locus but 
did contain a homologous SB transport locus included S. lentus, S. agnetis and S. 
schleiferi. The only isolate shown to contain both the homologous sirABC and sbnA-I was 
S. schweitzeri. While carrying out sequence analysis of strains containing the 
staphylobactin locus, other key iron acquisition loci were found to be present, including 
the Isd and Fhu locus. 
2.3.8 Genome mining 
To identify secondary metabolite gene clusters, genome mining was carried out. 
Additional biosynthetic gene clusters found in the S. aureus CC130 genomes may 
contribute to its success and its ability to adapt to multiple species. Microorganisms 
produce a wealth of structurally diverse specialised metabolites with a remarkable range 
of biological activities. Previously, genome-mining approaches have been used to 
predict NRPs that are highly conserved within S. aureus (204). A widely used 
computational tool for biosynthesis gene cluster (BGC) identification 
is antiSMASH (antibiotics and secondary metabolite analysis shell) (358-362), allowing 
direct analysis of protein sequences and detection of additional classes of specialised 
metabolite BGCs (360). Scanning sequenced genomes using antiSMASH from our strain 
collection (C03 365, LGA251, 71277 and KO), S. lugdunensis strains (N920143 and HKU-
09), S. aureus strains in the public domain (MRSA 252, Newman and USA300) and S. equi 
4047 led to identification of BGCs. All the S. aureus genomes searched, staphyloferrin A 
and staphyloferrin B were identified, and as expected not present in S. lugdunensis or S. 
equi.  
2.3.8.1 Bacteriocins and microcins 
Bacteriocins, which are antimicrobial peptides or proteins produced by bacteria that can 
enhance environmental adaption, were identified in all the S. aureus isolates from our 
collection (C03 365, LGA251, 71277 and KO), along with two in MRSA 252 and five in S. 
equi. Using BAGEL3 (BActeriocin GEnome mining tooL), a bacteriocin search software, 
analysis of the 71277 genome identified two putative bacteriocins or modified peptides. 
Terpene was identified in every staphylococci genome searched, along with lantipeptide 
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in LGA251, Newman and USA300. A single microcin was identified in S. aureus strains 
71277 and KO, five were identified in S. lugdunensis strain N920143. Microcins are very 
small bacteriocins, for example microcins produced by commensal E. coli strains help 
outcompete pathogenic strains (363).  
2.3.8.2 NRPS 
A NRPS was identified in isolates C03 365, 71277, KO, MRSA252, Newman, USA300 and 
two in N920143. On closer inspection of the NRPS identified in the genome of 71277, 
the NRPS was identified as the Aureusimine BGC. These are not antibiotics, but function 
as regulators of virulence factor expression (204). antiSMASH analysis also led to the 
identification of an as yet undescribed NRPS gene cluster. This cluster contains 14 genes 
transcribed in the same direction in S. aureus isolates C03 365, 71277 and KO and 
orthologs are present in S. lugdunensis and S. equi, but is absent in other S. aureus 
isolates, MRSA252, USA300, Newman and LGA251. After taking a closer look, this was 
found to be the staphylobactin gene cluster. Gene neighbourhood alignments of this 
NRPS cluster were gathered using the Integrated Microbial Genomes-Joint Genome 
Institute (IMG-JGI) database (364) and the Gene Ortholog Neighbourhood Finder 
program (365). This identified this NRPS gene cluster in S. aureus strains O11 and O46 
and S. lugdunensis strains UCIM6116, VCU139, VCU150, N920143, ACS-027-V-Sch2, 
VCU148, M23590 and HKU-09. 
 
2.3.9 Regulation of the staphylobactin operon 
Upstream of the eqb operon is a metal ion-dependent repressor, EqbA. Heather et al. 
(296) described the equibactin locus reporting that the eqbA gene showed 42% and 40% 
amino acid sequence identity with two putative repressors in S. agalactiae and 
Clostridium kluyveri  (301, 366). It was also shown to be homologous to MntR, a 
manganese-dependent repressor, in Bacillus subtilis, and DtxR, an iron-dependent 
repressor in Corynebacterium diphtheriae (168, 367). An updated BLASTp of EqbA 
shows: 
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 52% identity to a transcriptional regulator belonging to the MarR family in 
Anaerococcus prevotti. 
 48% identity to the iron-dependent repressor in Streptococcus anginosus. 
 48% identity to a transcriptional regulator in Clostridium novyi. 
 50% identity to an iron-dependent repressor in Tissierellia bacterium.  
This provides further supporting evidence that EqbA acts as an iron-dependent 
repressor of the equibactin operon.  
Sequence alignment of the equibactin locus and the staphylobactin locus shows that S. 
aureus is missing the homologous eqbA gene. To identify a potential regulator of the 
staphylobactin locus, tBLASTn of the EqbA sequence against a S. aureus strain C03 365 
(CC130) was carried out and identified the protein with the highest identity (21/71 (30%) 
is MntR (SARLGA251_05680); a DtxR-like protein. MntR regulates the expression of the 
mntABC and mntH genes, which encode putative manganese transporters in S. aureus 
(290). Analysis of the region immediately upstream of stbB in strain C03 365 identified 
a 57 bp sequence 27 bp upstream of the stbB start codon that shares 29/57 (50.8%) 
nucleotide identities with the MntR box upstream of mntABC in S. aureus. MntR 
represses expression of the mntABC operon by binding to the MntR box upstream of 
mntABC, which contains a somewhat conserved DtxR box (Figure 2.10A) (368). The 49 
bp inverted repeat region upstream of stbB overlaps the 36bp imperfect palindrome 
that is -73 bp to -38 bp upstream of eqbB (Figure 2.10B). It was previously shown using 
an electrophoretic mobility shift assay that the DNA palindrome is essential for EqbA 
binding to the eqbB promoter region (296). 
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Figure 2.10. Putative DtxR-like regulator of staphylobactin 
(A) Nucleotide alignment of the six DtxR binding sites of staphylococcal species. Unique SNPs 
are highlighted in green. SNPs present in more than one other alignment are highlighted in blue. 
The 19bp DtxR consensus sequence is indicated below the alignment (368).  
(B) An alignement of S. epidermidis SirR box (top) (369) with the S. aureus 5’-stbB sequence 
(bottom). The 49 bp conserved imperfect repeat and the putative ribosomal binding start and 
ATG translation start codon of stbB are shown. Conserved bases between the two alignements 
are highlighted in bold. 
 
A 
S. epidermidis         TATTATAAAATAAATTAGGTTAACCTAAACTTTTTATTA-GGAGGTTTTAATATTTG 
S. aureus                 TATTATACAATTAATTAGGTTAGCCTAAACTTTTAATTA-GGAGGTATAAACGTTTG 
S. warneri               TATTATAAAATAAATTAGGTTAACCTAAACTTTTAATTA-GGAGGTATTAATATTTG 
S. lugdunensis        TATCATGAAATAAATTAGGTTAACCTAAACTTTTTATTA-GGGGGTGTAAACATTT 
S. saprophyticus    TATTATAAATTAAATTAGGTTAGCCTAAAAATATTATTAAGGAGGTTTAAAATGTTA 
S. aureus 5’stbB    AATATTATCAAAAAATATTTAATCATACACCTATTGATA-ACCGTTATCAATAGGTG 
DtxR consensus          TTAGGTTAGCCTAACCTAA 
      DtxR box 
B 
             5’-TATTATAAAATAAATTAGGTTAACCTAAACTTTTTATTAGGAGGTTTTAATATTTG -3’                   
5’-GACACAATATTATCAAAAAATATTTAATCATACACCTATTGATAACCGTTATCAATAGGTGTATGATTAAAATGTAAGTTTTTATAAATG-3’                        
                                          49 bp imperfect repeat      RBS                      
                  Met 
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2.4 Discussion 
2.4.1 Prevalence 
Whole genome sequencing of our strain collection to investigate evolution and 
epidemiology of a novel zoonotic strain of MRSA was performed. From sequence 
analysis we noted most isolates from a specific MRSA lineage, CC130, have a region 
homologous to the equibactin synthesis loci in S. equi. This 23 kb region consisting of 14 
genes, all in the same orientation, organisation and similar to that of the equibactin 
locus, was termed staphylobactin. The genes of this cluster show 54% aa identity and 
64% nucleotide identity (43% coverage) with the equibactin locus and exhibit the 
potential to produce a siderophore. Three of the predicted polypeptides, StbE, StbF and 
StbG, share sequence similarity with predicted NRP and polyketide synthetases in other 
bacteria. The region encodes components of an ABC transporter, which has been 
proposed to transport the iron bound siderophore into the cell. The predicted StbH, StbI 
and StbJ proteins share similarity with membrane transporter proteins. The 
staphylobactin locus resides on the genome 3.9 kb downstream of the mecC gene and 
the sequences flanking the staphylobactin cluster were homologous with the S. aureus 
LGA251 genome, suggesting that the cluster was inserted into a conserved genomic 
region. These flanking regions were found in other S. aureus isolates, suggesting that 
gene sharing might have occurred via homologous recombination. Mobile genetic 
elements and plasmids can transfer important genetic elements, with the potential to 
facilitate adaption not only within one species but also between two closely related 
species, which has possibly happened with S. aureus and the other CNS containing the 
staphylobactin locus (370).  
2.4.1.1 Identification of staphylobactin locus in our strain collection 
There are a broad number of sequence types in our strain collection. However it should 
be noted that there is a sampling bias towards CC130 and CC425 mecC isolates 
associated with bovine hosts from a broad geographical area across Europe. When 
presenting the results for the prevalence of the staphylobactin locus in our strain 
collection, the number of strains belonging to each sequence type is given. For example, 
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all 408 strains in our collection belonging to ST130 contained the stb locus, but only one 
out of 200 strains belonging to ST425 contained this region. The phylogenetic tree gives 
an overall population structure of our strain collection, showing the prevalence of the 
stb locus. The staphylobactin locus is present in all S. aureus CC130 isolates from a 
diverse host species including bovine, human, cat and deer. With many of the strains 
isolated from mastitis and milk that are particularly low iron environments and nearly 
all isolates containing the staphylobactin locus coming from animals, this suggests an 
important role for staphylobactin in adaption of S. aureus to animal hosts. The region 
was also found sporadically in other isolates. In ST425, there are 200 strains in our 
collection with only one isolate containing the staphylobactin region, suggesting this was 
recently acquired. In all the S. aureus containing stb, there appears to be a direct repeat 
either end of the locus, allowing for the region to be gained or lost. S. lugdunensis was 
shown to contain the closest homologue to the staphylobactin region. In S. lugdunensis, 
there are no direct repeats found either side of the locus, suggesting that the 
lugdunbactin region is probably not mobile. In evolutionary terms, this gene complex 
probably started out in a non-S. aureus strain. Through random interactions with phages 
or plasmids, eventually this region got put into an ICE (self-transmissible mobile genetic 
element with predicted or demonstrated integrative and conjugative properties (371, 
372)), which allowed it to transfer to other species. This is normally a key factor in the 
emergence of new pathogenic strains. The staphylobactin locus probably came from an 
ancestral strain such as S. sciuri or S. xylosus, where homologous staphylobactin genes 
have been identified (Figure 2.5).  
The staphylobactin locus may contribute to the biological success of these strains, either 
by conferring a selective advantage through adaption of the strains to their specific 
environments. Or has some advantage in some ecological niches or it would be unlikely 
to be conserved, and where it has moved it has moved in its entirety. However, after 
searching all the available bacterial genomes in our sequence collection and in the public 
domain, staphylobactin was not identified in a large number of bacterial genomes. Other 
than equibactin found it S. equi, it is not a common gene cluster and is probably not 
highly valuable to the general success of the bacteria, as we would see it in more species. 
Therefore it seems likely to be of advantage for a particular ecological niche. There is 
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not much in the way of variation within the region, and it is highly conserved within 
sequence types. This is often the case through acquisition of antibiotic resistance 
mechanisms or the production of new fitness factors, such as the mecA and mecC genes 
that exist on mobile genetic elements (MGE), allowing them to jump in and out 
independently of the core genome. The stb locus was found in MSSA and mecC strains 
in our strain collection and BLAST identified the region in mecA strains O11 and O46, 
suggestion the stb locus was gained independently of the mecA/mecC genes. 
2.4.2 Function 
BLASTp analysis of the proteins produced by the staphylobactin cluster to predict their 
functions suggested that StbB encodes a thioesterase. Thioesterases are enzymes that 
optimise NRPS-dependent peptide siderophore synthesis (373), such as PchC 
thioesterase of the siderophore, pyochelin, in Pseudomonas aeruginosa (356). Though, 
the thioesterase, YbtT, has been found not to be necessary for both product release and 
full in vitro activity of the yersiniabactin assembly machinery (185).  
StbC is predicted to function as a 4'-phosphopantetheinyl transferase. These proteins 
transfer the 4'-phosphopantetheine (4'-PP) moiety from coenzyme A (CoA) to the 
invariant serine in an acyl carrier protein (ArCP) and has been found to be essential for 
siderophore biosynthesis in Aspergillus nidulans (374). In S. equi, EqbC is predicted to 
activate the ArCP domain of EqbE and the peptide carrier domains (PCP) of EqbE and 
EqbG (296). StbC is highly likely to carry out the same function in Stb.  
StbD is predicted to encode a DHB-AMP ligase. This enzyme participates in biosynthesis 
of siderophores by activating 2,3-dihydroxy-benzoic acid and has been shown to be 
involved in the biosynthesis of the siderophores; bacillibactin and enterobactin (375, 
376).  
StbE is predicted to encode a NRPS, similar to that of the iron acquisition yersiniabactin 
synthesis enzyme, Irp2. As previously mentioned in the introduction, NRPs are 
synthesised by one or more specialised NRPS enzymes via a ribosome- and mRNA-
independent mechanism. The NRPs produced have a broad range of biological activates, 
including antibiotics and siderophores. The NRPS genes for a certain peptide are usually 
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organised in one operon, and this seems to be the case with the genes of the 
staphylobactin locus.  
StbF and StbG shows aa identity with polyketide synthases (PKSs), including the 
yersiniabactin synthetase, thiazolinyl reductase component, Irp3, and the iron 
acquisition yersiniabactin synthesis enzyme (Irp2). PKSs are multi-enzyme complexes 
that are responsible for the biosynthesis of polyketides and are very similar to NRPS. 
Many metabolites are combinations of NRPs and polyketides, normally when the PK 
module follows the NRP module. For example, yersiniabactin synthesis occurs by a 
mixed NRPS/PKS mechanism. The Stb locus shows similarity to the yersinabactin locus, 
suggesting Stb could be synthesised via a similar mechanism.  
StbF1 encodes a small protein that currently has no predicted function, and is possibly 
a gene remnant that does not have a function within the locus.  
StbH-L encode components of an ATP-binding cassette transporter (ABC transporter). 
ATP-binding cassette transporters (ABC transporters) are members of a transport 
system superfamily present in a range of phyla from prokaryotes to humans (377). ABC 
transporters often consist of multiple subunits, one or two of which are transmembrane 
proteins and membrane-associated ATPases and can actively transport chemically 
diverse substrates across the lipid bilayers of cellular membranes. The ABC uptake 
system of staphylobactin is predicted to be involved in iron uptake by an iron-
siderophore complex. While searching for the staphylobactin genes in our strain 
collection, as well as publicly available genomes. All S. aureus genomes searched 
contained genes homologous to stbK and stbL (76% and 75% identity) next to each other 
on the genome, not in association with the staphylobactin complex and are also 
predicted to encode components of an ABC transporter. This possibly occurred through 
recombination from a common ancestor and possibly carries out a different transport 
function.  
StbM is predicted to encode an oxidoreductase. An oxidoreductase is an enzyme that 
catalyses the transfer of electrons from one molecule to another and usually uses NADP 
or NAD+ as cofactors.  
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There is no eqbN homologue in the staphylobactin locus. EqbN was predicted to encode 
a putative α/β hydrolase, suggested to provide a potential mechanism for hydrolytic 
chain release similar to coelichelin (296). The eqbN gene was required for optimal 
production of the eqb NRPS product(s) by E. coli and induction of increased streptonigrin 
sensitivity in cross-feeding assays. However, absence of eqbN did not abolish production 
of the NRPS product(s) in this system suggesting that E. coli may produce an endogenous 
hydrolase that can complement the activity of EqbN. S. aureus may also produce an 
endogenous hydrolase, therefore abolishes the need of the stbN gene.  
StbO is predicted to encode a salicylate synthase. All proteins encoded by the 
staphylobactin gene cluster, except StbF1, were putatively linked to siderophore 
production based on further analyses.  
BLASTp analysis of the stb locus found S. aureus ovine strains O11 and O46 were highly 
conserved. These two strains induce severe and mild mastitis. Comparison of O11 and 
O46 revealed 103 truncated genes present in one strain or the other, corresponding to 
point mutations or indels causing frameshifts or leading to a premature stop codons. 
Among these truncated genes, 3% were involved in iron metabolism, isdH, feoA and hrtB 
(337). The stb locus was identified in a number of CoNS; S. hyicus, S. lugdunensis and S. 
sciuri. Compared to S. aureus, less is known about these strains when searching 
literature, especially about their iron acquisition systems. S. hyicus was originally 
isolated from skin infections in pigs. It is a known animal pathogen that can cause skin 
disease in cattle, horses and pigs. Both staphyloferrin A and staphyloferrin B 
siderophores have been isolated and characterised in S. hyicus (197, 203, 378). S. sciuri 
is also animal associated and commonly present on skin and mucosal surfaces of a wide 
range of pets, livestock and wild animals. S. lugdunensis seems to be the most widely 
studied of the CoNS in terms of iron acquisition systems. S. lugdunensis is commonly 
found as a normal constituent of the skin microbiota and able to cause a wide variety of 
infections, mainly human skin and soft tissue infections (SSTIs) but also infections of the 
blood and indwelling medical devices (379). Two genomes of S. lugdunensis strains, 
N920143 and HKU09-01 (330, 331) were released and allowed the identification of 
molecular determinants, including an Isd system for haem acquisition comparable with 
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S. aureus (333). Strain N920143 contains one of these Isd locus, however strain HKU09-
01 contains a duplicated Isd locus (332). The Isd system of S. lugdunensis effectively 
facilitates the use of both haem and heamoglobin as iron sources in vitro, and may 
represent the preferred iron sources of this pathogen, as it is unable to synthesize 
endogenous siderophores (334). The staphylobactin locus shared 45% and 43% aa 
identity with Anaerococcus lactolyticus and the equibactin region of S. equi. 
2.4.3 Substrate predictions 
The staphylobactin NRPS has two A-domains that have conserved NRPS codes for 
cysteine and salicylate for all staphylococci containing the NRPS. In the equibactin locus, 
EqbD is predicted to activate salicylate since it shares the conserved cysteine at position 
239, which is then transferred to the phosphopantotheine thiol of the ArCP domain of 
EqbE (Table 2.4). According to bioinformatics based predictions, StbD is predicted to 
activate salicylate, and also has the conserved alanine at position 278 (according to GrsA 
Aphe numbering), that is changed to glycine in EqbD. This differs from other NRPS 
systems that utilise salicylate. At positions 322 and 330 both residues are isoleucine, the 
same as EqbD. Evidence for the addition of salicylate is required for the production of 
equibactin due to salicylate being required for optimum production of equibactin in 
conditioned medium when expressed in E. coli. The single A-domain of EqbE is predicted 
to activate cysteine which is then transferred to the phosphopantotheine thiol of each 
of the three PCP domains of the NRPS (two in EqbE and one in EqbG). Unlike EqbE, StbE 
has the conserved asparagine at position 278, which is changed to asparate in EqbE. 
Other than a single change to phenylalanine from either leucine or methionine at 
position 299, StbE is conserved in all other residues in respect to other critical residues 
lining the A-domain binding pocket. Yersiniabactin is released from the last PCP domain 
by a C-terminal thioesterase domain. However, the C-terminal thioesterase domain of 
EqbG has the critical serine residue (S1092) of the predicted serine, histidine, aspartate 
catalytic triad essential for function (GXSXG motif) mutated to alanine. StbG does not 
contain this mutation and maintains the serine residue. This analysis adds weight to the 
notion that the staphylobactin cluster is likely to be functional.  
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2.4.4 Regulation 
MntR, a DtxR-like regulator in S. aureus shares the greatest identity to EqbA. The S. 
aureus MntR protein controls manganese homeostasis by the regulation of the mntABC 
and mntH operons. Expression of mntABC is repressed in the presence of Fe2+and 
Mn2+ions by MntR (380), but functions as a positive regulator of mntH.  MntR also 
regulates genes involved in manganese homeostasis in B. subtilis (168) and E. coli (381). 
The control of iron and manganese uptake in bacteria is mediated by members of the 
Fur and DtxR families (382-386). In Treponema denticola, the DtxR-like transcriptional 
regulator (TroR) is a manganese and iron-dependent transcriptional repressor (387). 
Therefore MntR in S. aureus is likely to play an important role in regulating both 
manganese and iron homeostasis in these isolates containing the staphylobactin region. 
DtxR controls expression by binding to a 19-bp operator sequences. DtxR-type metal 
ion-dependent repressors, present in many bacterial pathogens, not only regulate genes 
for iron acquisition but also regulate expression of virulence genes. For example the 
diphtheria toxin gene in Corynebacterium diphtheriae (388). The sequence 27 bp 
upstream of stbB contains a 57 bp sequence that is highly similar to consensus DtxR box 
sequences (389), suggesting that staphylobactin transcription is iron-regulated via the 
activity of the DtxR repressor protein. While carrying out antiSMASH analysis of the 
CC130 genomes, a region encoding an Arc family transcriptional regulator adjacent to 
the staphylobactin region was highlighted, representing a possible alternative promoter 
similar to that in Yersinia pestis that induces yersiniabactin synthesis or uptake of 
siderophore similar to that in B. subtilis. In Yersinia pestis, as well as Fur repression of 
the yersiniabactin operons, transcription is regulated by YbtA, a member of the AraC 
family of transcriptional regulators. YbtA in the presence of yersiniabactin induces 
yersiniabactin operons involved in yersiniabactin biosynthesis, iron-yersiniabactin 
uptake and salicylate synthesis, and the Fe-yersiniabactin receptor. In B. subtilis, Fur 
represses bacillibactin synthesis in iron-replete conditions. Btr, a member of the AraC 
regulators encodes an activator that binds to a conserved direct repeat promoter region 
and activates transcription of the siderophore uptake system (390). It is encoded 
adjacent to the uptake system. The 49bp imperfect repeat that is upstream of stbB could 
possibly be used to identify the regulator of the staphylobactin operon. 
Investigation of a novel iron-uptake system and other genomic features in mecC 
Staphylococcus aureus 
72  Claire Raisen - January 2019 
3 GENETIC MANIPULATION OF 
MECC S. AUREUS 
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3.1 Introduction 
Molecular genetic manipulation is required to study the function of genes in S. aureus. 
The gene of interest can be inactivated and mutants tested for function in phenotypic 
assays. To do this, directed mutagenesis by allelic replacement is used to alter the 
genome. Compared to laboratory strains of E. coli, and many other pathogens, S. aureus 
can be difficult to genetically manipulate because of its intrinsic restriction modification 
systems, low transduction frequency and low efficiency of recombination. Functional 
genomic analysis of S. aureus has been limited by an inability to genetically manipulate 
the majority of clinical isolates. Therefore, many methods and molecular tools have 
been developed by various researchers for genetic manipulation. 
3.1.1 Restriction Modification Systems 
The majority of S. aureus isolates have restriction modification (RM) systems consisting 
of enzymes that act like an immune system by attacking ‘foreign’ DNA entering the cell. 
This makes S. aureus difficult to genetically manipulate as it is necessary to be able to 
transform S. aureus with plasmids that have been constructed in E. coli strains, hindering 
exchange of DNA (391).  
Restriction modification systems recognise the methylation status of DNA at their 
specific target sequence. Fully methylated DNA is recognised to be part of the host 
genome and hemimethylated DNA is recognised as newly replicated host DNA. The 
methylation status of the genomic DNA is maintained by the methyltransferase (MTase). 
Incoming unmethylated DNA, such as that of plasmid or bacteriophages, is recognised 
to be foreign and cleaved by the restriction endonuclease (REase). 
Due to the strong restriction barrier present, this has limited mutagenesis to a small 
number of transformable laboratory strains such as Newman and 8325-4 that are 
amenable to genetic manipulation. The majority of mecA MRSA isolates mainly cluster 
into five clonal complexes (CC5, CC8, CC22, CC30 and CC45) of which until recently, only 
CC5 and CC8 had been successfully manipulated genetically. 
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3.1.1.1 Types of restriction modification systems 
Restriction modification systems are currently classified into four different types (Type 
I-IV) based on their subunit composition, cofactor requirements, target recognition, and 
DNA cleavage mechanism. 
Of these four known types only three are found in S. aureus and type I and IV are the 
most common. 
3.1.1.1.1 Type I 
Type I RM systems is encoded by three genes, hsdR (restriction), hsdS (specificity) and 
hsdM (modification) (392). The products of these genes form complexes. The specificity 
subunit (S) is required for recognition of a specific DNA sequence, the MTase subunit 
(M) catalyses DNA methylation and the REase subunit (R) is essential for DNA cleavage 
(392). 
3.1.1.1.2 Type II 
The majority of Type II RM systems consist of separate REase and MTase proteins that 
recognise the same DNA sequence. In S. aureus, the REase cleaves both DNA strands of 
the unmodified palindromic GATC sequence just 5’ to the guanine nucleotides. The 
MTase protects DNA from cleavage by methylating the recognition site at the C5 
position of cytosine (393). 
3.1.1.1.3 Type IV 
Type IV systems are modification-dependent REases that cleave DNA substrates only 
when their recognition sites have been modified. The REases recognise modified DNA 
with low sequence specificity. The Type IV system in S. aureus is SauUSI (394). It 
comprises of SauUSI endonuclease, which specifically recognise cytosine methylated 
DNA. SauUSI, which is highly conserved in S. aureus, has been found to be a major barrier 
for DNA uptake in S. aureus. 
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3.1.1.2 Overcoming the restriction barrier 
To overcome this barrier, E. coli and S. aureus strains have been developed as cloning 
intermediates. Passage of DNA through these strains modifies the foreign DNA to 
resemble the hosts before being transferred into the recipient S. aureus strain. 
3.1.1.2.1 Bypassing type I RM using RN4220 S. aureus 
S. aureus strain RN4220 is deficient in type I restriction HsdR but retains the modification 
function.  
It was obtained by extensive chemical mutagenesis of strain 8325-4 (395). RN4220 has 
been used extensively as an initial recipient before transferring DNA to other strains. 
However, many strains accept DNA isolated from RN4220 at an extremely low frequency 
and is therefore only useful for a small subset of closely related strains.  
3.1.1.2.2 Bypassing type IV RM using DC10B E. coli 
Monk et al. (396) created a DNA cytosine methyltransferase (dcm) deletion mutant in 
the high efficiency E. coli cloning strain DH10B (called DC10B). The absence of cytosine 
methylation allows plasmid DNA to bypass the type IV restriction system, but not type 
I. Plasmids isolated from DC10B can be directly transformed into clinical isolates of S. 
aureus without the need for using RN4220 as the intermediate host. DNA isolated from 
DC10B was introduced into 15 strains from different clonal complexes that were chosen 
to represent a diverse selection of S. aureus lineages and cover laboratory and clinically 
relevant clonal complexes.  
3.1.1.2.3 Bypassing type I RM from CC8 and CC30 using SA30B or SA08B E. coli 
E. coli strain DC10B was modified to express either CC8 or CC30 type I RM genes HsdMS 
to create strains SA08B and SA30B (397). These strains mimic the clonal complex specific 
methylation profile, improving the transformation rate further of S. aureus isolates of 
clinical importance. CC8 strains include USA300, Newman and 8325-4 and CC30 isolates 
include strains MRSA252 and Cowan. 
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3.1.2 Electroporation of S. aureus 
Electroporation is the method of choice for introducing plasmid DNA into S. aureus cells, 
as this process is approximately ten times more effective than chemical transformation.  
3.1.2.1 Preparation of electrocompetent S. aureus 
The most widely used protocol involves the growth of cells into early logarithmic phase 
followed by washing with a hypertonic buffer (e.g. 500 mM sucrose) to remove salts and 
stabilise the cells (398). The cells are concentrated to 1-3 x 1010 CFU/ml and purified 
plasmid DNA added. A defined electric pulse is discharged through the cells to facilitate 
the uptake of DNA. The cells are then grown in broth for a short period of time to allow 
recovery and for the growth to begin prior to plating on media containing an antibiotic 
that selects for the plasmid containing transformants. In 2012, Monk et al. (396) 
modified an electroporation protocol published by Löfblom (399) that gave a 50-fold 
improvement in the transformation frequency over the sucrose wash method, showing 
that improving the efficiency of electroporation allowed the type IV and type I RM 
systems to be bypassed. The protocol was modified as follows: Preparing 
electrocompetent cells by washing in water then 10% glycerol. Treatment of cells prior 
to electroporation. Recovery of transformed cells after electroporation. 
3.1.3 Plasmids 
The majority of methods for inactivating a chromosomal gene exploit the cells’ 
homologous recombination machinery. A wide variety of naturally occurring and 
engineered plasmids have been developed for genetic manipulation of the S. aureus 
genome. These plasmids have different characteristics including different copy numbers 
and temperature sensitivities. Clinically isolated S. aureus are often resistant to several 
antibiotics, therefore multiple gene deletion in a strain may be extremely difficult due 
to the limited number of available antibiotic markers.  In order to overcome this 
problem, drug-resistant markerless gene deletion vectors have been developed. These 
include E. coli/S. aureus shuttle vectors such as pMAD (400), pKOR1 (401), pIMAY (396), 
that can be used to facilitate the construction of mutations by allelic exchange in the S. 
aureus genome. These plasmids normally encode for replication in both E. coli and S. 
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aureus and a multiple cloning site to facilitate insertion of DNA sequences. For selection 
within the host strain, these plasmids carry genes conferring antibiotic resistance 
markers and are temperature sensitive. The plasmids used in this study are described 
below. 
3.1.3.1 pMAD 
Arnaud et al. (400) created the allelic replacement vector, pMAD. A temperature 
sensitive plasmid that was made by joining pE194ts to pBR322 with the addition of a 
bgaB gene encoding a constitutively expressed thermostable β-galactosidase (Figure 
3.1). This enables the use of a blue-white colony assay on plates containing X-Gal (5-
bromo-4-chloro-3-indoyl-β-D-galactopyranoside) to identify plasmid free bacteria. 
Plasmid free colonies appear white, while colonies that retain the plasmid appear blue. 
 
Figure 3.1. Physical map of the pMAD plasmid 
Figure from (400). pMAD plasmid consisting of a multiple cloning site, with unique restriction 
sites indicated bottom left. The bgaB gene encoding a thermostable β-galactosidase. Antibiotic 
resistance genes, ermC and bla, for the selection of the plasmid.   
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3.1.3.2 pIMAY 
pIMAY was developed by Monk et al. (396). It has a highly expressed chloramphenicol 
resistance (cat) gene which allows selection as a single copy when integrated into the 
chromosome. It has the pVWO1ts replicon, which is highly temperature sensitive in 
Staphylococci. The replicon is functional at the permissive temperature (30 ᵒC), but the 
plasmid cannot replicate at the restrictive temperature of 37 ᵒC, allowing plasmid 
integrants to be selected. The plasmid also carries the tetracycline-inducible secY 
antisense counterselection determinant (Figure 3.2). 
 
 
 
Figure 3.2. Genetic map of pIMAY  
Figure from (396). Temperature sensitive plasmid pIMAY consists of the highly expressed cat 
gene, the temperature sensitive replicon repBCD and the tetracycline-inducible antisense secY 
region.  
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3.1.3.3 Steps for genetic manipulation 
1. The procedure for creating a mutation is an integration and excision process 
represented in Figure 3.3.  
2. Plasmids carrying the mutational cassette are introduced into S. aureus by 
electroporation, and the bacteria are grown at the permissive temperature for 
replication, selecting for the phenotype conferred by the marker that resides on 
the plasmid. 
3. Integration by a single crossover (SCO) event at either the upstream or 
downstream region for homology is selected by growing at a non-permissive 
temperature for replication.  
4. Plasmids that have integrated into the chromosome are selected for antibiotic 
resistance encoded by the plasmid.  
5. Bacteria are then grown at the permissive replication temperature without 
antibiotic selection. This allows for excision of the plasmid by a SCO event and 
loss of plasmid. 
6. This results in either a wild-type or mutant strain which can be verified by PCR. 
 
 
 
Figure 3.3. Allelic exchange in S. aureus  
Figure adapted from (391). The two-step approach (integration/excision) is shown above for the 
creation of directed mutations. A deletion construct consisting of fragments flanking the gene 
of interest is assembled in the multiple cloning site of a plasmid and then transformed into the 
target strain at a temperature permissive for replication. A temperature shift, to one non-
permissive for plasmid replication (in the presence of selection for antibiotic resistance encoded 
by the plasmid), stimulates integration through either the upstream (AB) or downstream (CD) 
region of cloned homologous DNA. Decreasing the temperature and removing antibiotic 
selection stimulates replication which leads to vector excision. If the plasmid integration event 
occured through the AB side, plasmid excision through the AB side recreates the wild-type locus, 
while CD excision creates a mutated gene (shown in figure).  
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The different allelic exchange plasmids developed contain additional features which aid in 
discrimination of colonies lacking the plasmid post excision. (a) pMAD: constitutive bgaB for the 
detection of white colonies on agar containing X-Gal, (b) pIMAY: ATc inducible secY antisense to 
repress growth of plasmid-containing strains. 
 
 
 
3.1.4 Objectives 
The aim of this work was to create gene deletion mutants in the mecC CC130 S. aureus 
strains that had previously not been genetically manipulated, by developing and 
optimising a method using the current tools and techniques available. Knocking out the 
genes of the staphylobactin region, along with other genes involved in iron acquisition, 
will allow for testing of the CC130 strains in phenotypic assays in order to determine the 
function of the staphylobactin locus. 
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3.2 Materials and Methods 
3.2.1 Bacterial strains, plasmids and growth media 
Bacterial strains and plasmids used are described in Table 3.1. DNA was extracted using 
Epicenter MasterPure Gram Positive DNA Purification Kit according to the 
manufacturers protocol and diluted to 50 µg/ml for PCR amplification. The identification 
of S. aureus strains were confirmed by plating onto DNase agar methyl, Brilliance MRSA2 
and Brilliance Staph 24 Agar plates (Oxoid, UK) and tested using Staphylase Test for 
agglutination (Oxoid, UK). Oligonucleotides were purchased from Sigma-Aldrich. 
Primers were designed using PrimaClade (primaclade.org) to include the desired 
restriction sites and additional bases to facilitate direct cloning or splicing by overlap 
extension (SOE) PCR (Table 3.1). For routine culture, E. coli was grown in Luria Broth (LB) 
or on LB agar (Oxoid, UK) at 37 ᵒC, shaking at 200 rpm. S. aureus was grown on Tryptone 
Soya Agar (TSA) or Brain Heart Infusion Agar (BHI) or in Tryptone Soya Broth (TSB) 
(Oxoid, UK) shaking at 200 rpm, incubated at 28 ᵒC or 37 ᵒC accordingly.  
Bacterial stocks were stored in glycerol at -80 ᵒC. Antibiotics were purchased from 
Sigma-Aldrich and used in the following concentrations as appropriate: ampicillin (100 
µg/ml) or chloramphenicol (10 µg/ml) for E. coli; erythromycin (5 µg/ml) or 
chloramphenicol (10 µg/ml) for S. aureus. For colorimetric blue-white screening of 
bacteria, 40 µl of X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside; Melford) 
(200 mg/ml in dimethyl sulfoxide (DMSO)) was spread onto agar plates. All solutions and 
media were made with water purified through a Milli-Q water purification system 
(Millipore).   
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Table 3.1. Strains, plasmids and oligonucelotides used in this study. 
Strain/Plasmid Description  
Source or 
Reference 
E. coli strains   
DC10B ∆dcm in the DH10B background; Dam methylation only (396) 
TOP10 Host for DNA cloning Invitrogen 
C2984 Turbo Competent E. coli cells 
New 
England 
Biolabs 
SA08B DC10B expressing hsdMS genes from CC8 (397) 
SA30B DC10B expressing hsdMS genes from CC30 (397) 
S. aureus strains   
LGA251 ST425, mecC reference strain (67) 
Enr. 7594/1975 ST130, mecC clinical isolate This study 
MS-18.31 ST130, mecC clinical isolate This study 
8572 ST130, mecC clinical isolate This study 
08-02004 ST130, mecC clinical isolate This study 
2383/03 ST130, mecC clinical isolate This study 
C03 365 ST130, mecC clinical isolate This study 
71277 ST130, mecC clinical isolate (67) 
71277∆sfa 71277 with sfa deletion This study 
71277∆sbn 71277 with sbn deletion This study 
71277∆sfa∆sbn 71277 with sfa and sbn deletion This study 
71277∆stbE 71277 with stbE deletion This study 
71277∆stbHIJ 71277 with stbHIJ deletion This study 
71277∆stbE-O 71277 with stbE-O deletion This study 
71277∆stbB-O 71277 with stbB-O deletion This study 
71277∆stbE∆stbHIJ 71277 with stbE and stbHIJ deletion This study 
71277∆stbE∆stbHIJ
∆sfa∆sbn 
71277 with stbE, stbHIJ, sfa and sbn deletion This study 
71277∆stbE-J 71277 with stbE-J gene deletions This study 
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71277∆stbE-
J∆sfa∆sbn 
71277 with stbE-J, sfa and sbn gene deletions  This study 
71277∆stbB-
O∆sfa∆sbn 
71277 with stbB-O, sfa and sbn gene deletions This study 
RN4220 Restriction-defective derivative of 8325-4 ST 8  (395) 
Plasmids   
pMAD Shuttle vector for generating gene inactivation mutants (400) 
pCR2 TOPO Cloning vector Invitrogen 
pCR4 TOPO Cloning vector Invitrogen 
pLI50 E. coli - S. aureus shuttle vector; ApR/CmR (402)  
pLI50stbE pLI50 with stbE gene from 71277 This study 
pLI50sfa pLI50 with sfa gene from 71277 This study 
pLI50sbn pLI50 with sbn gene from 71277 This study 
pRMC2 E. coli - S. aureus shuttle vector, AmpR, CmR (403) 
pXB01 
E. coli - S. aureus shuttle vector pRMC2 with bla deletion; 
CmR 
(404) 
pXB01stbHIJ pXB01 with stbHIJ genes from 71277 This study 
pIMAY 
pIMC5 with tetracycline inducible secY antisense from 
pKOR1; CmR 
(396) 
pIMAY∆stbE Modified pIMAY for deleting stbE gene This study 
pIMAY∆stbHIJ Modified pIMAY for deleting stbHIJ genes This study 
pIMAY∆stbE-J Modified pIMAY for deleting genes stbE-J This study 
pIMAY∆stbE-O Modified pIMAY for deleting genes stbE-O This study 
pIMAY∆stbB-O Modified pIMAY for deleting genes stbB-O This study 
pIMAY∆sfa Modified pIMAY for deleting gene sfa This study 
pIMAY∆sbn Modified pIMAY for deleting gene sbn This study 
Primers   
∆stbE_A ATATGGTACCTTTATGAGACGCAAGGAAAGC KpnI 
∆stbE_B GCTAAACTCCCCTTTCCAATTCAATAAG  
∆stbE_C 
GAAAGGGGAGTTTAGCAACATGAAGAAGTGCATAGTTTGTG
G 
 
∆stbE_D ATATGAGCTCAACCTGGTATGGTCCTTCTTCTC SacI 
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∆stbE_outF CGGCCAAAGATATTGAAGACA  
∆stbE_outR TTCTTCGGAAATAACACTTGGC  
∆stbHIJ_A ATATGGTACCTATAGGATATTGTTCCGGGGG KpnI 
∆stbHIJ_B ATTACTAACTCCTATTCATTAC  
∆stbHIJ_C AATAGGAGTTAGTAATATTGTGTTGAAGAAAGGAGCC  
∆stbHIJ_D ATATGAGCTCCGATGCTACTTGGTGCTCAT SacI 
∆stbHIJ_outF GCGGAGCTTAAAAAGGATGATT  
∆stbHIJ_outR GCTGAAACCAAATACATGCCTAC  
∆stbEJ_C GAAAGGGGAGTTTAGCATTGTGTTGAAGAAAGGAGCC  
∆stbEO_C GAAAGGGGAGTTTAGCGGTTAATTTATTTAGGTGAAGC  
∆stbEO_D ATATGAGCTCGCCGTGATGAACTGAAATCAT SacI 
∆stbEO_outR GCTAAACTCCCCTTTCCAATTCAATAAG  
∆sfa_A ATATGGTACCGCAATACCAACTGGTTTAACGTC KpnI 
∆sfa_B TATATTAATCAATAAGTCTAAG  
∆sfa_C TAGACTTATTGATTAATATAAAATTATAGAATTTTATTAATC  
∆sfa_D ATATGAGCTCTTGGGTATATGAAAGACCGTAAGC  SacI 
∆sfa_outF GCAACAACTGCTGGAAGCAC  
∆sfa_outR GTTTCCTAGCGTTTCTATTAATCGC  
∆sbn_A ATATGGTACCGCGACAATTAACTCCGGTTTT KpnI 
∆sbn_B AAAGCGCTTCCTCCTCAAATTTAAA  
∆sbn_C GAGGAGGAAGCGCTTTGTTTTACTGTGATGTTGAGGG  
∆sbn_D ATATGAGCTCTTTTCCTCATGCTCATTCCC SacI 
∆sbn_outF CCAGCATATCCACCAGCAT  
∆sbn_outR GCAGCAATAATCGCATATACA  
IM151 (pIMAY MCS 
F) 
TACATGTCAAGAATAAACTGCCAAAGC  (396) 
IM152 (pIMAY MCS 
R) 
AATACCTGTGACGGAAGATCACTTCG  (396) 
pMAD stbE_A 
AGTCGGATCCCAGGTGTTGAATTTCAAAGAGAGATAAGAGC
G 
BamHI 
pMAD stbE_B GTTCTAAATGACACCTTCTTCGTTTGC  
pMAD stbE_C 
AGGTGTCATTTAGAACCTATGTATAGAGTAGGTCATTTGCAA
TATAAAGTG 
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pMAD stbE_D 
AGTCCCATGGACGTCATATGATTAGTTAATCTAAATAATTCG
CC 
NcoI 
pMAD stbHIJ_A AGTCGGATCCGAGAATATTGAAAACGCAAGTTATGTTGCG BamHI 
pMAD stbHIJ_B 
GAAATTTGATAAAAATTCAAACGAGACCCGCCTTTTTGAAAT
G 
 
pMAD stbHIJ_B1 
GAAATTTGATAAAAATAATTCAGTTGGCGAATTCAAACGAG
ACCCG 
 
pMAD stbHIJ_C ATTTTTATCAAATTTCAATGATAAAGGAGGATACC  
pMAD stbHIJ_D AGTCCCATGGCACCAATTAACGCTAACAATGAGACCTCCC NcoI 
T7F TAATACGACTCACTATAGGG 
 
Sequencing 
of SOE 
insert  
M13R CAGGAAACAGCTATGACC Sequencing 
of SOE 
insert  
 
3.2.2 PCR Amplification of homologous regions for cloning 
PCR was performed upstream and downstream of the target gene to be deleted. PCR 
reactions were performed in 50 μl. Where required PCR reactions were optimised using 
a Biometra T Gradient PCR machine. When using pMAD for gene deletion, Velocity High 
Fidelity DNA Polymerase (Bioline) was used on genomic DNA from strain C03 365. When 
using pIMAY for gene deletion, PCR was performed using KOD Hotstart DNA polymerase 
(Novagen) or Phusion DNA polymerase (Finnzymes) on genomic DNA from strain 71277. 
3.2.3 DNA visualisation and purification 
Agarose gels between 1%-2% w/v were used depending on the size of the product 
(UltraPure Agarose, Invitrogen) and 1 x TBE buffer (Crystal 10xTBE Buffer, Bioline) was 
used for gel electrophoresis.  DNA was stained using SYBR Safe DNA gel stain (Invitrogen) 
within the agarose gel and visualised with a UVP UV Transilluminator or a BioRad Gel 
Doc camera system.  For size analysis, either Hyperladder IV (1 kb) or Hyperladder I (10 
kb) was used (Bioline). DNA samples were mixed with 6x Blue/Orange loading dye 
(Promega).  Electrophoresis was performed at 100-120 V for 45 mins-1hr depending on 
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the degree of resolution required. DNA bands of interest were excised from the gel with 
a scalpel and purified using a QIAquick Gel Extraction Kit (Qiagen) and Qiagen MinElute 
PCR Purification Kit (Qiagen) according to the manufacturer instructions or using the 
Gel/PCR DNA Purification Kit (YORBIO). 
3.2.4 Splicing by overlap extension (SOE) PCR 
Fusion of PCR products was either carried out using Velocity DNA Polymerase (Bioline) 
or Accuprime Pfx (Invitrogen) followed by the addition of 1µl BIOTAQ DNA Polymerase 
(Bioline) and 1µl dNTPs (Bioline) for 10 min at 72˚C for the addition of an ‘A’ overhang 
for integration into TA cloning vector (pCR2 or pCR4).  For direct cloning into pIMAY, 
KOD Hot Start DNA Polymerase (Merck, UK) was used for SOE-PCR of products. For 
performing SOE-PCR, the Master Mix consisted of 5 μl KOD buffer (5X), 5μl dNTPs, 3 μl 
MgSO4, 0.7 μl KOD enzyme and 26.4 μl Milli-Q water. Template DNA (5μl, 2.5 AB, 2.5μl 
CD PCR product) was added and SOE-PCR was run for 10 cycles under the following 
conditions: 94 °C for 5 min; 10 cycles of 94°C for 30 s, 60°C for 1.5 min and 72 °C for 2.5 
min. An extra step of 10 °C for 5 min was added in the program for adding 2.5 μl primer 
A and 2.5 μl primer D in the reaction tube. SOE-PCR then was continued under the 
following conditions: 95 °C for 2 min; then 35 cycles of 95 °C for 20 s, 59 °C for 10 s and 
70 °C for 50 s; and one final extension step of 70 °C for 5 min.  
3.2.5 DNA Restriction digests 
Restriction enzymes from New England Biolabs were used and reactions were 
performed according to the manufacturer’s instructions in 50 µl volumes. DNA was 
digested at 37 ˚C for 2 hours followed by heat inactivation for 10 min at 65˚C. Digests 
were separated by gel electrophoresis. The bands containing the insert and linearized 
plasmid were extracted and purified. 
3.2.6 Plasmid isolation and purification 
Plasmid DNA was isolated from E. coli using the QIAprep Spin Miniprep Kit (Qiagen), 
following the manufacturer’s guidelines. To isolate plasmids from S. aureus, cells were 
incubated for 30 min at 37˚C in P1 buffer containing 50 mg/ml lysostaphin prior to 
addition of lysis buffer P2 before proceeding with extraction using QIAprep Spin 
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Miniprep Kit (Qiagen) as per the manufacturer’s guidelines. S. aureus plasmid DNA was 
also isolated by QIAprep Spin Midiprep Kit, HiSpeed Plasmid Midi Kit (Qiagen) or 
NucleoBond PC500 Kit using the AX500 Columns (Macherey-Nagel) following low-copy 
plasmid purification protocol. Plasmid DNA was concentrated by ethanol precipitation 
(with Pellet Paint, Millipore) or by a rotating evaporator. DNA quantity and purity were 
determined by optical density measurements using a NanoDrop spectrophotometer 
(Thermo Scientific). The plasmid DNA was eluted in sterile water to reduce the 
conductivity and minimise the risk of arcing caused by salt contaminants in the 
electroporation step. 
3.2.7 Dephosphorylation and purification of vector 
pMAD was dephosphorylated to increase the efficiency of ligation with an insert. pMAD 
was treated with alkaline phosphatase (Roche) using 1 unit per µg of vector DNA. This 
was carried out immediately after digestion, by incubation with alkaline phosphatase at 
37ᵒC for 1 hour followed by inactivation at 70ᵒC for 10 min. Purification of the 
dephosphorylated cut pMAD vector was carried out using a standard 
Phenol/Chloroform extraction protocol, followed by concentration of the sample by 
ethanol precipitation. 
3.2.8 DNA Sequencing 
DNA sequencing of the insert was carried out by Source Bioscience. Sequence data was 
analysed using FinchTV and BLAST. Primers used for sequencing are T7F and M13R for 
pCR4 TOPO plasmid and IM151/IM152 for sequencing of the insert in pIMAY. 
3.2.9 Ligation reaction 
Ligation reactions were performed using T4 DNA Ligase (Thermo Scientific) according to 
the manufacturers instructions, incubated at 16°C overnight and heat inactivated at 
65˚C for 10 min. 
3.2.10 Colony PCR of positive clones 
A colony PCR with MCS primers was used to confirm the presence of replicating plasmid. 
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For screening of plasmids in E. coli cells, MyTaq DNA Polymerase (Bioline) was used by 
mixing a very small amount of cells with the PCR master mix and cycling at the following 
conditions. 95 ᵒC 5 min, 35 cycles (95 ᵒC- 15 s, 58ᵒC – 10s, 72ᵒC 30s), 72ᵒC for 10 min. 
For S. aureus cells, a pipette tip was touched on a single colony and a very small amount 
was mixed with 3 µl of water in a PCR tube. 47 µl of Phire Hot Start II DNA polymerase 
(Thermo Fisher) master mix was added to the PCR tube and PCR was carried out with 
the following cycling conditions. 95 ᵒC 10 min, 98 ᵒC 30 s, then 35 cycles (98ᵒC- 10s, 59ᵒC 
– 10s, 72ᵒC 20s), 72ᵒC for 5 min.  
3.2.11 Preparation of E. coli chemical competent cells 
E. coli cells were made heat-shock competent by growing a single colony in LB overnight 
at 37 ᵒC, shaking at 200 rpm. The overnight culture was inoculated 1:2000 into LB and 
grown at 37 ᵒC, 200 rpm until they reached an OD600 of 0.4. Cells were pelleted at 3,000 
x g, 4 ᵒC for 10 min. The supernatant was removed and the bacterial pellet was washed 
with 100 mM ice cold MgCl2 and centrifuged (3,000 x g, 4 ᵒC, 10 min). The pellet was 
washed in 100 mM ice cold CaCl2, incubated on ice for 10 min and centrifuged as above. 
Cells were resuspended in 4 ml of ice cold 100 mM CaCl2 in 15% glycerol (w/v) and frozen 
at -80 ᵒC in 50 µl aliquots. 
3.2.12 Heat shock transformation of E.coli 
50 µl of chemically competent E. coli were defrosted on ice, 10 µl of plasmid DNA was 
added and incubated on ice for 30 mins. The cells were placed in a heat block at 42 ᵒC 
for 45 seconds, and then immediately returned to ice for 2 mins. 1 ml of SOC or LB was 
added and cells were incubated at 37 ᵒC for 1 hour, 200 rpm. The cells were plated on 
selective plates and grown overnight.   
3.2.13 Preparation of electrocompetent S. aureus and electroporation 
(Oskouian and Stewart) 
This was done according to the method adapted from Oskouian and Stewart (398). S. 
aureus was grown in TSB for 16 hrs at 37 ᵒC shaking at 200 rpm. This was diluted 1:100 
into 100 ml LB, incubated at 37 ᵒC, 200 rpm until OD450 reached 0.2. Culture was stood 
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on ice for 10 min, followed by a 10 min centrifugation at 3000 xg, 4 ᵒC to pellet bacteria. 
The bacterial pellet was washed twice in 10 ml ice cold 500 mM sucrose. The pellet was 
resuspended in sucrose and snap frozen. For electroporation, 5 µl of plasmid DNA was 
added to 200 µl electrocompetent S. aureus cells in a 0.2 cm cuvette and pulsed at 2.5 
kV, 25 µF and 400 Ω with a Bio-Rad MicroPulser (Bio-Rad Lab) followed by the addition 
of 1 ml TSB. This was incubated at 37 ᵒC for 1 hour and plated on X-Gal selective plates 
and incubated overnight at 37 ᵒC. 
3.2.14 Preparation of electrocompetent S. aureus and electroporation 
(McNamara) 
This was done according to the method by McNamara (405). A single colony was grown 
overnight in TSB. 4 ml of overnight culture was added into 200 ml TSB and grown to an 
OD660 of 0.4 at 37 ᵒC, 200 rpm. The culture was centrifuged at 5,000 xg for 20 min at 4 
ᵒC and the pellet was resuspend in 200 ml ice-cold 0.5 molar (M) sucrose. Centrifugation 
was repeated. The pellet was resuspended in 100 ml 0.5 M sucrose and stood on ice for 
30 min. Cells were centrifuged as above. 20 ml ice cold 0.5 M sucrose was added and 
centrifugation was repeated as above. The cells were resuspend in 300 µl ice cold 0.5 M 
sucrose. Cells were frozen at -80 ᵒC in 80 µl aliquots or used immediately. For 
electroporation, 1 µg of plasmid DNA was added to 80 µl of electrocompetent cells in a 
0.2 cm cuvette and electroporated at 100 Ω resistance, 25 mF capacitance, and a charge 
voltage of 2.5 kV. Immediately after electroporation, 1 ml of SMMP broth was added 
and transferred to a 1.5 ml Eppendorf. This was incubated at the appropriate 
temperature with shaking followed by plating on selective media. 
3.2.15 Preparation of electrocompetent S. aureus and electroporation 
(Löfblom) 
Adapted by Monk et al from the Löfblom protocol (399). 5 ml of overnight culture of S. 
aureus cells were diluted to an optical density of 0.5 OD600 in 45 ml of prewarmed TSB 
and incubated at 37 ᵒC, 200 rpm for 30 min. The culture was placed on ice for 10 min, 
and then harvested by centrifugation (3,900 x g, 10 min at 4 ᵒC). Supernatant was 
discarded and cells were washed twice with 50 ml of ice cold sterile water. The cells 
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were then washed with 5 ml followed by 1 ml of sterile ice cold 10% (w/v) glycerol. 
Finally the pellet was resuspended in 250 µl of 10% glycerol, 50 µl aliquots of cells were 
immediately transferred to -80 ᵒC. Electrocompetent cells were thawed on ice for 5 min 
and incubated at room temperature for 5 min. Cells were centrifuged at 5,000 x g for 1 
min, the supernantant discarded and the cells resuspended in 50 µl of 10% glycerol/500 
mM sucrose. Added to the cells was 5 µl of purified plasmid (up to 5 µg) and mixed by 
gentle flicking. Cells were transferred to a 0.1 cm electroporation cuvette (Biorad) and 
electrotransformed using 21 kV/cm, 100 Ω and 25µF, with a time constant around 2.0-
2.4 ms. Immediately 1ml TSB with 500 mM sucrose was added and transferred to an 
Eppendorf tube, incubated at 28 ᵒC for 2 hrs and 200 µl plated out on TSA with 10 µg/ml 
chloramphenicol and incubated at 28 ᵒ C for 48hr. Putative positive colonies are streaked 
out and grown overnight at 28 ᵒC on TSA + Cm10.  
3.2.16 Generating gene deletions using pMAD 
Transformants from the electroporation of S. aureus with modified pMAD were selected 
by plating on X-Gal TSA plates containing erythromycin (5 µg/ml) at 30 ᵒC for 48 hours. 
Single blue colonies which contain the modified pMAD plasmid were restreaked onto X-
Gal TSA with erythromycin (5 µg/ml) and incubated at 30 ᵒC. The plasmid was 
recombined into the bacterial chromosome by inoculating a blue colony into 5 ml TSB 
without antibiotic and incubating the culture for 2 hours at the permissive temperature 
(30 ᵒC) with shaking, followed by 6 hours at the restrictive temperature (42 ᵒC). Serial 
dilutions of this culture were plated on X-Gal TSA plates with erythromycin (5 µg/ml) 
and incubated at 42 ᵒC overnight. To resolve the plasmid out of the chromosome, and 
generate possible deletion mutants, single colonies were inoculated into 5 ml TSB grown 
at 30°C for 6 hours and serial dilutions were plated on to X-Gal TSA plates at 37 ᵒC 
overnight. White colonies were screened by streaking onto X-Gal TSA plates at 37 ᵒC and 
tested for erythromycin sensitivity. Colonies that are white on X-Gal and erythromycin 
sensitive were likely to be deletion mutants (confirming loss of plasmid) and were 
confirmed by colony PCR and sequencing.  
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3.2.17 Generating gene deletions using pIMAY 
A single colony from the 28 ᵒC plate containing modified pIMAY, was vortexed in 200 µl 
of TSB and then diluted 10-3 and all dilutions plated on TSA with chloramphenicol (10 
µg/ml) and incubated at 37 ᵒC. Colonies from the overnight plate were restreaked onto 
TSA with chloramphenicol (10 µg/ml) at 37 ᵒC. Confirmation of plasmid integration was 
confirmed by colony PCR using primers external to the MCS of the plasmid, with a 
negative result showing plasmid integration into the chromosome. Clones that gave a 
negative result were screened for the site of integration, using primers OUT FW/D or 
OUT RV/A. A single colony from either side of integration was inoculated into 5 ml TSB 
and grown at 28 ᵒC, 200 rpm for 2 hours. The broth was diluted 1:10 to 10-6 and 50 µl 
aliquots were plated onto BHI containing 1 µg/ml anhydrotetracycline (ATc) (Sigma) and 
incubated at 28 ᵒC for 48 hours. Colonies were restreaked onto BHI with ATc (1 µg/ml) 
and incubated at 37 ᵒC overnight to obtain single colonies. Single colonies were then 
restreaked onto BHI with ATc (1 µg/ml) and TSA with chloramphenicol (10 µg/ml) plates, 
incubated at 37 ᵒC overnight. Colonies sensitive tochloramphenicol were screened by 
colony PCR using the OUT primers for confirmation of the deletion. DNA sequencing 
across the deletion site was also used to verify chromosomal deletions. 
 
 
 
3.3 Results 
To determine the function of the staphylobactin cluster and to establish if it encodes 
putative siderophore synthetase involved in iron acquisition, staphylobactin gene 
deletion mutants were constructed in the S. aureus CC130 chromosome. Originally, 
seven strains containing the staphylobactin locus were chosen to target for gene 
deletion, six CC130 strains and the single CC350 strain. These strains were selected 
because they cover a broad range of host species, sites of isolation and country of origin 
(Table 3.2). 
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Table 3.2. S. aureus strains containing the staphylobactin locus to target for gene 
deletion 
Strain Country Origin Isolated from Date CC 
08-02004 Germany Roe Deer Nasal Swab 25/08/2008 130 
71277 Denmark Human Blood 12/05/2010 130 
2383/03 Denmark Human Unknown 03/09/2003 130 
MPS–18.31 England Bovine Milk  2012 130 
Enr.7594/1975 Denmark Human Blood 1975 130 
C03 365 England Bovine Milk 07/2006 130 
8572 England Horse Tracheal Wash 16/11/2005 350 
 
These seven mecC wild-type isolates were streaked from glycerol stocks onto blood agar 
plates and genomic DNA was extracted. To confirm that the strains were S. aureus, single 
colonies were streaked onto identification plates and tested for agglutination. The first 
genes to be targeted for deletion in the staphylobactin region were the stbE gene (6018 
bp) which is predicted to encode a non-ribosomal peptide synthetase (NRPS) and stbH, 
stbI and stbJ genes (2763 bp), which are predicted to encode an ABC transporter 
associated with iron import. The homologous equibactin genes were shown to be 
required for iron import (296). 
3.3.1 Generating a deletion mutant cassette 
To obtain gene deletion mutants, firstly an insert was made carrying the upstream and 
downstream sequence of the target gene to be deleted. The size of the flanking regions 
was approximately 600 bp long (400 bp being the minimum length of PCR fragment for 
recombination to occur, longer fragments may increase recombination frequency) and 
contained the additional bases for SOE PCR and restriction sites for cloning (Figure 3.4).  
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Figure 3.4. Schematic of the homologous regions upstream and downstream of the 
gene to be deleted, including restriction sites and overlapping base pairs for SOE PCR 
of the primers. 
 
 
 
The genomic DNA was amplified using a high fidelity polymerase to avoid generating 
mutations in the homologous sequence that would affect the genes surrounding the 
target gene.  Primer annealing temperature was optimised using a PCR gradient machine 
(Figure 3.5). The PCR was run on an agarose gel and bands of the correct size were 
extracted.  
 
 
Figure 3.5. Optimisation of primer annealing temperature for PCR of upstream and 
downstream fragments of target gene for primers AB and CD.  
Primers for the pMAD vector were used targeting stbE and stbHIJ genes for deletion. 
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The two fragments were then joined by SOE PCR, mediated by an overlap between 
primer C and primer B. The expected product size was 1.2 kb, however using Velocity 
High Fidelity Polymerase did not produce any product, despite optimisation using a 
gradient PCR machine. When the SOE PCR was run on an agarose gel, only bands around 
600 bp appeared. The SOE PCR was also run with standard polymerase, this produced 
bands of the correct size. These PCR fragments were ligated into the pCR2.1 TOPO 
cloning vector and the inserts sequenced. However, when the sequencing data was 
analysed, all inserts contained at least one or more base pair mutations, so could not be 
used for future work. Five different high fidelity taq polymerase were tested, Platinum 
Taq, Pfx50, Accuprime, PCR Platinum Supermix (ThermoFisher) and Velocity along with 
5 PCR cycles prior to the addition of primers to allow annealing of PCR fragments (Figure 
3.6). This protocol worked very well for SOE PCR using the Accuprime Taq for both 
targets. Platinum, Pfx50 and Platinum SuperMix did not produce any bands of the 
correct size and Velocity only produced one band for the stbE cassette. 
 
Figure 3.6. Optimisation of SOE PCR with High Fidelity Taq Polymerase 
SOE PCR run with five different High Fidelity Taq polymerase according to manufacturers 
protocols. For each polymerase, SOE PCR was run for both stbE (left) and stbHIJ (right). Bands 
that are approximately 1.5 kb in size show successful SOE PCR, whereas bands around 600 bp 
are PCR fragments AB and CD.  
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Therefore AccuPrime High Fidelity Polymerase was chosen for future work, along with 
the modified PCR protocol. The addition of standard polymerase at the end of the PCR 
cycle along with dNTPs to the PCR reaction allowed for the addition of ‘A’ overhangs to 
the PCR fragment which enabled cloning into the pCR vector. The SOE PCR was ligated 
to the pCR4 TOPO vector and then transformed by heat shock into TOP10 E. coli cells. 
The cells containing the plasmid plus insert were selected using plates containing 
ampicillin. Originally the vector pCR2.1 TOPO was used, however this required both 
ampicillin and X-Gal plates to select for cells containing the plasmid. pCR4 TOPO contains 
a lethal gene that only allows growth of positive recombinants, therefore blue/white 
screening is not required making it quicker and easier to select for colonies containing 
the plasmid plus insert. To confirm the plasmid was carrying the correct insert, plasmid 
was extracted from four colonies for each construct, stbE∆ and stbHIJ∆. They were 
digested with EcoRI which cuts either side of the insert and with BamHI/NcoI which cuts 
the restriction sites in the primers (Figure 3.7). The plasmids with the correct restriction 
bands were also sent for sequencing using primers T7F and M13F.  
 
Figure 3.7. Restriction digest of vector pCR4 TOPO containing the insert fragment using 
NcoI/BamHI and EcoRI. 
EcoRI cuts 7-10bp upstream and downstream of the PCR insert producing 2 bands. The insert 
1300bp and plasmid 4000bp in size. BamHI and NcoI cut either side of the insert and one other 
place in the vector producing 3 bands, 1300bp, 1500bp and 2500bp in size. 
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The plasmid available in the lab at the start of this project to carry out allelic replacement 
was the pMAD system developed by Arnaud et al. (400). pMAD can be used to generate 
gene inactivation mutants, with or without an associated antibiotic resistance gene, that 
will not disrupt downstream genes. The absence of a selection marker means I could 
make multiple mutations and potentially delete whole regions in a stepwise deletion. 
This avoids the issues with creation of multidrug resistant MRSA and potential artefacts 
caused by resistance markers.  
The full length 1.3 kb fragment containing perfect copies of the target region in the pCR4 
vector was restricted with NcoI/BamHI, along with the pMAD vector, and run on an 
agarose gel. The correct restriction bands were extracted and purified. The fragments 
were ligated to the cut pMAD vector and transformed into C2984 E. coli cells and plated 
onto LB agar containing ampicillin for selection of cells containing the plasmid. The 
ligation was unsuccessful, as colonies contained empty plasmid. Therefore, pMAD was 
treated with alkaline phosphatase to prevent self-ligation and then cleaned up with a 
phenol/chloroform extraction followed by concentration using ethanol precipitation. 
The phenol purification step was used as it increases the likelihood that the purified DNA 
will be amenable to further manipulation. This step proved to be successful in creating 
modified pMAD vector containing the correct insert. Ligation reactions were typically 
transformed into E. coli first. This step takes advantage of the high 
transformation/electroporation frequency associated with E. coli but not S. aureus. The 
plasmid was then grown in E. coli under selection, purified, and used to electroporate 
into S. aureus. Four colonies from each ligation were extracted with the Qiagen Mini Kit, 
plasmid was digested with NcoI and BamHI, and the amount of plasmid extracted 
checked using a NanoDrop. The yield of modified pMAD extracted was very low (less 
than 30 ng/µl), and a higher yield was needed for cloning to be successful. This may have 
been due to pMAD being produced at a low copy number, even in E. coli. The extraction 
was repeated with the Qiagen Midi and Qiagen HiSpeed Midi kit. These still produced a 
low yield so the extracts were concentrated using a rotating evaporator. 
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3.3.2 Passage of plasmid through restriction deficient strains 
The plasmid was passaged through S. aureus RN4220 (which had been made 
electrocompetent using the Oskouian & Stewart protocol) to modify the methylation 
status of the DNA, therefore bypassing the type I RM system before transferring to wild-
type CC130 strains. pMAD containing the insert was electroporated into RN4220 and 
selected for on TSA plates containing erythromycin, at 30 ᵒC for 48 hours. Plasmid was 
extracted from RN4220 using the Qiagen mini kit, however this produced a very low 
yield (less than 12 ng/µl) with 5 µg/ml needed for transformation. Extraction was 
repeated with the Qiagen Midiprep Kit and the HiSpeed Plasmid Midi Kit, to try and 
increase the amount of plasmid, though still very low concentrations were extracted. 
Therefore plasmid was concentrated in a rotating evaporator prior to electroporation. 
The NucleoBond kit was also tested with the protocol for low copy number plasmids. 
This produced a higher yield and plasmid was concentrated using ethanol precipitation. 
Presence of the correct modified pMAD containing the deletion insert from the 
extraction was confirmed either by restriction digest with EcoRI (Figure 3.8) or PCR using 
primers that amplify the SOE insert. 
 
Figure 3.8. Restriction digest with EcoRI of modified pMADΔstbE extracted from 
restriction deficient S. aureus RN4220. 
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The plasmid pMAD∆stbHIJ was also passaged through DC10B restriction deficient E. coli 
cells (therefore bypassing the type IV RM system), producing a high enough yield when 
extracted with the Qiagen Mini Kit without the need to be concentrated. This was due 
to the high efficiency cloning background (DH10B) of DC10B, allowing for good quality 
plasmid preps.  
3.3.3 Generating deletion mutants using pMAD 
The modified recombinant pMAD vector was used in a two-step strategy for allele 
replacement in S. aureus CC130 strains. Both pMAD∆stbHIJ (extracted from DC10B) and 
pMAD∆stbE (extracted from RN4220) were electroporated into the seven strains 
containing the staphylobactin region (made electrocompetent using the Oskouian & 
Stewart protocol) and selected for on X-Gal plates containing erythromycin at 30 ᵒC, a 
temperature permissive for replication. Positive colonies containing the modified pMAD 
vector appeared blue for strains 8572, 2383/03 and 7594/1975 when targeting for stbHIJ 
deletion, however the transformation frequency was very low with only one blue colony 
per transformation. No colonies were obtained from cells transformed with 
pMAD∆stbE. Discrimination of blue white colonies on X-Gal plates was difficult. This was 
possibly due to pMAD having a low copy number and not being strongly expressed, or 
the white S. aureus CC130 cells do not contain the plasmid and are intrinsically resistant 
to erythromycin. This low frequency of transformation may be due to not enough 
plasmid so a higher concentration may increase successful transformation, or that it is 
not possible to transform pMAD into CC130 cells, due to their specific restriction 
modifications or other barriers. Blue colonies containing the plasmid were integrated 
into the chromosome by homologous recombination between a target gene and 
homologous sequences carried on a plasmid by a single or consecutive double crossover. 
Cells were grown at the permissive temperature then at the non-permissive 
temperature, followed by plating on X-Gal plates and incubation at the non-permissive 
temperature. Light blue colonies were due to the integration of the vector by a single 
crossover event, or white colonies represent candidate clones resulting from a double 
crossover event and loss of the vector. However, no colonies were visible on the agar 
plates after 2 hours at 30 ᵒC followed by 6 hours at 42 ᵒC.  
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3.3.4 Optimisation of transformation frequency 
To address the issues that I had encountered in making deletion mutants, a number of 
areas were researched to improve protocols and try to overcome these problems. 
As already mentioned, S. aureus have strong restriction barriers, making them difficult 
to genetically manipulate, so the low transformation frequency may be due to inability 
to bypass this. pMAD∆stbHIJ was isolated from strain DC10B which modifies DNA to 
bypass the type IV RM system and pMAD∆stbE was isolated from strain RN4220, which 
modifies DNA so that it can bypass type I RM system. Whereas strains SA30B/SA08B can 
bypass type I restriction systems but specifically target strains from CC8 and CC30. The 
type IV restriction system has been identified as the major barrier to transformation 
with foreign DNA. When the strains belonging to CC130 are mapped on a phylogenetic 
tree compared to strains from CC8 (Newman, USA300 and 8325-4) and CC30 (MRSA252) 
which have been successfully genetically manipulated, it can be seen that these strains 
are widely separated phylogenetically and likely to have very different genetic 
backgrounds (Figure 3.9). 
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Figure 3.9. Phylogenetic tree of the major MRSA lineages and other animal associated 
lineages. 
S. aureus isolates beloning to CC8 and CC30 that have previously been genetically manipulated 
are on divergent branches of the S. aureus phylogenetic tree from CC130 suggesting very 
different genetic backgrounds. Clonal complex 8, 30 and 130 are highlighted with blue arrows. 
Phylogenetic tree created using RaxML (310).  
 
  
 
The type I RM system comprises three genes, hsdM, hsdR and hsdS which encode a host 
specificity determinant (hsd). The recognition sequence for hsd methylation is clonal 
complex specific, preventing transfer between lineages of S. aureus and from E. coli. 
These genes were found to be present in the CC130 strains, allowing comparison to their 
homologues in strains 8325-4, Newman, USA300 (CC8) for which RN4220 has previously 
been used for genetic manipulation, and MRSA252 (CC30) - using BLAST to assess their 
amino acid identity (Table 3.3). The hsdM gene is 1557 bp in size for all strains observed, 
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with a 96% amino acid sequence identity when the CC130 hsdM gene compared to the 
other four strains. The hsdR gene is also the same size in all strains (2790 bp), with a 99% 
sequence identity when compared to the four strains. The hsdS gene had the biggest 
difference between strains from the different clonal complexes. Strains from CC8 have 
an hsdS gene consisting of 1,199 bp, CC30 is 1,155 bp and CC130 is 1,221 bp. When 
compared to other strains, the CC130 hsdS gene only had a very small homologous 
region of 176 bp of 96%, which matched the central region of the gene sequence. When 
a BLAST search of the hsdS gene from CC130 strain 71277 was carried out, very few 
strains showed sequence homology with the whole region, with the closest strain 
scoring 98% sequence identity (1198/1221 bp). This large difference in sequence 
homology compared to the CC8 strains may account for the inability for plasmid 
passaged through RN4220 to be modified. 
 
Table 3.3. Sequence identity of the type I restriction modification genes from CC130 
strains compared to CC8 and CC30 strains. Nucleotide BLAST.  
Nucleotide identity, % identity in brackets. 
 
 
 
 
 
 
 
 
 
 
To improve the transformation frequency, certain parts of the protocol were tested. 
Strain hsdM hsdR hsdS 
MRSA252 (CC30) 1491/1557 (96%) 2764/2790 (99%) 
161/180 (89%) 
68/71 (96%) 
USA300 (CC8) 1489/1557 (96%) 2762/2790 (99%) 
166/176 (94%) 
156/171 (91%) 
8325.4 (CC8) 1492/1557 (96%) 2762/2790 (99%) 
166/176 (94%) 
156/171 (91%) 
Newman (CC8) 1489/1557 (96%) 2762/2790 (99%) 
166/176 (94%) 
156/171 (91%) 
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3.3.5 Ability of wild-type CC130 strains to accept plasmid 
mecC CC130 strains had never been genetically manipulated before, therefore 
experiments were carried out to assess which of the wild-type strains listed in Table 3.4 
were able to accept empty plasmid. 
pRMC2 (a non-temperature sensitive shuttle plasmid) was passaged through E. coli 
strain DC10B. 5 µg/ml of isolated pRMC2 plasmid was electroporated into the CC130 
strains and plated on TSA plates containing chloramphenicol for selection. Out of the 
seven CC130 strains, five were found to be to acquire plasmid, producing between 1 to 
6 colonies per transformation. Strain Newman and RN4220 were also included as a 
comparison. Newman produced 9 colonies per transformation and RN4220 produced 
over 200 colonies per transformation, 32 when diluted 1 in 10 (Table 3.4). This 
highlighted strains 2383/03, 71277, 18.31 and 08-02004 as targets for genetic 
manipulation.  
 
Table 3.4. Ability of wild-type CC130 strains to accept plasmid isolated from DC10B 
Strain Number of colonies (pRMC2) Number of colonies (-ve) 
Newman 9 0 
RN4220 200+ 0 
7594/1975 0 0 
2383/03 6 0 
71277 4 0 
8572 0 0 
C03 365 1 0 
18.31 4 0 
08-02004 5 0 
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3.3.6 Plasmid isolation from restriction modification strains 
The CC130 strains with higher transformation frequencies were used to test which 
“restriction modification” strains used for the isolation of plasmid DNA were accepted. 
pRMC2 plasmid isolated from E. coli strains: DC10B, SA08B or SA30B, were 
electroporated into wild-type CC130 strains, along with the routinely manipulated strain 
Newman as a positive control. Water was added to the S. aureus cells to act as a negative 
control, and the cells were plated for selection of plasmid. Of the restriction strains 
tested, no colonies were produced from strain SA08B along with the negative control. 
Strain 71277 and Newman had a small number of colonies when plasmid was isolated 
from SA30B, but all strains grew a bacterial lawn when pRMC2 had been isolated from 
DC10B. Therefore, DC10B was the restriction deficient strain for isolation of plasmid for 
the targeting of CC130 cells.  
3.3.7 Preparation of electrocompetent S. aureus and electroporation using 
McNamara protocol 
A different protocol (McNamara Protocol) for making electrocompetent cells was tried 
along with heat shock of electrocompetent cells at 56 ᵒC for 2 min prior to 
electroporation to temporarily inactivate the restriction modification systems and allow 
for better uptake of plasmid. These made no detectable difference to the 
transformation frequencies, so were not included in future protocols.  
3.3.8 Intrinsic antibiotic resistance of S. aureus CC130 strains  
The background resistance on CC130 strains may have been affecting the screening of 
colonies containing the plasmid if they have intrinsic resistance to the same antibiotics 
as the plasmid for gene deletion. To test their susceptibility to certain antibiotics used 
in the generation of gene deletion, these strains were streaked onto plates containing 
kanamycin, erythromycin, chloramphenicol and plates containing no antibiotic. No 
colonies grew on the erythromycin and kanamycin plates and so were all considered 
susceptible, however there was a small amount of growth on plates containing 
chloramphenicol for strains RN4220, LGA251, 08-02004, 2383/03 and C03 365. 
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Therefore only strains 71277 and 18.31 were used to target for gene deletion with 
plasmid passaged through strain DC10B. 
3.3.9 Increasing frequency of cointergrate resolution 
The modified pMAD vector had been successfully introduced to wild-type CC130 strains 
at very low frequency for strains 2383/03, 7494/1975 and 08-02004 for pMADΔstbHIJ. 
However, once the plasmid had been introduced into the target strain for deletion and 
generation of deletion mutants by incubation at 30 ᵒC for 2 hours followed by 6 hours 
at 42 ᵒC had taken place, no colonies were produced. Kato and Sugai (406) reported that 
sequential non-selective passage at a reduced temp (2 x 25 ᵒC) improves frequency of 
cointegrate resolution. This was tested with these strains containing pMAD by 
subculturing twice at 37 ᵒC to try to increase the chances of integration into the 
chromosome. This was unsuccessful as no colonies were detected. It was also not 
possible to check for cointegration of the plasmid into the chromosome by PCR as both 
crossover steps were carried out together in broth at 42 ᵒC.  
3.3.10 Testing temperature sensitivity to replicate 
pMAD was tested for its sensitivity to replicate at 42 ᵒC. In order for homologous 
recombination to occur, pMAD needs to not be replicating. This was tested along with 
the temperature sensitive plasmid pIMAY, which can also be used to target gene 
deletion. E. coli cells containing the empty plasmids were streaked onto LB containing 
appropriate levels of antibiotic for selection and incubated overnight at their permissive 
(30 ᵒC for pIMAY and 37 ᵒC for pMAD) and non-permissive temperature for replication 
(37 ᵒC for pIMAY and 43 ᵒC for pMAD). Both plates with E. coli cells containing the 
plasmid grew at the temperature permissive for replication. However, when pMAD was 
grown at 43 ᵒC which should be non-permissive for replication, colonies were present 
on the plate suggesting that pMAD was not sufficiently temperature sensitive for 
successful recombination. Therefore pIMAY was used to generate gene deletion 
mutants, as no colonies appeared on the plate at the non-permissive temperature. 
Chapter 3: Genetic manipulation of mecC S. aureus 
 
Claire Raisen - January 2019   105 
3.3.11 Construction of S. aureus mutants using pIMAY 
The pIMAY plasmid is temperature sensitive at 37 ᵒC and also has counter selection. PCR 
can be easily applied to demonstrate that extrachromosomal plasmid is no longer 
present with primers external to the multiple cloning site (MCS) on pIMAY (IM151 and 
IM152), and determine whether plasmid integration has occurred via the upstream or 
downstream region of homology cloned into the plasmid. Sequences upstream and 
downstream were amplified using primers A/B and C/D that contain the new restriction 
sites (KpnI/SacI) for direct cloning into pIMAY on genomic DNA from strain 71277. The 
PCR was optimised by testing the different high fidelity taq polymerase used previously, 
along with KOD (Merck), Phusion and Q5 (NEB). A small amount of PCR product was run 
on an agarose gel to check the presence of bands around 600 bp long, and the remaining 
PCR product was purified using YORBIO Gel/PCR Purification Kit for better recovery of 
product, compared to running the whole PCR sample in an agarose gel followed by band 
extraction and purification. These fragments were used as a template for SOE PCR with 
primers AD using the KOD polymerase SOE PCR method, resulting in fragment AD. The 
PCR product of about 1.2 kb was purified from agarose gel using YORBIO Gel/PCR 
Purification Kit. pIMAY and AD fragments were both digested with SacI and KpnI 
followed by ligation. The resulting plasmid was designated pIMAY∆stbHIJ or 
pIMAY∆stbE. The plasmid was directly transformed into chemically competent DC10B E. 
coli cells (bypassing the need for extra cloning intermediates) and selected for on plates 
containing chloramphenicol. Colonies were screened by PCR for the presence of the 
insert using primers IM151/IM152 with the MyTaq colony PCR protocol (Figure 3.10).  
Positive clones were extracted using the Qiagen Mini Prep Kit and analysed by restriction 
digest and sequencing of the insert. 
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Figure 3.10. Colony PCR of E. coli DC10B for the presence of pIMAY deletion cassette. 
Eight colonies were screened for pIMAY deletion cassette from each transformation using 
MyTaq PCR and MCS primers. Empty plasmid produced bands at approx. 200 bp and successful 
constructs containing the deletion cassette produced bands of approx. 1.5 kb. 
 
 
 
Confirmed plasmid pIMAY∆stbE or pIMAY∆stbHIJ was electroporated into the target S. 
aureus strain (71277 and 18.31) and plated onto TSA with chloramphenicol (Cm) 10 
µg/ml, at 28 ᵒC for 48 hours. Colonies were produced for strain 71277 and 18.31. Colony 
PCR was used to check for the presence of the plasmid containing the insert by MyTaq 
colony PCR with MSC primers. Colony PCR was found to produce clearer results if the 
plate was placed at 4 ᵒ C for a few hours prior to carrying out the PCR. To integrate pIMAY 
into the chromosome, a single colony from the transformation plate was homogenized 
in TSB and spread onto TSA+Cm10, and incubated overnight at 37 ᵒC to stimulate single 
crossover integration.  Large well isolated colonies were picked from these plates and 
restreaked onto TSA+Cm10 at 37 ᵒC overnight to make sure the colonies were well 
isolated and then MyTaq colony PCR was used to determine the absence of 
extrachromosomal DNA. PCR was also used to check whether plasmid integration 
happened upstream or downstream of the gene. Colonies negative for replication 
plasmid and containing the integration upstream and also downstream were picked and 
grown in TSB at 28 ᵒC, on a roller (200 rpm) for a few hours to stimulate replication. 
Cultures were then diluted and spread onto BHI with 1 μg/ml ATc, incubated at 28 ᵒC for 
48 hours. Expression of the secY antisense RNA inhibits the growth of cells maintaining 
the plasmid. Colonies were restreaked onto BHI with 1 μg/ml ATc at incubated at 37 ᵒC. 
The colonies incubated at 28 ᵒC for 48 hours were mixed, containing both wild-type and 
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mutants, and therefore produced a false result. Restreaking these colonies improved 
success rate as this produced well isolated single colonies that could be easily identified 
for the mutation on selective plates (BHI+ATc1 and TSA+Cm10) (Figure 3.11). 
 
Figure 3.11. Screening of potential mutant colonies using chloramphenicol sensitivity 
Single colonies were streaked onto BHI+ATc1 (left) and TSA+Cm10 (right). Colonies sensitive to 
chloramphenicol indicate the loss of the pIMAY plasmid. 
 
 
Colonies sensitive to chloramphenicol, indicating the loss of the pIMAY plasmid, were 
screened by colony PCR using primers ΔstbE_outF/R (Figure 3.12) or ∆stbHIJ_outF/R 
(Figure 3.13) depending on the expected mutation using the Phire colony PCR protocol. 
Colony PCR was also run in parallel using the MyTaq protocol, however most of the time 
no PCR product was produced, especially for the wild-type genes. This may be due to 
Phire Taq being able to handle ‘dirty’ template better and also produce larger PCR 
fragments when using this protocol. Therefore MyTaq was used for colony PCR for 
confirmation for the presence of extrachromosomal DNA and Phire was used for the 
confirmation of deletion mutants. Deletion mutants gave a PCR product around 1.5 kb, 
while wild-type colonies gave a larger fragment. Chromosomal deletions were 
confirmed through sequencing of PCR amplicons generated from across the deleted 
regions. The genes stbHIJ were easier to delete in terms of the number of deletion 
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mutants obtained when screened by colony PCR and chloramphenicol sensitivity. This 
may be due to the stbE gene being twice the size of the region being deleted for the 
stbHIJ genes.  
 
 
Figure 3.12. Colony PCR of strain 71277 screening for the deletion of stbE using Phire 
Taq.  
Colony PCR using primers ΔstbE_outF/R for confirmation of gene deletion run on agarose gel. 
Bands at 6 kb represent wild-type strains, bands of approx. 1.5 kb show strains containing the 
deletion. 
 
 
 
Figure 3.13. Colony PCR of strain 71277 screening for the deletion of stbHIJ using Phire 
Taq.  
Colony PCR using primers ΔstbHIJ_outF/R for confirmation of gene deletion run on agarose gel. 
Bands at 3 kb represent wild-type strains, bands of approx. 1.5 kb show strains containing the 
deletion. 
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Double deletion mutants were generated by deleting genes stbE (6018 bp) and stbHIJ 
(2763 bp) using plasmids pIMAY∆stbE and pIMAY∆stbHIJ followed by deleting genes 
stbF, F1, G (5577 bp) using plasmid pIMAY∆stbE-J. Subsequently genes stbE-O (5880 bp) 
were deleted using plasmid pIMAY∆stbE-O and then the whole staphylobaction region 
(genes stbBCDEFF1GHIJKLMO consisting of 23,298 bp), by plasmid pIMAY∆stbB-O 
(Figure 3.14). The SOE PCR using KOD protocol, modified pIMAY passaged through 
DC10B, electroporation using the updated Löfblom protocol and colony PCR using Phire 
Taq were all used as described above to create the resulting deletion mutants listed in 
Table 3.1. These deletions were carried out in the mecC strain 71277 as this strain was 
the most amenable to genetic manipulation of the CC130 strains targeted, resulting in 
the whole staphylobactin region to be deleted in a stepwise manner without antibiotic 
resistance markers that can be tested in a number of phenotypic assays to determine 
the role of this region. 
 
Figure 3.14. Schematic representation of the deletion of the staphylobactin region in 
a stepwise manner.  
Deletion of stbE and stbHIJ was followed by deletion of stbF,F1, G using plasmid pIMAY∆stbE-J.  
This was followed by deletion of stbK, L, M, O using plasmid pIMAY∆stbE-O. 
 Finally the whole staphylobactin region was deleted by using plasmid pIMAY∆stbB-O. 
Genes of the staphylobactin locus to be deleted in blue. 
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Once the staphylobactin mutants were generated using this optimised protocol, it was 
quicker and easier to create deletion mutants in other genes of interest using the exact 
same protocol. Staphylobactin is predicted to encode a NRPS that is involved in iron 
acquisition. S. aureus is known to produce the siderophores, staphyloferrin A (encoded 
by the genes sfaABCsfaD) and staphyloferrin B (sbnABCDEFGHI). These genes were 
targeted in the wild-type and staphylobactin mutant strain, resulting in a CC130 S. 
aureus strain 71277∆sfa∆sbn and 71277∆stbB-O∆sfa∆sbn devoid in siderophores known 
to be involved in iron acquisition. 
3.4 Discussion 
The construction of gene deletion mutants is one of the important techniques for 
assessing the gene function in bacteria. Genetic manipulation is frequently impeded by 
the lack of efficient transformation protocols, native genetic elements interfering with 
available vector systems, or other limiting factors including cell envelope composition 
or DNA methylation patterns that mean only a small number of strains have been 
amenable to genetic manipulation. During my project these have been one of the 
biggest obstacles to overcome, taking considerable time and work in order to create 
deletion mutants in the mecC CC130 strains for phenotypic studies. 
During this study I have developed a methodology using a variety of techniques and 
tools to create gene deletions in S. aureus CC130 chromosomes. To achieve this I have 
assessed and optimised many protocols in order to facilitate genetic manipulation of 
strains that had not previously been genetically altered, enabling the study of ‘wild’ or 
clinical isolates rather than just the existing small subset of laboratory strains amenable 
to genetic manipulation. This will speed up the process of mutant construction and the 
understanding of S. aureus mecC strains in future studies.  
3.4.1 Bypassing the restriction barrier  
Restriction modification systems of most S. aureus strains act as an efficient barrier 
against foreign DNA.  
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3.4.1.1 RN4220 
For transformation of foreign DNA into S. aureus, RN4220 (which has an impaired ability 
to restrict foreign DNA, therefore allowing E. coli-derived plasmid DNA to be properly 
methylated) has been extensively used as an initial recipient before transferring DNA to 
other S. aureus strains.  However, many strains accept DNA isolated from RN4220 at an 
extremely low frequency, if at all. Passage of the pMAD vector through RN4220 and then 
electroporation into wild-type CC130 strains occurred at an extremely low frequency or 
not at all. When looking at the genome sequences of the CC130 strains and comparing 
the similarity of the hsdS, hsdR and hsdM genes against strains from CC8 and CC30 that 
have previously been manipulated using RN4220. The hsdS gene from CC130 was 
dramatically different from those from CC8 and CC30 strains. In S. aureus, the hsdM and 
hsdR genes appear to be conserved (407), while the hsdS genes share much less 
homology among various clonal complexes. However, hsdS is conserved within each 
clonal complex, suggesting a specificity of the RM system within the same clonal 
complex (407). This may explain the inability to transform plasmid isolated from RN4220 
into CC130 strains. Also, plasmid isolation from RN4220 produced a very poor yield and 
quality compared to that isolated from E. coli. RN4220 is not an ideal cloning 
intermediate. Firstly, maintenance of plasmid in S. aureus is not ideal. Secondly the 
ability to bypass using it will reduce the time involved for plasmid transfer, due to 
additional time for growth at 30 ᵒC because of the temperature sensitive plasmid. This 
reduces the cost due to lesser need for extensive extraction and purification of plasmid. 
3.4.1.2 DC10B 
The type IV RM factor SauUSI has been found to be a major barrier for DNA uptake in S. 
aureus and E. coli DC10B was constructed to overcome this. When pRMC2 was isolated 
from DC10B and introduced into CC130 strains it proved to be very successful and was 
used as a cloning intermediate for bypassing the restriction modification systems for the 
generation of gene deletions in these strains. High concentrations of good quality 
plasmid DNA can be quickly and efficiently isolated from DC10B using the Qiagen 
Miniprep Kit, overcoming poor transformation efficiency and direct transformation can 
be performed with plasmid isolated from DC10B. This reduces the need to pass through 
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RN4220 as the intermediate host and other intermediate steps through TOP10 and 
C2984 E. coli cells.  
The transformation rate was not improved using DNA isolated from SA30B (type I RM 
genes hsdMS cloned into DC10B) and plasmid isolated from SA08B was unable to be 
transformed into CC130 at all. 
Comparison of S. aureus genome sequences has found that both type I and/or type IV 
systems are highly conserved. However, some strains encode additiional type I or II RM 
systems, which can impair transformation. Understanding the biology of RM in various 
clinical isolates is important for overcoming the RM barrier for DNA uptake and 
developing better genetic engineering tools and techniques.  
If CC130 strain were found to be refractory to genetic manipualtion using the RM strains 
described above, then a number of approaches could have been tried to overcome this. 
In 2015, Monk et al. (397) described the construction and characterisation of the IMXXB 
series of E. coli strains that mimic the type I adenine methylation profiles of S. aureus 
clonal complexes 1, 8, 30, and ST93. The IMXXB strains enable direct, high-efficiency 
transformation and genetic manipulation of major S. aureus lineages. If CC130 strains 
were found to be completely refractory to transformation with plasmid DNA isolated 
from RN4220, DC10B, SA08B and SA30B plasmid then Pacbio Single-Molecule Real-Time 
(SMRT) Sequencing could have been used to detect the adenine methylation pattern of 
the CC130 strains (408). E. coli strains such as DH10B could then have been modified to 
express the adenine methylation profile from CC130 strains as detailed for CC1 and CC30 
(397). In 2012, Morikawa et al (409) reported that expression of the sigH gene renders 
S. aureus cells competent for transformation by plasmid or chromosomal DNA. This 
could be exploited for genetic manipulation of S. aureus instead of the need to be 
transformed by electroporation protocols. 
3.4.2 Plasmids for genetic manipulation: pMAD vs pIMAY 
3.4.2.1 pMAD 
The plasmid available in the lab at the start of my project was the pMAD system (400) 
consisting of a temperature sensitive plasmid and a blue/white screening for mutant 
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identification. Plasmid constructs were made targeting the deletion of the stbE and 
stbHIJ genes in the CC130 strains and were successfully electroporated into three 
strains, producing blue colonies. However, shifting the temperature from 30 ᵒC to 42 ᵒC 
to allow a single crossover event to take place, failed to produce cointegrants. 
Subculturing twice at 25 ᵒC of the single crossover integrants, in an attempt to improve 
the frequency of cointegration resolution, was unsuccessful in promoting allelic 
exchange in S. aureus CC130. When the pMAD plasmid was tested for temperature 
sensitivity at 42 ᵒC (the non-permissive temperature for replication), colonies still grew. 
This may be the reason for the inability to generate deletion mutants as the plasmid has 
to not be replicating for homologous recombination to take place.  
Screening of colonies didn’t work because pMAD does not contain a counterselectable 
marker for mutant identification so plasmid excision cannot be selected and relies on 
colour screening of colonies when plated on X-Gal plates. Blue colonies indicate that the 
plasmid is still in its episomal state, light blue represents colonies with chromosomal 
integration (single crossover) and white suggest successful replacement and loss of the 
plasmid (double crossover). I found colour of colonies difficult to distinguish making it 
harder to identify the state of the plasmid inside the cell.  
3.4.2.2 pIMAY 
pIMAY was selected as the alternative choice for making gene deletions as it has a 
counter-selective device for selecting successful mutants and is temperature sensitive 
for replication at 37 ᵒC. This was screened for its ability to replicate at 37 ᵒC. No colonies 
appeared on the plate at the non-permissive temperature. Having a lower selection 
temperature compared to that of pMAD means S. aureus is less prone to second site 
mutations when incubated at temperatures non-physiological to the cell.  Additionally a 
high level of chloramphenicol resistance is obtained by expression of the cat gene from 
a strong promoter. This reduces the pressure for a selection of variants with increased 
chloramphenicol resistance, which, combined with the low copy number of the plasmid, 
lessens the chance of tandem duplication occurring during chromosomal integration 
and aids in selection of correct single-copy integrands. pIMAY is considerably smaller 
than pMAD, which has advantages for transformation and stability. pIMAY was 
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successfully used to make deletion mutants in CC130 strains without associated 
antibiotic resistance. This facilitated the deletion of multiple genes in a single strain, 
including the whole staphylobactin region in a stepwise fashion. Screening of mutants 
was easy when streaked on selective plates and confirmation by colony PCR. The ability 
to check for replicating plasmid and sites of integration at the first crossover event using 
colony PCR allowed improved mutant generation. Monk et al. (396) found that 
resuspension of a colony and direct plating rather than broth grown at the 
nonpermissive temperature for plasmid replication improves the isolation of both single 
crossovers and this was incorporated into the protocol for generating deletions. 
3.4.3 Optimisation of transformation frequencies  
In order to reach transformation frequency levels that were required to make gene 
deletion mutants in CC130 strains, the various parameters in the transformation process 
were investigated and evaluated. This included the preparation of electrocompetent 
cells, the electroporation procedure and the recovery of cells after transformation. The 
modified protocol published by Löfblom (399) that was adapted by Monk et al. (396) 
resulted in significantly higher electrocompetence of the S. aureus cells compared to the 
sucrose wash method descried by Oskouian (398) and an updated version by 
McNamara. Another advantage of this protocol is the reduced time required for the 
production of competent cells, taking 2 hours instead of 4 hours. 
3.4.4 Summary 
In summary, I facilitated genetic manipulation of mecC strains of S. aureus. This was 
done by using the temperature sensitive plasmid pIMAY, combined with an improved 
transformation protocol, and the ability to bypass the restriction barrier by using 
plasmid DNA isolated from the DC10B strain of E. coli.  
The timescale from start of cloning through to mutant confirmation, can be completed 
in under two weeks. This methodology should be useful for other researchers going 
forwards and could be used for other S. aureus strains that have not been genetically 
manipulated. After this long process, I was finally in a position to analyse the function of 
the staphylobactin locus.
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4 PHENOTYPING THE 
STAPHYLOBACTIN LOCUS 
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4.1 Introduction 
Prior to this study, S. aureus was known to produce two characterised α-
hydroxycarboxylate-type siderophores, termed staphyloferrin A and staphyloferrin B, 
which are induced under conditions of iron limitation (410). In this study, mutagenesis 
was performed to eliminate sfa, sbn and stb loci from the staphylococcal chromosome 
in an attempt to investigate the entire complement of known S. aureus siderophore 
biosynthesis systems, as well as to dissect their individual and combined contribution to 
growth of S. aureus in iron-restricted environments, and to assess their roles in 
virulence. 
4.1.1 Regulation and expression of siderophores in an iron-dependent 
manner 
Sequence analysis of the staphylobactin region showed that it was missing the eqbA 
homologue, a DtxR-like regulator. BLAST of EqbA against the S. aureus CC130 genome 
identified MntR, an iron-dependent repressor, as a possible regulator. The intergenic 
region immediately upstream of the stbB operon contains a 57 bp sequence that has a 
50% nucleotide identity with the MntR box sequence in S. aureus, suggesting that the 
staphylobactin transcripts are regulated by the activity of the MntR protein. In S. aureus, 
MntR has been shown, by gel shift assay, to bind to the mntABC operator in the presence 
of Fe2+ or Mn2+ and transcription of the mntABC operon is repressed in the presence of 
Fe2+or Mn2+ (380). PerR acts with MntR to control the expression of mntABC and 
manganese uptake. The expression of PerR regulated genes, including fur (ferric uptake 
regulator), was diminished in ∆mntR strains when grown in excess Mn2+. Therefore, the 
control of Mn2+ associated members of the PerR regulon and the Fur protein are 
modulated by MntR through its control of Mn2+ uptake. 
In S. equi, transcriptional regulation of the NRPS gene (eqbE) by the putative DtxR-like 
repressor (EqbA) was assessed through the comparison of eqbE transcript levels in the 
∆eqbA and parent strain when grown in Todd-Hewitt broth (THB)(296). Deletion of eqbA 
resulted in a 13 fold increase in eqbE transcript levels relative to the wild-type strain. 
Binding of EqbA to the eqbB promoter was increased in the presence of additional Fe2+ 
or Zn2+ and to a lesser degree by Mn2+, but not by Fe3+ or Cu2+. Deletion of eqbA resulted 
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in a small colony phenotype in S. equi, possibly due to iron toxicity resulting from 
overproduction of the product(s) of the equibactin cluster and increased iron uptake. 
Supplementing of Todd-Hewitt Agar (THA) with an iron chelator restored near normal 
colony size in the ∆eqbA strain. The increased production of equibactin in the ∆eqbA 
mutant was further supported by 55FeCl3 incorporation assays, which showed an almost 
twofold increase in intracellular iron in the repressor deletion strain, compared with 
wild-type or the ∆eqbAE mutant. ∆eqbAE crossfed with filter sterilised stationary phase 
culture supernatant from the ∆eqbA strain but not the ∆eqbAE strain, showed a similar 
increase in 55FeCl3 accumulation (296).  
In S. aureus, all the iron uptake systems studied to date have been shown to be regulated 
by Fur. Staphyloferrin A and B are expressed under conditions of iron restriction in a 
Fur/Fe dependent fashion. Real-time PCR analysis confirmed that transcripts are 
upregulated in an iron deprivation dependent fashion, i.e. they are repressed by iron 
saturation of the culture medium, but continue to be readily expressed regardless of 
iron availability in a fur inactivated mutant (210, 411).  
To optimise their ability to acquire environmental iron, some bacteria have evolved 
systems to prioritise the production and transport of specific siderophores. As a result, 
many siderophore systems are regulated at two different levels. Firstly iron-dependent 
repression mediated by Fur and substrate induction mediated by an activator protein 
whose activity is controlled by the cognate siderophore (412-415). The second class 
involves the “iron subfamily” of AraC-type transcription activators. In these systems, an 
AraC-type regulator mediates the siderophore dependent induction of the uptake 
system and, in some cases, of the corresponding biosynthetic operon. Siderophore-
mediated regulation by AraC-type transcription factors has been documented 
in Yersinia pestis (YbtA), P. aeruginosa (PchR), and Bordetella spp. (AlcR and BfeR) (416-
419). All four promoter regions of the yersiniabactin region (psn, irp2, yntA and ybtP) 
possess a Fur binding site and are negatively regulated by this repressor in the presence 
of iron. In the presence of yersiniabactin, YbtA (a member of the AraC family of 
transcriptional regulators) activates expression from the psn, irp2 and ybtP (transport 
and biosynthetic genes) promoters but represses expression of its own promoter (420).  
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4.1.2 Growth in minimal media 
Many siderophores are competitive with transferrin and lactoferrin for iron binding, and 
several studies have demonstrated that microbial siderophore production contributes 
to the growth of pathogens in the iron-restricted milieu of serum (Table 4.1). 
Chromosomal inactivation of staphyloferrin biosynthesis loci sfa and sbn was reported 
to severely restrict growth of S. aureus under conditions of severe iron chelation (410). 
However, deletion of individual loci had mild to unnoticeable effects on growth of S. 
aureus in mammalian serum (210).  
Table 4.1. Siderophores contributing to growth of bacteria in the presence of 
transferrin or in serum 
Species Siderophore Ref. 
Aeromonas spp. Amonabactin (421) 
Bordetella bronchiseptica Alcaligin (422) 
Burkholderia cepacia Salicylic acid (423) 
Escherichia coli Aerobactin, enterobactin (424) 
Mycobacterium spp. Exochelins (425) 
Pseudomonas aeruginosa Pyoverdin, pyochelin (426) 
Pseudomonas pseudomallei Malleobactin (427) 
Salmonella enterica Salmochelin, enterobactin (260) 
Staphylococcus aureus Staphyloferrins A and B (210, 238) 
Vibrio parahaemolyticus Vibrioferrin (428) 
Vibrio vulnificus Vulnibactin (263) 
Yersinia pestis Yersiniabactin (264) 
 
Growth of S. equi in minimal media containing serum, transferrin or lactoferrin as an 
iron source and equibactin’s contribution to growth have not been reported (296).  
When S. equi was grown in vitro, deletion of eqbE had no effect on the growth rate on 
nutrient rich THA. This may be due to import of cations through the activity of alternative 
cation transport systems. The S. equi genome encodes an HtsABC haem-binding system 
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(306), a putative MtsABC Mn2+ and Fe3+ metal transport system and a putative FtsABCD 
Fe3+ ferrichrome transport system that share sequence identity to cation transport 
systems of  S. pyogenes (429, 430). Deletion of the eqbA promoter produced a small 
colony phenotype and the double deletion strain ∆eqbAE, had a large colony phenotype 
when grown on THA. This proved that the slow growth rate in the ∆eqbA strain was due 
to the function of the eqbE gene product. Complementation of the ∆eqbA strain with a 
plasmid that contained a second copy of eqbA under the control of the eqbA promoter 
produced a large colony phenotype when grown on THA. Transformation of the ∆eqbAE 
strain with a plasmid that contained a second copy of eqbE under the control of the eqbB 
promoter produced a small colony phenotype (296). 
4.1.3 Transport 
The antibiotic streptonigrin interacts with intracellular iron to form reactive oxygen 
species that leads to DNA damage and eventual cell death (431, 432). Bacteria that 
contain intracellular iron are therefore sensitive to its effects, while iron transport and 
siderophore mutants are more resistant due to decreased iron content. Numerous 
bacterial iron transport mutants have been isolated and characterised using 
streptonigrin, including the identification of the aerobactin transport system (433), 
transferrin-specific iron uptake in Neisseria meningitidis (434) and Haemophilus 
influenza (435). This assay was used in S. equi and demonstrates that equibactin is 
secreted by S. equi and that the eqbH, eqbI and eqbJ genes are required for its associated 
iron import (296). Quantification of 55Fe accumulation by different S. equi strains 
showed reduced levels of 55Fe in the ∆eqbHIJA strain, suggesting that the eqbH, eqbI 
and/or eqbJ gene products are essential for the majority of eqb product-dependent iron 
accumulation.  
The S. aureus genome encodes at least six known and predicted ATP-binding cassette 
(ABC) transporters for iron or haem acquisition. Haem acquisition is mediated by the Isd 
system (436), while iron siderophore uptake systems (Sir, Hts and Fhu) have been 
characterised (218, 238, 437, 438). Streptonigrin sensitivity has been used in S. aureus 
to demonstrate that sirABC is involved in transport of staphyloferrin B, with sirA or sirB 
deletion mutants exhibiting increased resistance to iron-starved S. aureus to 
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streptonigrin (218, 228). From computer analysis of the staphylobactin region, stbHIJKL 
is predicted to encode an ABC transporter and therefore it was hypothesised that stbHIJ 
is responsible for transport of staphylobactin. 
4.1.4 Virulence 
As already shown in Table 1.1 (Chapter 1), numerous studies have demonstrated the 
impact of siderophores on virulence in both animals and plants. In S. aureus, the sbn 
gene cluster that encodes staphyloferrin B biosynthesis and efflux have been implicated 
in virulence in both the mouse bacteraemia and the rat infective endocarditis models 
(202, 439). In a murine sepsis model, single-locus deletions for either staphyloferrin 
biosynthesis (sfa, sbn) or uptake (sirA, hts) did not produce statistically significant 
reductions of bacterial counts in any organ, while deletion of catechol iron uptake 
(sst) alone or deletion of the sfa-sbn or hts-sir combination did yield significant 
reductions in heart colonisation.  Combined inactivation of sst with staphyloferrin 
biosynthesis resulted in a noticeable decrease in heart and liver colonisation, but 
combining sst with the staphyloferrin uptake mutant resulted in an even larger drop in 
bacterial counts recovered from the heart, liver and kidneys (238).  
Wild-type S. equi and eqbE deletion mutant strains were tested for virulence in ponies. 
The ∆eqbE strains significantly reduced the amount of pyrexia and pathology at post 
mortem examination. This suggests that deletion of the equibactin locus renders S. equi 
significantly less able to cause acute disease in the natural host and may enhance 
survival within, and abscessation of, lymph nodes (305). It was therefore hypothesised 
that staphylobactin plays a role in virulence. In this study the wax moth virulence model 
was used to study the impact of staphylobactin on virulence. This model has been shown 
to provide an insight into the pathogenesis of a wide range of microbial infections 
including mammalian fungal and bacterial pathogens including S. aureus (440) and 
Campylobacter jejuni (441), and has previously been used in our lab to study antibiotic 
treatment of mecC MRSA strains (404).  Specifically, bacterial iron acquisition systems 
have been studied for their effect on virulence in the wax moth model (240, 442, 443).  
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4.2 Materials and Methods 
4.2.1 Bacterial growth conditions 
Bacterial strains and plasmids used are summarised in Table 4.2. For routine culture, all 
bacteria were cultured at 37 ᵒC, shaking at 200 rpm unless otherwise indicated. E. coli 
was grown in LB broth or on L-agar (Oxoid, UK). S. aureus was grown in TSB (Oxoid, UK) 
or as specified below in: Tris-minimal succinate broth (TMS) (61); TMS chelated with 
2,2’-dipyridyl (Sigma-Aldrich) or the non-metabolisable iron chelator ethylenediamine-
N,N’-bis(2-hydroxyphenylacetic acid (EDDHA) (LGC Standards); a 40:60 mixture of TMS 
and heat inactivated horse serum (Sigma-Aldrich) (HoS-TMS); TMS treated for 24 h at 4 
ᵒC with 10% w/v Chelex-100 resin (Bio-Rad) prior to addition of post-autoclaving 
nutrients (C-TMS). For iron repletion of restricted growth media. FeCl3 was added to a 
final concentration of 50 to 100 µM. For selection of plasmids and recombinant alleles, 
antibiotics were added to media at the following concentrations; ampicillin (100 µg/ml), 
chloramphenicol (10 µg/ml). All media was made with water purified through a Milli-Q 
water purification system (Millipore). Plastic wear was used for growth of cultures to 
avoid residual iron contamination.   
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Table 4.2. Bacterial strains and plasmids used in this study 
Strain/Plasmid Description  
Source or 
Reference 
S. lugdunensis N920143 
Staphylococcus lugdunensis isolated from a breast 
cancer abscess 
(330) 
S. aureus strains   
Newman Wild-type clinical osteomyelitis isolate (444) 
8325-4 Prophage-cured laboratory strain (445) 
8325-4∆sfa∆sbn 8325-4Δsbn::Tet Δsfa::Km; TetR KmR (210) 
LGA251 ST425, mecC reference strain (67) 
LGA254 ST425, mecC clinical isolate (67) 
H093880936 ST425, mecC clinical isolate This study 
m-MR-6AA ST133, mecC clinical isolate This study 
PI 41/95 ST425, mecC clinical isolate This study 
C05 232 ST151, mecC clinical isolate This study 
Enr. 7594/1975 ST130, mecC clinical isolate This study 
MS-18.31 ST130, mecC clinical isolate This study 
8572 ST130, mecC clinical isolate This study 
08-02004 ST130, mecC clinical isolate This study 
2383/03 ST130, mecC clinical isolate This study 
C03 365 ST130, mecC clinical isolate This study 
KO ST130, mecC clinical isolate This study 
71277 ST130, mecC clinical isolate (67) 
71277∆sfa∆sbn 71277 with sfa and sbn deletion This study 
71277∆stbE∆stbHIJ 71277 with stbE and stbHIJ deletion This study 
71277∆stbE∆stbHIJ∆sbn 71277 with stbE, stbHIJ and sbn deletion This study 
71277∆mntR 71277 with mntR deletion This study 
71277∆sfa 71277 with sfa deletion This study 
71277∆sbn 71277 with sbn deletion This study 
71277∆stbE 71277 with stbE deletion This study 
71277∆stbHIJ 71277 with stbHIJ deletion This study 
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71277∆stb 71277 with stbB-O deletion This study 
71277∆stbE-J 71277 with stbE-J gene deletions This study 
71277∆stbE-J∆sfa∆sbn 71277 with stbE-J, sfa and sbn gene deletions  This study 
71277∆stb∆sfa∆sbn 71277 with stbB-O, sfa and sbn gene deletions This study 
RN4220 Restriction-defective derivative of 8325-4 ST 8  (395) 
LS-1 Spontaneous murine arthritis isolate (446) 
LS-1∆HtsA LS-1 derivative, ∆htsA (447) 
Plasmids   
pLI50 E. coli - S. aureus shuttle vector; ApR/CmR (402)  
pLI50stbE pLI50 with stbE gene from 71277 This study 
pLI50sfa pLI50 with sfa gene from 71277 This study 
pLI50sbn pLI50 with sbn gene from 71277 This study 
pRMC2 E. coli – S. aureus shuttle vector. AmpR, CmR (403) 
pXB01 
E. coli - S. aureus shuttle vector pRMC2 with bla 
deletion; CmR 
(404) 
pXB01stbHIJ pXB01 with stbHIJ genes from 71277 This study 
4.2.2 Real-time PCR 
S. aureus cells were grown to stationary phase overnight in TMS with 100 μM 2,2-
dipyridyl. Iron-starved cells were washed twice in saline buffer and diluted 1:100 into 
HoS-TMS broth. Cultures were grown at 37 °C to mid-logarithmic phase (OD600 ~ 1.0) 
then partitioned into two aliquots of equal volume. One aliquot from the pair was spiked 
with 100 μM FeCl3. Growth was allowed to resume for 1 h and then pelleted by 
centrifugation with the addition of RNA Protect Bacteria Reagent (Qiagen). Total RNA 
was extracted from bacteria using RNeasy kit (Qiagen) according to the manufacturers’ 
instructions. RNA extraction was preceded by mechanical cell disruption through two 20 
second treatments in 500 µl RLT buffer in a 2 ml Precellys ceramic tube (Peqlab). An 
additional DNAse treatment was carried out using Turbo DNA-free kit (Ambion) before 
being reverse transcribed with ProtoScript II (NEB) as directed, with primers listed in 
Table 4.3 using universal primers for gryB as a control. Quantitative real-time PCR (qPCR) 
was performed with a Rotor-Gene Q instrument (Qiagen) using SensiFAST SYBR No-ROX 
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Kit (Bioline). For the qPCR, template cDNA was diluted five-fold with nuclease free water. 
Quantification relative to the housekeeping gene gryB was performed. For each 
representative RNA extraction, one-step reactions were performed in triplicate. Reverse 
transcriptase-negative controls were included to confirm the absence of contaminating 
DNA from RNA samples.  
 
Table 4.3. Oligonucleotides used in this study  
Primer Sequence 
stbE-RT-PCR-F AACAGGTTCTCAGGTTAATTCTGC 
stbE-RT-PCR-R GCATGTCAGTCACAACATCGT 
stbG-RT-PCR-F GAGGGGTGTGAAGCTACTCG 
stbG-RT-PCR-R AATCACTTCGTTTTCCACGC 
sfaD-RT-PCR-F CCTCTAATGCAATGCCATATTTA  
sfaD-RT-PCR-R ACAATGAATCACCTATCGTGACA  
sfaA-RT-PCR-F AGTCTATCATGCGCCAACAAC  
sfaA-RT-PCR-R AACCTGTCGCCATAATCAATAA  
NewmanhtsA-RT-PCR-F TTTAAATCCAGAGCGTATGATCA  
71277htsA-RT-PCR-F GCTGACTTAAATCCTGAACGC 
htsA-RT-PCR-R CAGAAGAAATTAAGCCACGAGAT  
gyrB-RT-PCR-F ATAATTATGGTGCTGGGCAAAT  
gyrB-RT-PCR-R AACCAGCTAATGCTTCATCGATA  
StbE_KpnI FW  ATATGGTACCGGAAAGGGGAGTTTAGCATGGG 
StbE_SacI RV ATATGAGCTCGCACTTCTTCATGTTCTAAATG 
StbHIJ_KpnI FW   ATATGGTACCGAATAGGAGTTAGTAATATG 
StbHIJ_SacI RV  ATATGAGCTCGGCTCCTTTCTTCAACACAAT 
pLI50MCS_FW  GCGCACATTTCCCCGAAAAG 
pLI50MCS_RV TCCAATACAAAACCACATAC 
pRMC2MCS-FW TCCCCTCGAGTTCATGAAAA 
pRMC2MCS-RV GTTGTAAAACGACGGCCAGT 
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4.2.3 Bacterial growth curves 
For each strain, a single isolated colony grown on TSA plates was inoculated into 5 ml C-
TMS broth and incubated at 37 ᵒC, 200 rpm shaking until it reached stationary phase. 
From this culture, cells were washed twice in sterile phosphate buffered saline (PBS), 
normalised to an OD600 of 0.1 and diluted 1:100 into C-TMS, 60:40 HoS-C-TMS, 20:80 
HoS-C-TMS broth or C-TMS broth containing human transferrin (Sigma-Aldrich). Culture 
medium was used as described (iron deplete) or supplemented with 50 µM or 100 µM 
FeCl3 (iron-replete) or with NiCl2, CoCl2, MnSO4, MnCl2, ZnCl2 or FeSO4 added to C-TMS 
at concentrations of 0.001 µM to 1000 µM. Cultures were grown under constant high 
amplitude shaking in a Bioscreen C machine at 37 ᵒC, with absorbance measured at 600 
nm every 30 minutes for 48 hours. Each strain was tested in triplicate. For growth in 
milk, sterilised liquid milk was purchased at a retail store and added to C-TMS. 
4.2.4 Streptonigrin sensitivity 
Streptonigrin sensitivity was performed using microbroth dilution for minimum 
inhibitory concentrations (MIC) according to BSAC protocols (http://bsac.org.uk/wp-
content/uploads/2012/02/Chapter-2-Determination-of-MICs 2006updated.pdf). Test 
strains were grown on TSA overnight at 37 ᵒC. At least four morphologically similar 
colonies were touched with a sterile loop and inoculated into 5 ml Iso-Sensitest broth 
(Oxoid, UK). Inoculated broth was incubated at 37 °C with 200 rpm shaking until the 
visible turbidity was that of a 0.5 McFarland standard. This culture was diluted 1:100 in 
Müller-Hinton broth (MHB) (Oxoid, UK), for inoculation. A flat-bottomed 96 well cell 
culture plate (Greiner Bio-One, CELLSTAR®) was loaded with appropriate antibiotic 
dilutions. For each test isolate, 75 μl of each antibiotic dilution were added to a row of 
wells and 75 μl diluted test isolate culture was added into the wells. The 96 well plate 
was then placed in a plastic bag to minimise evaporation. Each isolate was tested in 
triplicate for streptonigrin minimum inhibitory concentration (MIC) by incubation at 35 
°C for 20 hours before readings were recorded. Antimicrobial susceptibility was 
interpreted by comparing growth from a well containing no antibiotic. The antibiotic 
ranges were prepared in MHB a step higher than the final concentrations 64 – 8 ng/ml 
for streptonigrin. 
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For bacterial growth curves in the presence of streptonigrin, cultures were grown 
overnight in TSB or TMS to late logarithmic phase under aerated conditions at 37 °C. 
Cells were diluted 1:100 into fresh test broth of either TSA, C-TMS, 60:40 HoS-TMS, C-
TMS plus 250 µg/ml transferrin, C-TMS plus 50 µM FeCl3 containing increasing 
concentrations of streptonigrin (1 – 20 ng/ml) and grown under constant high amplitude 
shaking in a Bioscreen C machine at 37 ᵒC, with absorbance measured at 600 nm every 
30 minutes for 48 hours. Each strain was tested in triplicate.  
4.2.5 Bioactivity test 
The antimicrobial activity of staphylobactin containing isolates was determined using a 
variety of bacterial isolates for the capacity to inhibit growth. Overnight cultures of the 
test strains were grown in TSA and diluted 1:1000 into 0.9% NaCl and streaked onto 
either Basic Medium (BM) agar (448), supplemented with 200 µM 2,2’-Bipyridine for 
iron limiting conditions. 10 µl of S. aureus CC130, 71277∆stb or S. lugdunensis culture 
grown in C-TMS overnight was spotted onto sterile paper discs. The plates were 
incubated for 24 hours at 37 °C and observed for a zone of inhibition around the paper 
disc to confirm antimicrobial activity. 
4.2.6 Chrome-azurol S assay for siderophore activity 
Quantification of siderophore output from S. aureus strains was performed by testing 
the iron-binding activity of culture supernatants, using a chrome-azurol S (CAS) shuttle 
solution (449). S. aureus cells were grown to stationary phase in C-TMS and washed 
twice in saline buffer. These cultures were diluted 1:100 into C-TMS containing either 
50 µM FeCl3 or C-TMS only (iron deplete). Cultures were grown at 37 ᵒC, shaking at 200 
rpm. Readings were taken at 24 and 48 hours by adding equal volumes of culture 
supernatants to CAS shuttle solution and incubated in darkness at room temperature 
with gentle shaking for 15 min before the absorbance was taken at 630 nm. With an 
empty cuvette serving as the blank, siderophore units were calculated as follows: 
Siderophore units =   100 x dilution factor x (A630 of control solution – A630 of sample) 
                                                               A630 of control solution 
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For the determination of siderophore activity of raw culture supernatants, siderophore 
units were normalized to a culture OD600 of 1.0.  
4.2.7 Production of siderophore from culture supernatants and high 
resolution liquid chromatography mass spectrometry (LC-MS) analysis 
S. aureus cells grown to stationary phase in C-TMS and washed twice in saline buffer. 
These cells were diluted 1:100 into TMS or C-TMS and grown at 37 ᵒC, 200 rpm to post 
exponential phase (approximately 40 h) in plastic Falcon tubes. Cells were removed by 
centrifugation at 5000 rpm, 4 ᵒC and culture supernatants (50ml) were frozen using dry 
ice. Comparative metabolic profiling of the wild-type 71277, 71277∆stbE strains were 
performed using LC-MS with Dionex 3000RS UHPLC coupled with Bruker MaXis Impact 
Q-TOF mass spectrometer by staff of the laboratory of Greg Challis (Warwick University) 
as follows. An Agilent Zorbax Eclipse plus column (C18, 100x2.1mm, 1.8µm) was used. 
Mobile phases are consisted of A (water with 0.1% formic acid) and B (acetonitrile with 
0.1% formic acid). After 5 minutes of isocratic run at 5% B, a gradient of 5% B to 100% B 
in 15 minutes was employed with flow rate at 0.2ml/min, then the column was washed 
with 100% B for 5 minutes before equilibrate back to initial condition in 3 minutes. UV 
detector was set at 210 nm. Mass spectrometer was operated in electrospray positive 
mode with a scan range 50-3,000 m/z. Source conditions are: end plate offset at -500V; 
capillary at -4500V; nebulizer gas (N2) flow at 1.4bar; dry gas (N2) flow at 8L/min; dry 
Temperature at 180 ᵒC. Ion transfer conditions as: ion funnel 1 RF at 200Vpp; ion funnel 
2 RF at 200vpp, hexapole RF at 200Vpp; quadruple ion energy at 5ev, quadrupole low 
mass set at 55 m/z; collision energy at 5.0ev; collision RF ramping from 800 to 1500 Vpp; 
transfer time set at from 100 to 155 µs; pre-Pulse storage time set at 5 µs. Calibration 
was performed with sodium formate (1 mM) through a loop injection of 20 µl of 
standard solution at beginning of each run. Sample injection volume was 2 µl. 
4.2.8 Wax moth larvae (Galleria mellonella) infection assay  
The wax moth larvae assay was based on a method previously described by Desbois et 
al. (450). Galleria mellonella larvae were purchased in bulk from Livefood UK. Larvae 
were stored at 4°C upon arrival and kept at 37°C during the course of the assay. Wild-
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type and deletion mutant S. aureus strains were selected to evaluate the contribution 
of staphyloferrins and staphylobactin to virulence. Single bacterial colonies were picked 
to inoculate 5 ml of TSB, and cultures were grown overnight (~16 hours) at 37°C and 200 
rpm shaking. Cultures were then diluted 1:100 into 5 ml of fresh TSB and grown for a 
further 4 hours at 37°C and 200 rpm shaking. Cultures were then centrifuged at 2,500 g 
for 10 minutes, the supernatant was removed, and pellets resuspended in sterile PBS to 
an OD595nm of 0.2, giving approximately 1.3 × 106 CFU/ml (range: 1.0 – 1.4 x 106 CFU/ml). 
For each strain, groups of G. mellonella (n=10 in each group) were injected with 10 μl 
aliquots of resuspended culture or PBS behind the rear thoracic segments using a Tridak 
Stepper Pipette Dispenser (Dymax, UK). Once infected, larvae were incubated at 37°C 
for 5 days, and survival rate scored every few hours. Larvae were considered dead when 
they did not respond to touch to the head. The experiment was performed three times. 
All the strains were tested in three independent experiments and the combined results 
of all three experiment are presented in the results. 
4.2.9 Construction of S. aureus gene deletion mutants 
Oligonucleotide primer sequences are listed in Table 3.1. All deletion mutants in mecC-
MRSA strains were generated by allelic exchange with the temperature-sensitive vector 
pIMAY, as described in Chapter 3.  
4.2.10 Complementation of mutant strains.  
For complement expression of stbE and stbHIJ, these genes were cloned into expression 
plasmid pLI50 or pXB01, a derivative of the tetracycline-inducible expression vector 
pRMC2 with the bla gene deleted (403, 404). Both genes were amplified from the strain 
71277 genome DNA with primer pairs StbE_KpnI FW/StbE_SacI RV or StbHIJ_KpnI 
FW/StbHIJ_SacI RV (Table 4.3) using high fidelity Taq polymerase. PCR products were 
digested with KpnI and SacI and ligated with the pXB01 or pLI50 vector cleaved with the 
same enzymes, generating plasmids pXB01-stbHIJ and pLI50-stbE. The plasmids were 
transformed into E. coli DC10B, and plasmid DNA was then extracted and electroporated 
into mutant strains for complementation with expression induced with 200 ng/ml 
anhydrotetracycline (Sigma-Aldrich, United Kingdom). Confirmation of mutant strains 
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containing the plasmid complement was performed by colony PCR using MyTaq 
polymerase with primers pLI50MCS-FW/RV or pRMC2MCS-FW/RV Table 4.3. 
 
4.3 Results 
4.3.1 Regulation of the staphylobactin locus by MntR 
To determine if the regulation of the staphylobactin (stb) non-ribosomal peptide 
synthesis (NRPS) is achieved through the action of transcriptional repression by MntR in 
an iron-dependent manner, deletion mutants of mntR were constructed using the 
pIMAY plasmid as previously described in S. aureus CC130 strain 71277. Wild-type strain 
71277 and 71277∆mntR were grown in minimal media with or without iron. RNA was 
extracted and qPCR was carried out for the expression of the predicted NRPS, stbE and 
the predicted polyketide synthase (PKS), stbG under these conditions (Figure 4.1A).  
 
Figure 4.1. Expression of stbE and stbG genes in wild-type and mntR deletion mutant 
(A) Regulation of stbE and stbG by MntR in S. aureus strain 71277 (CC130). Real-time PCR of 
wild-type and a mntR inactivated mutant demonstrates upregulation in the absence of iron, or 
in the absence of the MntR protein when iron is absent. Error bars represent standard deviation 
from the mean. (n = 3). Strains were grown in HoS-TMS medium.  The ‘+ Fe’ cultures were spiked 
with 100 µM FeCl3 for one hour at mid-log phase prior to cell harvesting. Quantification relative 
to housekeeping gene gryB was performed. Statistical differences between mutants and wild-
type parent strain were calculated using the Student’s unpaired t-test, stbE P = 0.1483, stbG P = 
0.5475. P value: significant difference is P<0.05. Results presented in linear scale. (B) Gene 
expression fold change for stbE and stbG calculated using double delta Ct analysis. Transcription 
levels of stbE (left) and stbG (right) with and without iron supplementation in wild-type and the 
mntR mutant. Results presented in linear scale. 
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RT-qPCR revealed a reduction in the stbE and stbG transcripts in 71277∆mntR, from 7 
fold to 4 fold, and 3 fold to 2 fold compared with 71277 when grown in minimal media 
without iron compared to iron supplemented media (Figure 4.1). This suggests that 
MntR is a positive regulator of the staphylobactin operon in an iron-dependent manner. 
Also, no small colony phenotype was observed in the 71277∆mntR which was observed 
in the eqbA deletion mutants. I cannot conclude anything for certain because there was 
no statistically significant difference between the wild-type and mutant strain 
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expression of stbE and stbG using the Students’ unpaired t-test. However, the results 
show a trend so further investigative work should be carried out. 
4.3.2 Expression of staphylobactin NRPS in an iron-dependent manner 
Previous work demonstrated that the sfa and sbn operon is expressed under conditions 
of iron restriction in a Fur/Fe-dependent fashion (202). It was of interest to determine if 
stb NRPS is expressed under conditions of iron restriction. Expression of the NRPS genes 
stbE and stbG were assessed in the wild-type strain 71277 when grown in iron deplete 
media compared to iron-replete media and results are shown as fold increase of 
expression (Figure 4.1). This was done using real-time PCR analysis to confirm if they are 
upregulated and expression of sfaD, sfaA and htsA were also assessed in the presence 
and absence of iron in the 71277 CC130 strain, to provide positive controls (Figure 4.2).  
 
Figure 4.2. Expression of the hts and sfa genes in an iron-dependent manner 
Regulation of htsA, sfaA and sfaD by iron in strain 71277. Real-time PCR of wild-type 
demonstrates upregulation in the absence of iron. Error bars represent standard deviation from 
the mean (n = 3). Strains grown in HoS-TMS medium. + Fe denotes cultures spiked with 100 µM 
FeCl3 for one hour at mid-log phase prior to cell harvesting. Quantification relative to 
housekeeping gene gryB was performed. Results presented in logarithmic scale.  
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Both sets of transcripts are upregulated in an iron-deprivation-dependent fashion, i.e. 
they are repressed by iron saturation of the culture medium. The staphylobactin genes, 
stbE and stbG, had a 7 and 3 fold increase but less than the staphyloferrin A genes (Figure 
4.2). The staphyloferrin biosynthesis genes sfaA and sfaD had an 80 fold and 20 fold 
increase and the staphyloferrin A transport gene HtsA had a 1000 fold increase over the 
same strain grown in iron-replete conditions (Figure 4.2).  
RT-PCR experiments were also carried out with deletion mutants 71277∆sfa∆sbn, 
71277∆stbE-J and wild-type 71277 in iron-replete and deplete minimal media to see if 
deletion of either staphyloferrins (sfa, sbn) or staphylobactin (stb), compromising iron 
uptake and exacerbating iron starvation, would consequently enhance expression of the 
unchanged iron acquisition genes, including those involved in staphylobactin production 
(218). Expression of sfaA, sfaD and HtsA in the 71277∆stbE-J strain, stbE and stbG in the 
71277∆sfa∆sbn strain were observed and compared to expression in wild-type 71277. 
Mutation of either locus had no obvious effect on the expression of the alternative locus 
in an iron-dependent manner compared to wild-type expression (results not shown).   
 
4.3.3 Growth of S. aureus in serum 
Previous studies have demonstrated that, in comparison to wild-type S. aureus, mutants 
lacking the ability to produce the two staphyloferrin siderophores (Sfa and Sbn) grow 
poorly in iron-restricted media containing transferrin or horse serum (as a source of 
transferrin) (210, 238). Given that S. aureus CC130 genomic information suggests that 
staphylobactin may produce a siderophore involved in iron acquisition, it was 
hypothesised that deletion of the locus would lead to a drop in siderophore production, 
and consequently this would result in a strain deficient in its ability to grow in iron-
chelated culture media (e.g. serum). To address this hypothesis, strains 71277∆stb, 
71277∆sfa∆sbn and 71277∆sfa∆sbn∆stb were created and the growth of S. aureus 
71277 compared to that of its staphyloferrin and/or staphylobactin deficient mutants in 
iron-restricted media was observed.  
In comparison to the wild-type CC130 strain, staphyloferrin mutants (71277∆sfa∆sbn 
and 71277∆sfa∆sbn∆stb) grew poorly in medium comprised of 40% low-iron Chelex-
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treated TMS broth (C-TMS) with 60% complement-deactivated horse serum (HoS) 
(Figure 4.3A). Even after extended incubation periods (48 hrs), the staphyloferrin 
mutants never reached a final biomass equivalent to that of the wild-type, only reaching 
an OD600nm of approx. 0.4. However, wild-type strain 71227 and 71277∆stb grew at an 
approximately equivalent cell density and showed no growth impairment. This implies 
that the growth deficiency of 71277∆sfa∆sbn and 71277∆sfa∆sbn∆stb was due to a 
deficiency in the ability to scavenge trace amounts of iron by the staphyloferrins and 
that staphylobactin did not contribute to iron-restricted growth in these conditions. 
Supplementation of the growth media with 50 µM (Figure 4.3B) or 100 µM of FeCl3 (data 
not shown) promoted rapid growth of all strains at the same rate and biomass. 
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Figure 4.3.  Growth of S. aureus CC130 71277 in serum.  
(A) S. aureus strain 71277 and staphylobactin (∆stb), and/or staphyloferrin A (∆sfa) and B (∆sbn) 
mutants were cultured in 60:40 HoS-TMS medium. Lack of staphyloferrin production severely 
restricted growth, however lack of staphylobactin did not. (B)  All mutant kinetics were 
ameliorated to wild-type with the addition of 50 µM FeCl3. 
(A) 
 
(B) 
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This growth curve was repeated using the full complement of staphyloferrin and 
staphylobactin deletion mutants, including the strains 71277∆sfa, 71277∆sbn, 
71277∆sfa∆stbE∆stbHIJ and 71277∆sbn∆stbE-J. Previously it was demonstrated that 
deletion of only the staphyloferrin A locus had no effect on growth, and deletion of 
staphyloferrin B only revealed reduced growth in serum, but not to the same extent as 
the  severe growth defect observed with a strain lacking both staphyloferrin operons. 
When grown in minimal media containing serum as an iron source, strains 71277∆sfa, 
71277∆sfa∆stbE∆stbHIJ and 71277∆stb grew at the same rate and similar cell density at 
the wild-type 71277 strain, reaching an OD600nm of approx. 1 after 500 minutes. This 
demonstrated that deletion of staphyloferrin A and/or staphylobactin did not affect 
growth of bacteria in serum. Deletion of staphyloferrin B (71277∆sbn) alone or in 
combination with staphylobactin (71277∆sbn∆stbE-J) did affect the growth rate which 
was slower compared to the wild-type strain, reaching an OD600nm of approx. 0.8 after 
1000 minutes. This suggested that staphyloferrin B is required for full growth in serum.  
To ensure these results were not specific to mecC CC130 strain 71277 carrying the 
additional staphylobactin locus, growth experiments were repeated using mecA CC8 
control strain 8325-4 and its staphyloferrin mutant. Similar growth dynamics were 
observed (Figure 4.4A). Equivalent cell density for the staphyloferrin mutants was 
achieved for both strains, 71277 and 8325-4, although 8325-4 wild-type strain grew at a 
slower rate and did not reach the same cell density as wild-type strain 71277 that 
contains the staphylobactin region. Growth could be corrected to wild-type levels if the 
medium was saturated with free iron (Figure 4.4B), suggesting that strains containing 
the staphylobactin locus may have enhanced growth over strains lacking this locus in 
iron-replete conditions. 
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Figure 4.4. Growth of S. aureus CC8 8325-4 in serum.  
(A) S. aureus strain 8325-4 and staphyloferrin A and B mutants were cultured in HoS-TMS 
medium. Lack of staphyloferrin production severely restricted growth. (B)  All mutant kinetics 
were ameliorated to wild-type with the addition of 50 µM FeCl3. 
(A) 
 
(B) 
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The same results were achieved when repeated in medium comprised of 80% C-TMS: 
20% HoS. The wild-type and 71277∆stb strain did not reach the same cell density or 
growth rate as the same strains grown in the serum rich minimal media. This is probably 
due to the lack of nutrients available in this low serum minimal media. Strains lacking 
staphyloferrins, with or without staphylobactin, showed severely attenuated growth. 
This defect could be corrected to wild-type levels if the medium was saturated with free 
iron. Strain 8325-4 and 8325-4∆sfa∆sbn produced nearly exactly the same results when 
grown in high or low serum minimal media, growing at the same rate and cell density 
(results not shown). Again this suggests that the presence of the staphylobactin region 
enhances growth in iron-replete conditions over those lacking this region, or this CC130 
strain contains other mechanisms to allow for enhanced growth compared to the CC8 
strain tested.  
Due to the growth dynamics observed between strains 71277 (CC130) and 8325-4 (CC8) 
in minimal serum media supplemented with iron, it was of interest to see if there was a 
difference in growth for strains from different clonal complexes, containing mecC (with 
or without the staphylobactin locus), mecA or CoNS (containing the homologous 
staphylobactin region, but not the staphyloferrin loci) from a range of host species. 
mecA strains; 8325-4 (CC8), Newman (CC8), RN4220 (CC8), BCVA92 (CC398) and LS-1 (CC 
unknown) were grown in 60:40 HoS-TMS medium with or without iron (Figure 4.5), 
along with mecC CC130 strains; 71277 and 2383/03 isolated from human, C03 365 and 
KO isolated from bovine and 08-02004 isolated from deer. mecC strains from other 
clonal complexes; LGA254 and LGA251 from bovine, H093880936 from human and PI 
41/95 from rabbit (all CC425), C05 232 from bovine (CC151) and m-MR-6AA from bovine 
(CC133) were also tested. Growth of mecA strains varied largely in both the growth rate 
and final optical density, from strains of the same clonal complex, ranging from OD600nm 
0.8-1.2 at 2000 minutes, even when media was supplemented with iron. The experiment 
was repeated and very similar results for all strains were seen when grown in either high 
or low serum minimal media, with or without iron supplementation (results not shown). 
This suggested that staphyloferrin biosynthesis and uptake, or other iron acquisition 
systems vary in their ability to utilise transferrin as an iron source for growth in these 
conditions and strains tested. 
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Figure 4.5. Growth of S. aureus mecA strains in serum.  
(A) S. aureus mecA strains: 8325-4, Newman, RN4220, BCVA92 and LS-1 grown in 60% HoS-40% 
TMS medium. (B) Addition of 50 µM FeCl3 to the 60% HoS-40% TMS medium. All strains encode 
for the staphyloferrins but not staphylobactin.  
(A) 
 
(B) 
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I tested strains from CC130, from a range of host species, containing both 
staphyloferrins and the staphylobactin loci, to see if growth in serum differed with the 
host or was enhanced by the presence of the staphylobactin locus. Less difference was 
seen in growth rates (OD600nm at 2000 minutes = 1.1-1.2), especially strains 71277, 08-
02004 and KO which grew at the same rate and optical density in both conditions. Strain 
2383/03 grew the fastest and to the highest OD, reaching a very high OD (OD600nm = 1.5) 
when supplemented with iron (Figure 4.6). The same growth trends were seen when 
repeated and grown in low serum media (results not shown). These results suggest that 
the mecC strains containing the staphylobactin and staphyloferrin loci have the ability 
to utilise transferrin in serum more efficiently to enhance growth compared to the mecA 
strains. mecC strains’ growth is not affected by the host from which the strain was 
isolated. 
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Figure 4.6. Growth of S. aureus CC130 containing the staphyloferrins and 
staphylobactin locus in serum.  
(A) S. aureus CC130 strain 71277, 2383/03, KO and 08-02004 containing the staphylobactin 
region were cultured in 60% HoS-40% TMS medium. Letters in brackets indicate the host that 
the strain was isolated from; H= Human, D= Deer, B= Bovine (B) Addition of 50 µM FeCl3 to the 
60% HoS-40% TMS medium. 
(A) 
 
(B) 
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mecC strains lacking the staphylobactin locus, from various clonal complexes and host 
species were also grown in serum containing media. Similar to the mecA strains, the 
mecC strains lacking the staphylobactin locus did not reach such a high optical density 
reading at 2000 minutes: OD600nm between 0.8 and 1, compared to 1.1-1.2 for the mecC 
strains containing the staphylobactin locus. Strain m-MR-6AA grew poorly, with a 
delayed log growth phase, along with LGA251, which only reached a stationary phase of 
OD600nm 0.57 (Figure 4.7). Results show that both mecC and mecA strains lacking the 
staphylobactin region take longer to reach the stationary phase of growth, 750 minutes 
or more without the stb locus and around 500 minutes with the stb locus. These strains 
do not reach the same biomass density as strains containing the stb locus despite being 
inoculated at the same optical density at the start of the growth curve.  
 
 
Figure 4.7.  Growth of S. aureus mecC strains lacking the staphylobactin locus in serum.  
(A) S. aureus strain LGA251, LGA254, H093880936, m-MR-6AA, PI 41/95 and C05 232 lacking the 
staphylobactin region were cultured in 60% HoS-40% TMS medium. Letters in brackets indicate 
the host that the strain was isolated from; H= Human, R= Rabbit, B= Bovine (B) Addition of 50 
µM FeCl3 to the 60% HoS-40% TMS medium. 
(A) 
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(B) 
 
 
 
 
4.3.4 Growth of S. aureus with human transferrin 
Bacteria with transport systems for certain siderophores can survive in the bloodstream 
using transferrin as a source of iron. Previously it has been shown that a deletion mutant 
of sfa and sbn had severely reduced growth in serum or where human transferrin was 
the sole source of iron; and that growth in the presence of transferrin could be rescued 
by the addition of saturating concentrations of iron (210).  Numerous microbial 
siderophores contribute to the extraction of iron from the serum sequestration protein 
transferrin (Table 1.1). To understand if staphylobactin might play a similar role in S. 
aureus CC130 strains, deletion mutants were grown in C-TMS with the addition of 
varying concentrations of human transferrin (5 µg to 5 mg) (Figure 4.8). The transferrin 
was partially iron saturated, acting as a source of iron for strains with suitable extraction 
strategies, and as a sink for strains unable to extract iron from transferrin. Strains tested 
for their ability to grow in minimal media supplemented with transferrin were wild-type 
CC130 strain 71277, single deletion mutants sfa, sbn or stb, double deletion mutants 
sfa/sbn, sbn/stbE-J, or triple deletion mutants sfa/sbn/stb or sfa/stbE/stbHIJ. 
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Figure 4.8. Growth of S. aureus CC130 71277 in human transferrin.  
(A) S. aureus strain 71277 and staphylobactin (stb), and/or staphyloferrin A (sfa) and B (sbn) 
mutants were cultured in C-TMS medium supplemented with 50 µg/ml of human transferrin 
(partially iron saturated). No production of the staphyloferrins resulted in delayed growth 
kinetics, ending in a culture density nearly equivalent to wild-type. Strains lacking production of 
just staphylobactin were sufficient for wild-type growth. (B)  All mutant kinetics were amended 
to wild-type with the addition of 50 µM FeCl3. Each line represents mean OD for 3 samples per 
strain. 
 
(A) 
 
(B) 
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Deletion of staphyloferrin A and B slightly delays the onset of exponential growth (Figure 
4.9A). It has already been demonstrated that iron extraction from transferrin is a 
redundant process mediated by both SA and SB. There was no difference between 
growth of the wild-type strain and strains lacking single deletions of the sfa, sbn or stb 
locus. When the concentration of transferrin was reduced to 5 µg/ml, no growth 
difference was observed between strains. When the concentrations were 5 mg/ml or 
500 µg/ml, the growth for strains sfa/sbn and sfa/sbn/stb was reduced overall but 
otherwise no differences were seen (results not shown). 
In this study, the strains 71277ΔsfaΔsbn and 71277ΔsfaΔsbnΔstb demonstrated 
markedly impaired growth compared to its wild-type parent and 71277Δstb within the 
first 44 h of incubation, but subsequently recovered to reach an approximately 
equivalent 48h cell density. Supplementation of the medium with free iron oblated this 
defect.  
Growth of the same mecA, mecC CC130 and mecC strains lacking the staphylobactin 
region were carried out in C-TMS supplemented with 250 µg/ml transferrin showed 
similar growth kinetics when grown in serum as the iron source. mecA strains and mecC 
strains had a delayed onset of exponential growth and did not reach the same OD600nm 
as the mecC CC130 strains. Also, there was greater variability in growth rates and final 
OD with strains lacking the staphylobactin locus (results not shown). 
4.3.5 Growth of S. aureus in the presence of metal ions  
Siderophores can chelate metals other than iron including copper, zinc and manganese. 
To test if staphylobactin might be involved in the uptake of metals other than iron, the 
staphyloferrin and staphylobactin mutants were tested in Chelex-treated minimal 
media, without serum and supplemented with various ions.   
4.3.5.1 Ferrous Iron 
Iron has two oxidation states: ferrous (Fe2+) or ferric (Fe3+). Ferrous iron predominates 
in low oxygen, low pH environments. Bacteria can utilise the small amounts of soluble 
ferrous (Fe2+) iron and may be directly imported by way of high affinity ferrous iron 
transporters (174). 
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Wild-type strain 71277 and its MntR, staphylobactin and staphyloferrin deletion 
mutants were grown in minimal media supplemented with 0.001 to 1000 µM FeSO4 as 
a ferrous iron source. No difference was seen in growth of strains at 0.001 to 1 µM and 
1000 µM. At concentrations 10 and 100 µM only strains 71277∆sfa∆sbn and 
71277∆sfa∆sbn∆stb were able to grow to the same OD as these strains grown in Chelex 
treated minimal media (Figure 4.9). 
 
Figure 4.9. Growth of S. aureus strains in minimal media in the presence of ferrous iron 
S. aureus strain 71277 and mntR, staphylobactin, and/or staphyloferrin A and B mutants were 
cultured in C-TMS medium supplemented with 100 µM FeSO4. Strains lacking the production of 
staphyloferrins were able to grow in minimal media supplemented with ferrous iron. Each line 
represents mean OD for 3 samples per strain. 
 
 
4.3.5.2 Manganese  
Manganese plays a central role in cellular detoxification of reactive oxygen species 
(ROS). Therefore, manganese acquisition is considered to be important for bacterial 
pathogenesis by counteracting the oxidative burst of phagocytic cells during host 
infection.  
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Strain 71277, 71277∆mntR and 71277∆stb were tested for their ability to grow in C-TMS 
supplemented with 0.001 to 1000 µM of manganese. When grown in concentrations 
ranging from 0.001-0.1 µM, the wild-type strain grew slightly quicker and to a higher OD 
than the deletion mutants. From 1-1000 µM, the wild-type 71277 grew well in this 
media. 71277∆stb grew at a slower rate but reached roughly the same OD as the wild-
type strain (Figure 4.10) 
 
Figure 4.10. Growth of S. aureus strains in minimal media in the presence of 
manganese  
S. aureus strains 71277, 71277∆mntR and 71277∆stb were cultured in C-TMS medium 
supplemented with 100 µM MnSO4. Deletion of the manganese transcriptional regulator 
resulted in the ability to grow in culture medium containing 1 µM MnSO4 or more. Each line 
represents mean OD for 3 samples per strain. 
 
 
71277 displayed no obvious growth defects under any of the conditions tested. 
71277∆stb displayed delayed growth kinetics, but reached the eventual culture density 
nearly equivalent to wild-type after 2000 minutes. By adding a range of manganese, it 
was determined that 71277∆mntR had a higher growth yield at low concentrations of 
Mn2+ and exhibited a reduced growth yield at raised Mn2+ levels. This result may be due 
to manganese toxicity at higher concentrations.  
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4.3.5.3 Zinc, Copper, Nickel and Cobalt 
S. aureus isolate 71277, 71277∆mntR and 71277∆stb were grown in C-TMS with metal 
ions zinc, copper, nickel and cobalt at concentrations 0.001-1000 µM and their growth 
monitored.  
The staphylobactin homologous siderophore, yersiniabactin, was shown to play a role 
in zinc acquisition in Y. pestis (265). Yersiniabactin is required for growth under zinc 
deficient conditions in a strain lacking the zinc ABC transporters ZnuABC, suggesting 
staphylobactin could play a similar role in S. aureus. No difference in growth between 
the three strains was observed at any of the concentrations, suggesting that 
staphylobactin does not play a role in zinc, copper, nickel or cobalt acquisition, or any 
growth defect is masked by another zinc transporter.  
4.3.5.4 Milk 
A natural niche of S. aureus is the mammalian skin and mucous membranes.  Many of 
the strains containing the staphylobactin region were isolated from cows with infected 
mammary glands. Milk contains the iron binding protein lactoferrin, which is distinct 
from transferrin in that it releases iron at a much lower pH (pH 3.0 vs 5.5), therefore 
rendering it a useful chelator in various host niches (451). To study the impact of the 
staphylobactin locus on growth in milk, strains 71277, 71277∆stb, 71277∆sfa∆sbn∆stb 
were monitored for growth in media comprised of 0.5% milk to 100% milk with C-TMS, 
with or without the addition of iron. When grown in the Bioscreen machine, in all strains 
grown in 20% milk or more, there was no difference between wild-type and mutant 
strains, in either iron-deplete/replete conditions. This was due to the media being too 
opaque to take accurate readings. From 0.5% to 10% milk, media containing iron grew 
to a higher optical density than strains grown in deplete media, however, no difference 
in growth was seen between wild-type and mutant strains in either conditions. In an 
attempt to see if there was a difference in growth in 100% milk, aliquots were plated 
over a 24 hour time course to look at difference in CFU. No difference was seen between 
strains. This may be due to low resolution in results due to the sample time being less 
frequent than the Bioscreen machine and the results based on CFU counts instead of 
optical density readings taken from samples grown in triplicate.  
Investigation of a novel iron-uptake system and other genomic features in mecC 
Staphylococcus aureus 
148  Claire Raisen - January 2019 
4.3.6 Transport and intracellular iron content 
Sensitivity to the antibiotic streptonigrin was used as a measure to compare intracellular 
iron content of the wild-type and the mutant strains that are lacking in siderophore 
production. Bacterial strains wild-type 71277, along with deletion mutants 
71277∆sfa∆sbn, 71277∆stb, 71277∆sfa∆sbn∆stb, and control strains 8325-4 and 8325-
4∆sfa∆sbn were tested using the microbroth dilution for minimum inhibitory 
concentrations (MIC) assay according to BSAC. Plates contained streptonigrin (20 ng/ml-
0.625 ng/m) in Mueller-Hinton (MH) broth and erythromycin as a control (0.5 mg/ml-5 
ng/ml). Each strain was tested in duplicate and the assay was repeated three times with 
no change in results (Table 4.4). 
 
Table 4.4. MIC of S. aureus strains and their siderophore mutant strains to 
streptonigrin and erthyromycin. 
Wild-type strains 71277 and 8325-4, and their siderophore mutant strains were tested to 
determine their MIC to the antibiotics streptonigrin and erythromycin.  
Bacterial Strain Streptonigrin MIC (ng/ml) Erythromycin MIC (µg/ml)  
71277 20 0.25 
71277∆sfa∆sbn 20 0.25 
71277∆stb 20 0.25 
71277∆sfa∆sbn∆stb 20 0.25 
8325-4 20 0.125 
8325-4∆sfa∆sbn 20 0.125 
 
There was no obvious difference in MIC of streptonigrin between wild-type and 
siderophore mutant strains, other than a lower MIC in strains 8325-4 (CC8) and 71277 
(CC130) for erythromycin.  
To investigate further, these strains were grown in iron-limited minimal media (C-TMS) 
and nutrient rich TSA media with varying concentrations of streptonigrin (1-20 ng/ml) 
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and their optical density measured every 30 minutes by a BioScreen analyser. In iron-
limited media, none of the test strains grew at a concentration of 20 ng/ml, confirming 
the results for the BSAC MIC assay. When the concentration was reduced to 10 ng/ml, 
all strains except 8315-4∆sfa∆sbn (not producing staphyloferrin A and B, but lacking the 
staphylobactin region) were sensitive to this concentration and were not able to grow 
over the 30 hour time period (Figure 4.11A). The concentration was reduced to 5 ng/ml, 
allowing for the growth of all strains except wild-type CC130 strain 71277. All deletion 
mutants grew to a higher OD compared to their wild-type parent strain. The 71277 
deletion mutant strains grew to approximately the same optical density over the 30 
hours, similar to that of the wild-type strain 8325-4. Again, strain 8315-4∆sfa∆sbn was 
shown to be the most resistant to the effects of streptonigrin at a concentration of 5 
ng/ml in minimal media (Figure 4.11B).  
 
Figure 4.11. Growth of S. aureus strains in minimal media in the presence of 
streptonigrin. 
S. aureus strains 71277 mecC and 8325-4 mecA and their siderophore deletion mutants grown 
in minimal media in the presence of streptonigrin. (A) OD600nm readings over 30 hours growth in 
the presence of 10 ng/ml streptonigrin. (B) OD600nm readings over 30 hours growth in the 
presence of 5 ng/ml streptonigrin. Each strain grown in triplicate, readings taken every 30 mins 
and each line represents average reading for each time point. 
(A) 
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(B) 
 
Very little difference was seen in growth between strains grown with 1 ng/ml of 
streptonigrin, and all strains had the same impaired growth when grown in minimal 
media alone (OD600 0.36-0.42). This OD is very low, but what would be expected for 
strains grown in minimal media without the supplementation of iron. Growth was 
repeated with strains grown in iron-replete TSB media. Strain 8325-4 was the only strain 
to grow well when the concentration was 20 ng/ml. When the concentration was 
reduced to 5 or 10 ng/ml, the deletion mutant strains grew to the same optical density 
as their wild-type parent strains. This shows no clear difference in growth due to the 
effects of streptonigrin. This suggests the same levels of intracellular iron concentrations 
in all strains (Figure 4.12). All strains grew well in 1ng/ml and TSB alone. 
 
 
Figure 4.12. Growth of S. aureus strains in TSB in the presence of streptonigrin 
S. aureus strains 71277 and 8325-4 and their siderophore mutants grown in TSB in the presence 
of streptonigrin. OD600nm readings over 25 hours growth in the presence of 5 ng/ml streptonigrin. 
Each strain grown in triplicate, readings taken every 30 mins and each line represents average 
reading for each time point. 
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It was expected that if staphylobactin mediated iron accumulation, the mutant would 
be more resistant to streptonigrin relative to the parent strain, due to a reduction in 
intracellular iron concentrations. All strains tested, however, were equally resistant to 
streptonigrin, as demonstrated in Figure 4.12 except when grown in C-TMS at 5 ng/ml 
(Figure 4.11B). The parent wild-type strain 71277 was more sensitive than the deletion 
mutants, but there was no difference in resistance between the single, double and triple 
deletion mutants of staphyloferrins and/or staphylobactin. All CC130 strains were 
equally resistant to streptonigrin when these experiments were repeated in iron-replete 
media (TSB). In control experiments, 8325-4 was sensitive to low concentrations of 
streptonigrin, while the mutant 8325-4∆sfa∆sbn, deficient in the siderophores, 
staphyloferrin A and B, was predictably more resistant to the antibiotic when grown in 
minimal media, as shown in Figure 4.11A. Surprisingly, when this was repeated in iron-
replete media, the wild-type strain was more resistant than the deletion mutant.  
To characterise the role of stbHIJ in staphylobactin transport, a ∆stbHIJ mutant was 
constructed. If stbHIJ is involved in iron transport then mutants lacking these genes will 
be less sensitive to streptonigrin. Growth of strain 71227 and its staphylobactin 
transport mutant 71277∆stbHIJ, along with the S. aureus isolate LS-1 and its 
staphyloferrin A transport mutant, LS-1∆htsA, were observed in a variety of media 
containing 10 ng/ml of streptonigrin to see if the iron source or growth conditions 
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affected their susceptibility. When grown in minimal media (TMS) supplemented with 
either 50 µM FeCl3 or 250 µg/ml transferrin as an iron source, wild-type isolates grew 
quicker and to a higher OD than their mutant counterparts. The strains lacking 
staphylobactin grew better than the strains containing the staphylobactin locus. The 
same growth for both wild-type and their transport mutant strains were seen when 
grown in 60:40 TMS or TSA. Again, strains that do not contain the staphylobactin locus 
grew quicker and to a higher final OD. Growth in just TMS media was so poor that no 
difference could be seen. These results were not as would be predicted if stbHIJ or HtsA 
are involved in transport of siderophores.  
4.3.7 NRPS antibiotic 
Whilst trying to investigate the possible role of staphylobactin, a study by Zipperer et al. 
(448) found that S. lugdunensis strains produce a NRPS, termed lugdunin, an antibiotic 
that prohibits colonisation by S. aureus. Lugdunin was only produced under iron limiting 
conditions and on solid agar surfaces, not in liquid culture. It was of interest to see if 
staphylobactin plays a similar role as a NRPS bioactive compound. Wild-type S. aureus 
CC130 strains and its ∆stb mutants were tested against a panel of other S. aureus and 
bacterial isolates in a bioactivity assay. S. aureus strain Newman and RN4220 were 
streaked onto basic agar and the S. aureus CC130 strains containing; the staphylobactin 
locus, 7594/1975, 2383/03, C03 365, 71277 and its deletion mutant, 71277∆stb, were 
spotted onto paper discs to screen for their antimicrobial activity. All strains, including 
71277∆stb displayed a zone of inhibition around the paper disc, showing antimicrobial 
activity towards S. aureus strain Newman and RN4220 with or without the addition of 
the iron chelator to the basic agar. S. lugdunensis strain N920143 did not show any 
antimicrobial activity. The S. aureus CC130 strains were also tested against other 
bacteria that were tested with lugdunin producing S. lugdunensis, E. coli DC10B, 
Enterococcus faecalis h-Tr119 and Pseudomonas aeruginosa PA01, but no antimicrobial 
activity was observed.  
The S. aureus CC130 strains seem to have the ability to kill other S. aureus, which may 
contribute to their success, but this doesn’t seem to be the role of the staphylobactin 
locus, as no loss of activity is seen in the ∆stb strain versus the wild-type. Iron-replete or 
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deplete media had no effect of the zone of inhibition. This activity could be attributed 
to a biosynthetic gene cluster identified during antiSMASH analysis (360). 
4.3.8 Chrome-azurol S assay for siderophore activity 
To access the production and function of staphylobactin as a siderophore, supernatants 
of iron starved wild-type and deletion mutant CC130 strains were tested for iron-binding 
compounds using the chrome azurol S (CAS) shuttle solution. Wild-type strain 71277 
along with deletion mutants of staphyloferrin A/B and staphylobactin were grown in 
iron-replete/deplete and culture supernatant siderophore activity was sampled at two 
time points (24 and 48 hours) (Figure 4.13). The CAS assay can detect total siderophores 
in chemically defined media irrespective of the chemical nature of the siderophores. The 
assay is based on the colour change of CAS-iron complex from blue to orange after 
chelation of the bound iron by siderophore. Strains 8325-4 and 8325-4∆sfa∆sbn were 
also used as controls as these have previously been tested using the CAS assay. 
The sfa/sbn mutant in strain 71277 showed a significant reduction in siderophore 
output. If staphylobactin is produced in iron deplete media and functions as a 
siderophore then I would expect a reduction in iron-binding compounds of the 
supernatant from the ∆sfa∆sbn∆stb strain. The wild-type and staphylobactin deletion 
mutant produced around 150 units at 24 hours. The deletion of staphyloferrin A and B 
reduced the siderophore units down to 50, with the addition of the staphylobactin 
knockout this further reduced the siderophore units down to 30. An almost identical 
result was produced at 48 hours. While the sfa/sbn mutant significantly impaired 
siderophore output at both sampling times, it nevertheless secreted quantifiable 
amounts of (an) alternate iron chelator(s) (Figure 4.13. Top graph, green bar), while its 
∆stb counterpart performed at a level comparable to the wild-type parent. Culture 
supernatant siderophore activity was repressed for all strains by the addition of 50 µM 
FeCl3 to the minimal media, confirming that the media was iron-replete, allowing for the 
production of siderophores. 
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Figure 4.13. S. aureus produce siderophores.  
Wild-type and mutants secreted iron-chelating metabolite(s) into the supernatant, detected 
using the CAS assay at 24 hours. Error bars represent standard error from the mean (n = 3). 
Statistical differences between mutants and the wild-type parental strain were calculated using 
the Student’s unpaired t-test, 71277 vs 71277∆sfa∆sbn P = 0.0001, 71277 vs 71277∆sfa∆sbn∆stb 
P = 0.0002, 71277 vs 71277∆stb P = 0.1753, 71277∆sfa∆sbn vs 71277∆sfa∆sbn∆stb P = 0.021, 
8325-4 vs 8325-4∆sfa∆sbn P = 0.0101. P < 0.05. 
 
 
4.3.9 Liquid chromatography mass spectrometry analysis of culture 
supernatants 
Comparative metabolic profiling of the 71277, 71277∆stbE and 71277∆sfa∆sbn mutant 
strains and 18.31 and 18.31∆stbE strains culture supernatants was performed using LC-
MS and were examined for differences in mass ion composition, especially for those of 
known structures of staphylococcal siderophores. However, despite siderophore activity 
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being detected in the CAS assay using the same medium, repeated LC-MS analysis of 
culture supernatants from minimal media (TMS) failed to identify staphylobactin and 
staphyloferrins. No difference in profiling was observed between wild-type and mutant 
strains in TMS media, suggesting that the culture was not iron deficient enough to elicit 
good levels of siderophore production. TMS media was treated with Chelex resin to 
render the cultures even more iron deficient.  This would allow for at least the detection 
of the staphyloferrins that are known to be produced under these conditions. LC-MS 
analysis from culture supernatants from C-TMS failed to identify staphylobactin and 
staphyloferrin B. Though, there is a possibility that staphyloferrin A may have been 
detected from spent culture from wild-type strain 71277 in C-TMS medium, but was not 
identified in TMS medium. A peak eluted from the 71277 C-TMS preparation, while no 
peak for that mass, above background levels of detection, was observed for the ∆sfa 
preparation (Figure 4.14).  
 
Figure 4.14. Identification of staphyloferrin A production by S. aureus strain 71277 
Top: Spent culture supernatant from the iron starved 71277 strains was subjected to LC-MS 
analysis. Bottom: Similar analysis to 71277 spent culture supernatant from the iron starved ∆sfa 
mutant. The selected ion chromatogram for the two samples is shown. 
 
 
The level of staphyloferrin A identified is slightly lower in the 71277∆stbE mutant than 
the wild-type 71277 strain. Even though not strictly quantitative, there is a possibility 
you would expect more to be produced by the mutant strain. The UV absorbance 
spectrum shows λmax 285 nm rather than the expected 320 nm (Figure 4.15).  
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Figure 4.15. Comparison of staphyloferrin A production by 71277 and 71277∆stbE in 
C-TMS 
Left: Spent culture supernatant from iron-starved 71277 (top) and the ∆stbE mutant (bottom) 
subjected to LC-MS analysis. The selected ion chromatogram for the two samples is shown, with 
the spectrum of that peak displayed on the right. 
 
 
4.3.10 The contribution of staphylobactin to virulence in vivo 
To investigate whether the staphylobactin locus and the staphyloferrins had an effect 
on virulence in vivo, the wax moth larvae infection model was used. S. aureus mecC 
CC130 strain 71277 along with deletion mutants for the siderophores, staphyloferrin A 
and B mutants were assayed by injection into the haemocoel of Galleria mellonella. 
Three separate experiments were carried out and the combined results are presented 
in Figure 4.16. Each test strain and a PBS control was injected into 10 larvae and the 
number of living larvae was recorded for seven days. For all strains, larvae started to die 
around 20 hours post infection. Wild-type strain 71277 dropped to 40% survival by 30 
hours, then plateaued at 10% survival from 72 to 130 hours. Strain 71277∆stb had a 
slightly higher survival rate (60%) at 30 hours compared to the wild-type strain. 
However, at 72 hours the survival had dropped to 7% where it remained until 130 hours 
post infection, showing very similar final survival rates to the wild-type strain. Strain 
71277∆sfa∆sbn had the highest survival rate of all the strains tested at 30 hours at 70%, 
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dropping to 30% by 50 hours and the plateauing at 17% by 78 hours. Finally 
71277∆sfa∆sbn∆stb had a very similar survival rate to the wild-type strain 71277 until 
50 hours, reaching 17% survival at 72 hours. Strain absent of the staphyloferrins had a 
slight better survival rate (17% survival) compared to the wild-type strain (10% survival). 
All three experiments showed broadly identical results. 
 
Figure 4.16. Galleria mellonella larvae infected with mecC MRSA strains 71277, 
71277∆stb, 71277∆sfa∆sbn and 71277∆sfa∆sbn∆stb 
Ten larvae in each group were experimentally infected and control larvae were injected with 
PBS alone. Figure shows the combined results of 3 separate experiments. CFU/ml 5x107 - 2x108 
 
 
 
The wild-type parent strains 71277 (mecC) and 82325-4 (mecA) were compared to their 
staphyloferrin deletion mutants, 71277∆sfa∆sbn and 8325-4∆sfa∆sbn to see if the result 
was the same for deletion mutants from different strain backgrounds. Strain 8325-4 had 
very little effect on survival, maintaining around 90% survival over the seven days post 
infection. Strain 8325-4∆sfa∆sbn dropped to around 60% survival after 7 days post 
infection, approximately 30% lower than its wild-type strain. No drop in survival rate 
was seen in these strains until around day 3 post infection. For deletion mutant strains, 
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both were significantly more virulent than the wild-type strain (Figure 4.17). Both mecC 
strains were more virulent than the mecA equivalents, but showed very similar trends 
with the wild-type strain being less virulent than the staphyloferrin A and B deletion 
mutant. 
 
Figure 4.17. Galleria mellonella infected with MRSA strains and their staphyloferrin A 
and B deletion mutants. 
Ten larvae in each group were experimentally infected and PBS alone. Figure shows the 
combined results of 3 separate experiments. 
 
 
 
Due to the difference in virulence observed between the wild-type 71277 and 8325-4 
strains, mecC CC130 strains (71277, KO and MS-18.31) were compared to strain 
Newman (mecA) from CC8 to see if virulence varied between strains from the same 
clonal complex and a different clonal complex, and try to understand why mecC strains 
are so virulent. Strain KO and 71277 killed over 60% of the larvae in 48 hours, MS-18.31 
took a longer time but killed the same amount of larvae as KO and 71277 after 7 days. 
Strain Newman was far less virulent than CC130 strains, only killing 20% after 7 days of 
the experiment (Figure 4.18). 
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Figure 4.18. Galleria mellonella infected with mecC-MRSA and mecA-MRSA strains. 
Ten larvae in each group were experimentally infected and PBS alone. Figure shows the 
combined results of 3 separate experiments. CFU/ml 4.2x108 to 6.4 x 108 
 
 
 
4.4 Discussion 
4.4.1 Regulation 
I expected MntR to act as a transcriptional repressor on the stb locus in an iron-
dependent manner. This is because equibactin and both the staphyloferrins have been 
shown to be under the control of iron-dependent negative repressors, EqbA and Fur, 
and deletion of these regulators results in upregulation of their siderophore biosynthesis 
genes (219). RT-qPCR revealed a reduction in the stbE and stbG transcripts in mntR 
deletion mutants compared to its wild-type parent strain, suggesting that MntR is a 
positive regulator of the staphylobactin operon in an iron-dependent manner. However, 
MntR is already known to act as a negative and positive regulator of the expression of 
mntABC and mntH genes, which encode manganese transporters and that expression of 
mntR is constitutive in S. aureus (290).  
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It would be interesting to see how deletion of mntR would affect other iron acquisition 
gene transcription due to its interaction with PerR, which in turn regulates fur. As well 
as looking at expression of mntABC and mntH with the addition of Mn2+ or Fe2+ to the 
minimal media. This will act as a control, as mntABC expression is repressed in the 
presence of these ions, and will confirm the results that MntR acts as a positive regulator 
of the staphylobactin region. This could be done using transcriptomics techniques such 
as DNA microarrays or RNA-Seq.   
Although not statistically significant the results are consistent and show a trend. I 
consider this trend unlikely to be the result of random variation, but further analysis 
would be required to gain a definitive result. 
When deletion mutants of mntR in S. aureus were grown on nutrient rich TSB agar, no 
obvious growth defect was observed, unlike S. equi which produced very small colonies 
when grown on Todd-Hewitt Agar. This may be due to the fact that: S. aureus has been 
shown to have many iron acquisition systems so can possibly compensate for iron 
toxicity; or because MntR is possibly a positive regulator of stb, then deletion of mntR 
would not result in overproduction of stb.  
4.4.2 Expression of the stb genes 
RT-qPCR results showed both stbE and stbG expression was increased slightly in iron-
deplete conditions compared to replete by 7 fold to 3 fold. This suggests that 
staphylobactin is expressed in an iron-dependent manner. These results are as 
expected. The genes are upregulated and the controls confirm that the correct genes 
are upregulated.  
In previous studies, when wild-type strain Newman was grown in serum minimal media 
with or without the addition of 100 µM iron, it was shown that sfaA expression increased 
approx 3 fold, sfaD approx 2 fold and htsA approx 20 fold when grown in iron-deplete 
media compared to replete conditions. When this experiment was carried out in strain 
71277, HtsA increased 1000 fold, sfaA 80 fold and sfaD 20 fold. These findings are in 
agreement with previous studies that used S. aureus Newman, suggesting that 
staphyloferrin A expression is upregulated in iron deplete conditions, even in strains 
containing the staphylobactin region. It would be of interest to look at the expression of 
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the staphyloferrin B operon in these conditions and examine the expression of the 
staphyloferrin A and staphylobactin operon. This may give insight into the dominant 
siderophore produced in these conditions and further confirm the results already 
obtained. RT-qPCR of eqbE in S. equi was carried out in THB, not a minimal media, it was 
not found if the regulation of equibactin was repressed in an iron-dependent manner 
via this method. However, when electrophoretic shift assays with EqbA were carried 
out, binding of EqbA to the eqbB promoter was increased on the presence of iron. The 
small colony phenotype of the eqbA mutant, due to the expression of the eqb genes 
leading to increased iron uptake, was reversed when media was supplemented with an 
iron chelator. These results demonstrate that expression of the eqb genes was regulated 
by EqbA in an iron-dependent manner (296). 
4.4.3 Growth in minimal media  
Growth of strain 71277 and its sfa, sbn and stb mutants were recorded over a 48h period 
to identify deficiencies in the growth rate that correlated with the loss of sfa, sbn or stb 
function. I showed that deletion of the staphylobactin locus did not independently 
demonstrate any detectable iron-restricted growth in either high or low serum, unless 
introduced into a strain bearing the sbn deletion. This indicates that staphylobactin has 
no significant role in Fe3+ uptake.  The stb, sfa, sbn triple mutant was predicted to be 
crippled in its ability to obtain Fe3+ and the results show that this mutant does not grow 
well in iron-limited media, however, its growth is just as attenuated as the sfa and sbn 
mutant, suggesting that staphylobactin does not contribute to iron acquisition in serum.  
A single deletion of sbn resulted in delayed growth kinetics and deletion of the sfa locus 
did not affect growth in iron deplete media, confirming results previously reported (210, 
218, 238). This suggests that staphyloferrins are the predominant siderophores 
produced by S. aureus. Staphylobactin could be a secondary mechanism for acquiring 
iron as the staphyloferrin-possessing strains are able to grow well in low iron conditions, 
and loss of either staphyloferrin A and staphylobactin are compensated for by the action 
of staphyloferrin B. In iron-replete growth media, the growth of mutant strains was 
unaltered in comparison to that of 71277. This shows that it’s an iron-dependent 
mechanism that’s causing the growth defect in iron-deplete media.  
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The S. aureus strain 8325-4 (mecA), a background that has been used to study the 
staphyloferrins previously, and strain 71277 (mecC) harbouring deletions in both sfa and 
sbn loci, grew very poorly in iron-deplete media containing serum or transferrin. The 
mecA strain lacking the stb locus grew at a slower rate and to a lower cell density than 
the mecC strain. This could suggest that staphylobactin plays a part in enhanced growth 
under these conditions. Maybe the strains containing the staphylobactin region are able 
to upregulate and efficiently utilise the staphyloferrins better than those strains lacking 
stb in these conditions.  
Comparison between mecA strains from different clonal complexes and host species 
varied largely in both growth rate and final optical density, suggesting that iron 
acquisition systems vary in their ability to utilise transferrin as an iron source. mecC 
CC130 strains from a variety of host species had the ability to utilise transferrin in serum 
more efficiently than mecA strains, but the ability to grow was not affected by the host 
that the strain was isolated from. 
mecC strains lacking the staphylobactin locus displayed similar growth to mecA strains, 
which grow slower with a lower final optical density, suggesting staphylobactin plays a 
part in enhanced growth. No conclusions can be drawn from the difference in growth 
rates and final optical density of strains isolated from different host species due to small 
sample size from each species.  
While carrying out growth curves, iron in its ferric state was added to the serum minimal 
media, allowing the mutant strains to recover to wild-type levels. The redox state of iron 
may have an effect on the results obtained and should be taken into consideration when 
carrying out future work. Addition of ferrous iron at varying concentrations to minimal 
media showed no difference in growth between strains at low (0.001), high (1 µM) and 
saturated (1000 µM). Only ∆sfa∆sbn mutants were able to grow at 10 and 100 µM 
concentrations. This may be due to the continued import of iron in the strains containing 
staphyloferrin biosynthesis, leading to toxic levels of intracellular iron. These results 
suggest staphylobactin is not involved in ferrous iron uptake. 
With the addition of manganese, 71277∆stb grew at a slower rate than wild-type but 
eventually reached the same OD. It was previously demonstrated that deletion of mntH 
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in S. aureus does not lead to an appreciable growth defect in metal depleted media, 
suggesting that MntABC may be the dominant manganese transporter in S. aureus under 
in vitro conditions (290). Staphylobactin may play a role in manganese acquisition, but 
only a slightly reduced growth defect was observed and any involvement in manganese 
acquisition may be masked by the more dominant manganese transporter. By adding a 
range of manganese, it was determined that 71277∆mntR had a higher growth yield at 
low concentrations of Mn2+ and exhibited a reduced growth yield at raised Mn2+ levels. 
This is not surprising as MntR is known to be a manganese-modulated transcriptional 
regulator (290). At high concentrations of Mn2+, 71277∆mntR had very limited growth, 
which may be due to manganese being constantly imported into the cell due to the 
manganese transporter not being repressed by MntR.  
Adding zinc, copper, nickel and cobalt ions to the minimal media had no effect on growth 
suggesting staphylobactin is not involved in acquisition of these ions. Low iron, 
lactoferrin containing milk displayed no difference in growth between strains, 
suggesting staphylobactin is not responsible for iron acquisition in these conditions. 
4.4.4 Transport- Sensitivity to streptonigrin 
Staphylobactin mutants were tested for sensitivity to streptonigrin to try and determine 
the contribution of staphylobactin locus to intracellular iron accumulation. When strains 
were tested for streptonigrin MIC in minimal media (iron deplete) and Mueller-Hinton 
broth (iron-replete) there was no obvious difference between strains. If staphylobactin 
was involved in iron acquisition you would expect the wild-type strain to have a lower 
MIC than the deletion mutants when grown in iron-restricted TMS, this was previously 
observed for ∆sirA and ∆sirB (involved in staphyloferrin B transport), but not in iron-rich 
media. This may be due to no difference between strains of intracellular iron 
concentrations.  
When these strains were monitored for growth in minimal media and TSA at a range of 
streptonigrin concentrations. No growth of any strain was observed at 20 ng/ml. At 10 
ng/ml, all strains except 8315-4∆sfa∆sbn were sensitive to the antibiotic, suggesting this 
strain does not accumulation iron making it reasonably resistant, compared to the wild-
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type strain, which is what would be expected, however, there is no difference to the iron 
that is accumulated between strain 71277 and its siderophore deletion mutants, 
suggesting there could be another mechanism involved in iron accumulation.  At 5 
ng/ml, wild-type strain 71277 was the only strain unable to grow in iron-limited media. 
This result may be due to the minimal media having a very small iron source, leading to 
lower intracellular iron pool concentrations, and therefore being more resistant to the 
toxic effects of streptonigrin. Where there was a difference in growth between strains 
in minimal media in the presence of streptonigrin, it was insignificant. The OD600 was 
between 0.1-0.3 compared to growth without streptonigrin (OD600 0.36-0.42). These 
differences are too small to be statistically significant and draw any conclusions. This 
slight reduction in growth compared to the minimal media control could be due to the 
toxic effects of streptonigrin on the cells as they have intracellular iron pools. When 
these strains were tested in the high iron media, TSB, allowing strains to accumulate 
higher intracellular iron pool concentrations, and be more sensitive to the damaging 
effects of streptonigrin than bacteria grown in low-iron media, highlighting the 
difference between wild-type and mutants.  
There was no difference between parent strains and their deletion mutants of 
staphyloferrins and/or staphylobactin, suggesting that staphylobactin does not 
contribute to iron acquisition by the organism, or any contribution is too small to 
measure by this assay. However, there was a difference between lineages, with 71277 
being slightly more susceptible than the 8325-4 background, which might suggest that 
there are other genes involved in iron accumulation or that the 8325-4 background 
could be metabolically less active, and just not accumulating iron. This result is the 
opposite of what I would expect because this wild-type strain has all its functioning 
siderophore transport systems allowing for transport of iron into the cell and therefore 
should have a higher intracellular concentration of iron making it more sensitive to 
streptonigrin.  
Annotation of the genes in the staphylobactin locus predicted that stbHIJ genes encode 
proteins with similarity to components of a putative iron uptake ABC transporter. As 
there was no difference between strains in the conditions tested suggests that 
staphylobactin or its predicted ABC transporter does not contribute to intracellular iron 
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accumulation. It has been shown that Fhu encodes proteins that are involved in 
hydroxamate siderophore iron transport in S. aureus. However, the Fhu mutant was 
equally sensitive to streptonigrin as the wild-type strain, suggesting that the fhu mutant 
was not reduced for intracellular iron concentrations in the absence of exogenous 
siderophore (452). This may be the case for staphylobactin mutants and why I see no 
difference between wild-type and stbHIJ or staphylobactin mutants. S. aureus encodes 
a multitude of ABC transporters involved in iron uptake, deletion of one may have little 
or no effect on intracellular iron concentrations due to compensation by other ABC 
transporters and this is why no major difference were seen in MIC or growth in media 
containing streptonigrin between wild-type and staphylobactin mutants. If StbHIJ is not 
functional, there is a possibility that the other known or an unknown siderophore 
transporters are responsible for the import of staphylobactin, for example Fhu which is 
known to import siderophores produced by other bacterial species. This assay could be 
repeated with strains that have had all the siderophore transports deleted, including Sir, 
Hts, Fhu and the predicted staphylobactin transporter stbHIJ. This may allow for better 
phenotyping of the staphylobactin region for iron import. The interpretation of the 
results from this assay are complicated by the number of different factors involved, 
including growth in minimal or iron-rich media, varying concentrations of streptonigrin 
and different combinations of siderophore biosynthesis and transport deletion mutants.  
4.4.5 Siderophore production-CAS assay 
The CAS assay can be used as a quantitative method for siderophore production. The 
compounds identified through this method belong to both hydroximate and catechol 
types and are identified by a colour change of the CAS medium from blue to orange. The 
CAS assay has become widely used since it is comprehensive, exceptionally responsive, 
and more convenient than other microbiological assays which, although sensitive, may 
be rigidly specific.  
No statistically significant difference in iron-chelating activity could be detected in the 
∆stb mutant compared to the wild-type. In fact there was a slight increase in 
siderophore production. In previous work with single staphyloferrin mutants, endpoint 
supernatant siderophore activity of the Δsbn mutant was equivalent to that of its parent 
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strain, as measured using the CAS assay, implying that staphyloferrin A might account 
for this recovery. This could be a possible reason why I did not see a difference between 
the wild-type and ∆stb mutant. The deletion of sfa and sbn locus from the 71277 and 
control 8325-4 strain showed significantly reduced production of iron-chelating activity. 
These are the results I would expect to see and showed that the assay was working. 
There was only a small reduction detected in the siderophore output of the 
∆sfa∆sbn∆stb mutant compared to ∆sfa∆sbn, however, this difference was statistically 
significant, providing some evidence that there is less siderophore produced and 
staphylobactin may have iron-chelating activity. The slight difference suggests that the 
concentration of staphylobactin in culture supernatant is low. It may not be produced 
in the conditions tested or the product of the stb cluster may have a low affinity for iron.  
No siderophore activity was seen in the equibactin mutant ∆eqbAHIJ when using the 
CAS assay (296), but deletion of eqbA would suggest an overproduction of eqbE 
according to the qPCR results. Therefore it would be more likely to detect equibactin in 
the culture supernatant. There is no information on whether the S. equi was grown in 
iron deplete media, allowing for the production of siderophore. The culture 
supernatants of S. lugdunensis grown in C-TMS (containing the staphylobactin 
homologue), tested negative in the CAS assay, indicating a lack of secreted iron binding 
molecules (334).  
A paper published by Ford et al. (453) used the SideroTech Kit (EmergenBio) to detect 
siderophore activity from culture supernatants. The kit works in the same way as the 
CAS assay but allows for the concentration of siderophore produced to be estimated 
from a reference curve produced by desferoxamine siderophore of varying 
concentrations. The CAS assay only detects siderophore concentrations above 2 µM, 
which could be well above the amount of staphylobactin produced. A high sensitivity 
modification of the CAS assay was developed by Andrews and Duckworth (454) for the  
detection of siderophore in natural waters that can be used to detect and quantify 
siderophore activity in the nM concentration range. The SideroTech kit or the high 
sensitivity assay could be used to try and detect if there were significant differences in 
siderophore activity in the mutant strains. Siderophores have variable affinity to iron, 
for example aerobactin and pyochelin have lower and others (e.g enterobactin) have 
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higher affinities to iron. If the staphylobactin cluster has a low affinity or acquires other 
metals there will be no detected result using these assays. Pyochelin, one of the two 
major siderophores produced and secreted by Pseudomonas aeruginosa, has been 
shown to bind and uptake other essential metals (455, 456) and this may also represent 
an alternative function for the stb NRPS product(s).  
4.4.6 Mass spectrometry 
Using LC-MS there is almost no difference mass ion composition of culture supernatants 
between wild-type and mutants with or without iron in the medium. This is despite 
siderophore activity using the CAS assay and also growth in minimal media being 
reduced for strains lacking the staphyloferrins.  
The same was observed for equibactin, when comparative metabolic profiling of the 
∆eqbA, ∆eqbAE and ∆eqbHIJA strains using LS-MS failed to identify equibactin. This was 
unexpected due to the effects of the streptonigrin sensitivity on strain ∆eqbAE in cross-
feeding assays. Examination of biologically active conditioned LB and minimal media 
from E. coli containing the reconstituted equibactin NRPS by LC-MS failed to identify 
equibactin. This suggests that the concentration of equibactin in culture supernatant is 
low or the product of the eqb cluster may have a low affinity for iron and a structure 
different from that proposed (296).  
Previous work carried out by Beasley et al. (210) examined low iron (C-TMS) culture 
supernatant concentrates of the S. aureus strain 8325-4, 8325-4∆sfa∆sbn, 8325-4∆sfa 
and 8325-4∆sbn for differences in mass ion composition using LC-ESI-MS identified 
staphyloferrin A and staphyloferrin B synthesised metabolite. A peak at m/z 447.14 
corresponded to the published structure of staphyloferrin B and a peak at 479.110 m/z 
represented staphyloferrin A.  
My results and previous work suggest that the media is iron deplete enough to elicit the 
production of staphyloferrins. Maybe the time from when the culture supernatant is 
removed, even though immediately frozen on dry ice, allows the siderophores to 
degrade before they are processed for LC-MS. In terms of staphylobactin production, 
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perhaps the concentration of staphylobactin is low or not produced in these conditions, 
therefore I have been unable to identify the metabolic product of staphylobactin. 
4.4.7 Virulence 
Finally, I sought to determine if the staphylobactin locus had an effect on S. aureus 
virulence in vivo using the wax moth larvae infection assay. Mammalian models of 
infection are costly and may raise ethical issues, therefore insects as infection models 
provide a valuable alternative. I chose to use larvae of the wax moth Galleria mellonella 
to study virulence as they are convenient and easy to handle, ethically acceptable, 
relatively inexpensive and a permissive host to study a variety of human and veterinary 
infectious diseases. The wax moth immune system shares a high degree of structural 
and functional similarity with the vertebrate innate immune system, and results have 
shown a strong correlation in virulence between mammalian models and wax moth 
(457). If the staphylobactin and staphyloferrin siderophores contributed to virulence 
then strains lacking either or both of these loci were expected to be less virulent than 
the wild-type strain. However, in the first set of experiments, strains lacking the ability 
to synthesise sfa, sbn and/or stb demonstrated no statistically significant difference in 
virulence compared to the wild-type isolate.  
Previously, staphyloferrin B mutants have shown attenuated virulence in a murine 
kidney abscess model of infection (202). However, inactivating siderophore biosynthesis 
has minimal or no impact on virulence in a mouse sepsis or skin abscess model of 
infection (238). Although, inactivating siderophore transport has a significant impact on 
virulence on a mouse sepsis model. This suggests that the model of infection used will 
have a big impact on the results obtained. All the S. aureus isolates containing the 
staphylobactin locus were isolated from mammals, so wax moths are not their natural 
host. A large proportion of these isolates came from mastitic cows. It would be of 
interest to carry out any future work on virulence in a mouse mastitis model of infection 
(458).  
Comparison of wild-type mecC strains and wild-type mecA strains, found that mecC 
isolates were significantly more virulent than the mecA strains tested, suggesting that 
these strains may contain additional virulence factors or the mecA background is 
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intrinsically less virulent. This was only tested in a small number of different isolates, so 
more work would need to be carried out with a broader number of isolates to draw any 
conclusions.  
When S. equi and its eqbE deletion mutants were tested for virulence in its natural host, 
deletion of the equibactin locus renders S. equi significantly less able to cause acute 
disease (305). The staphylobactin locus may be important during different stages of 
infection. The yersiniabactin system has been shown to be essential in the early 
lymphatic stages of bubonic plague, irrelevant in the septicaemic stage, and critical in 
pneumonic plague. Two siderophores produced by B. cereus, petrobactin and 
bacillibactin, were shown to play different roles in virulence in the insect model. 
Bacillibactin is an important adaption factor, allowing B. cereus to disseminate into the 
low iron environment encountered in the insect haemocoel. S. aureus which produce 
staphylobactin may be adapted to acquire iron and cause disease in a certain niche, 
which the staphyloferrins are unable to. In S. aureus, haem transport mutants were 
studied in the murine pneumonia and a systemic infection models. A difference in 
bacterial load was only observed in the systemic infection model, suggesting that haem 
iron is not required for infection in the pneumonia model in the first 24 hours, but 
required by S. aureus to establish and maintain infection in the longer systemic infection 
model (459). Interestingly, when I carried out the second experiment (Figure 4.17), 
comparison of isolates 71277 and 8325-4 lacking staphyloferrin production were found 
to be more virulent than their wild-type counterparts. By contrast siderophore mutants 
of other bacteria tested in the wax moth model displayed reduced virulence (240, 442, 
443). These results are difficult to interpret as I would expect the opposite result, 
suggesting the wax moth larvae model may not be particularly effective here.  
To date, I have not been able to demonstrate a role for stb in vivo in preliminary 
experiments using wax moth larvae. However, depending on the host infected, the type 
of tissues, and the available iron source, variation in the virulence phenotype of strains 
containing stb will be affected. Further studies in mammalian models are needed to 
elucidate this possibility. If staphylobactin is found to affect virulence then it could be 
used as a therapeutic target.  
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4.4.8 Conclusions 
To conclude, experiments showed weak but not convincing evidence that the 
staphylobactin gene cluster is involved in iron acquisition. If it is involved in iron 
acquisition then it must be interacting with other mechanisms which may explain the 
complexity and inconsistency of the results. At this point, it is not possible either to 
confirm or dismiss the hypothesis that the staphylobactin gene cluster is involved in iron 
acquisition.
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5.1 Introduction 
Coagulase is secreted by nearly all S. aureus strains and coagulates blood and plasma 
from various animals (121). S. aureus also produces clumping factor A (ClfA), which binds 
fibrinogen and contributes to platelet aggregation via a fibrinogen or complement 
dependent mechanism (122). In addition, vWbp binds von Willebrand factor (vWf) (123), 
a blood glycoprotein that is upregulated on host platelets and endothelial cells during 
haemostasis to promote blood coagulation (124). The ability of vWbp to bind this 
glycoprotein may have a role in localising prothrombin activation and therefore clot 
formation in the vicinity of the bacterium. The interaction between vWbp and vWf is 
highly specific and is mediated by a region of 26 amino acid residues in the C-terminal 
part of vWbp (123). When establishing endovascular infections, S. aureus adheres to the 
vessel wall under shear forces of flowing blood by vWbp-mediated binding to vWf (125, 
126). The secreted vWbp interacts with vWf and ClfA (a Sortase A-dependent 
staphylococcal surface protein) to form a complex that anchors S. aureus to vascular 
endothelium under shear stress (127).  
5.1.1 The contribution of vWbp and Coa to virulence  
Virulence studies with strains lacking the coa gene have been performed. Early work 
reported contributions of coagulase to the pathogenesis of staphylococcal infections 
(121, 460). In a mouse model, a role for coagulase in the development of pneumonia 
was suggested (461). Absence of coagulase activity improved outcome in models of skin 
infection, sepsis, catheter infection, and endocarditis (462). However, in murine models 
of subcutaneous and intramammary infection, no decrease in virulence was detected 
(463). Also, coa deletion mutants in S. aureus strain 8325-4 were still virulent in 
endocarditis, skin abscess and mastitis mouse models (462, 463). A paper published by 
Cheng et al. (118) suggested that Coa and vWbp are important for the pathogenesis of S. 
aureus infections, when measured as staphylococcal survival in the bloodstream, lethal 
bacteraemia or the ability of S. aureus to form abscesses and persist in mouse models.  
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5.1.2 Species specificity 
S. aureus can cause disease in a wide range of species, and certain S. aureus lineages (as 
defined by MLST) appear to be associated with a particular host species, providing 
evidence that S. aureus strains may adapt to their hosts by genetically determined 
mechanisms. The von Willebrand factor binding gene (vwb) has been linked with a role 
in host species specificity of S. aureus because distinct alleles of the gene appear to have 
varying abilities to coagulate different animal plasmas (464, 465). This specificity 
correlates with the host from which the strains were isolated, for example isolates from 
ruminants or horses can be differentiated from closely related human strains (466). 
Thus, the specificity of vWbp proteins can be used to infer the host specificity and 
evolutionary history of the S. aureus strains that harbour them.  
Many S. aureus strains have a highly conserved chromosomal vwb gene as well as a coa 
gene (123), which is not found in other Staphylococcus such as S. epidermidis. In addition 
to the chromosomally encoded vwb found in most S. aureus strains, many strains also 
possess a second vwb gene encoded on a mobile pathogenicity island (SaPI). The 
chromosomally encoded vWbp does not show species-specific coagulation activity 
(464). The SaPI-encoded vwb gene is widely distributed among strains infecting 
ruminant or equine hosts (467, 468).  
Most of the variation in vWbp from different strains is found in the N-terminal end, while 
the C-terminal end is more conserved and includes the vWf binding domain. vWbp 
shares 30% amino acid identity to the prothrombin binding domains of coagulase (123). 
The species-specific coagulation by vWbp has been shown to depend on its interaction 
with prothrombin (469) (Figure 5.1). Prothrombin is a conserved protein but species 
differences still exist (for example human and mouse prothrombin show 81% identity). 
The SaPI-encoded vWbps possess a unique N-terminal region specifically for the 
activation of ruminant and equine prothrombin (464). Equine SaPI vWbp can clot 
ruminant and equine plasma, however ruminant SaPI vWbp can only coagulate 
ruminant plasma. These SaPI-encoded vWbps may represent an important host 
adaption mechanism for S. aureus pathogenicity.  
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Figure 5.1 Alignment of vWbp and coagulase from S. aureus 
Part of the vWbp of S. aureus shows homology to coagulase. Amino acids (aa), von Willebrand 
factor-binding region (vW), fibrinogen-binding repeats (Fg) and prothrombin binding domain 
(prothrombin). Image modified from Bjerketorp et al. FEMS Microbiol Lett 2014 (469). 
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5.1.3 Host species adaption of mecC strains 
The mecC MRSA strains that have been sequenced by our group belong to a number of 
MLST sequence types including CC130, CC705, and CC425 lineages (470). These 
sequence types are able to cause infections across a broad range of host species. 
Analysis of the sequences in our strain collection led to the identification of strains 
within CC130 which have a chromosomal vwb allele that is divergent from chromosomal 
vwb in other S. aureus lineages. In this divergent vwb gene, a number of strains contain 
a non-synonymous mutation, exchanging adenine to thymine at position 398, which 
causes the generation of a premature stop-codon into the 5’ end of the gene. Strains 
with this mutation are found across the phylogeny, suggesting there is a selective 
advantage to loss of the vwb gene (86). As these isolates are commonly found in 
ruminants, repeated loss suggests that coagulation activity might be selected against, 
suggesting that the chromosomally encoded vWbp in CC130 has activity against 
ruminant plasma, unlike chromosomally encoded vWbp from other S. aureus lineages.  
Therefore I aimed investigate this, and specifically aimed to establish whether the 
chromosomal vwb alleles encoded by mecC positive strains have the ability to coagulate 
a broad range of animal plasmas, including human and/or bovine plasma and if the 
alleles encoded by these strains can contribute to host specific coagulation activity. This 
will provide evidence as to whether these strains are adapted to humans or cows, thus 
giving insight into strains’ likely origins and direction of transmission (humans to cows 
or cows to humans). In addition, the study also aimed to investigate the effects of the 
premature stop codon on the ability of strains to coagulate different animal plasmas. To 
do this, a range of mecC strains were tested for their ability to clot plasma from different 
species using a coagulation assay (Table 5.1). The following text in this introduction 
section describes unpublished work that was carried out by researchers, Dr Ewan 
Harrison, Alexandra Riddell and Martin Schulze in our group prior to my PhD studies.   
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Table 5.1. S. aureus isolates used in previous work performed by our group 
List of strains, the host species they were isolated from, geographical location, and sample site, 
year isolated with MLST and clonal complex. Strains with (*) contain the premature stop codon. 
5.1.4 Optimisation of coagulation assay performance 
Coagulation assays have previously been used to assess to ability of bacteria to 
coagulate plasma (464, 465, 471, 472). Firstly the coagulation assay described by Viana 
et al. (464) was tested for assay performance (description of clotting grading can be 
Strain Host Location Sample Year MLST CC 
LGA251 Bovine Somerset, England Bulk Milk 2007 425 425 
LGA254 Bovine Somerset, England Bulk Milk 2007 425 425 
M4A Bovine UK Milk 2012 425 425 
H093880936 Human Southeast England Ear swab 2009 425 425 
H102840444 Human Southwest England Nasal swab 2010 425 425 
MRSA P1 41/95 Cuniculi Belgium N/A 1995 425 425 
C03 365* Bovine 
Sutton Bonington, 
England 
Milk 2006-07 1245 130 
C03 362* Bovine 
Sutton Bonington, 
England 
Milk 2006-07 1245 130 
C04 831* Bovine Truro, England Milk 2006-07 1245 130 
10.1799.W* Human Tayside, Scotland Nasal swab 2010 1245 130 
73415 Human Herning, Denmark Wound 2010 1245 130 
KO Bovine Slagelse, Denmark Nasal swab 2011 130 130 
H061860351 Human Northwest England Sputum 2006 130 130 
70355* Human Hillerød, Denmark Nasal swab 2010 130 130 
51049 Human SLA, Denmark Wound 2006 130 130 
RN4220 Human N/A N/A 1983 8 8 
8_4 Human UK Nasal swab  398 398 
MRSA 1410 Murine Belgium N/A 2008-09 2273 49 
41764 Human SLA, Denmark Urine 2004 1943 
1943/
1946 
76626 Human Slagelse, Denmark Screen 2011 130 130 
25044 Canine Bavaria, Germany Abscess 2010 599 599 
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found in Table 5.2), including the number of colony forming units (CFU) added and effect 
on clotting time. The time taken for a given strain to coagulate bovine plasma was found 
to vary between repeats of the assay, from 4 hours to 24 hours. It was noted that strain 
RN4220 did not form clots within the 24 hour period, regardless of the CFU added. This 
is because some S. aureus isolates, RN4220 for example, have been found to contain an 
inactivating mutation in its chromosomal vwb gene and can only coagulate cuniculine 
plasma and not caprine, ovine or bovine plasma (464). However, when strain 8_4 was 
added to plasma there were clear differences in the rate of clot formation depending on 
the numbers of the bacteria used. It was able to form a grade 4 clot (fully clotted) at 2 
hours when 1 x 108 – 2 x 108 bacteria were added.  If more than 4 x 108 or less than 5 x 
107 were added to plasma, this reduced the formation of clots to grade 3 or 2, and no 
clotting was seen when greater than 1 x 109 or less than 1 x 107 added. Though after 24 
hours all strains formed grade 4 clots, showing how the number of bacteria affects the 
kinetics of clot formation but does not alter the results after 24 hours. The protocol 
described by Viana et al. was updated to reduce variation in CFU added, by incubating 
the culture at 37 ᵒC, shaking at 200 rpm for 14 hours. The clotting assay was carried out 
as described in the materials and methods section. 
5.1.5 Screening of mecC strains 
Once the coagulation assay had been optimised, screening of mecC strains were 
undertaken in order to determine whether the vwb alleles in the mecC positive strains 
accounted for differential coagulation activity. A selection of isolates from various 
animal origins (Table 5.1) were tested for their ability to coagulate a panel of mammalian 
plasmas. Comparison of the mecC strains sequenced show that their MLSTs separate 
into four clonal complexes and representative isolates from these clonal complexes 
were used. Analysis of the chromosomal vwb gene identified that the CC130 vwb is 
divergent (75% aa identity with strain Newman chromosomal vwb and 69% aa identity 
to the Equine SaPI vWbp (464)) from the vwb in other sequence types. Furthermore, a 
number of strains were identified that have the premature stop codon mutation 
(adenine to thymine at position 398) within their vwb gene. Representative isolates from 
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these four clonal complexes along with CC130 strains with or without the stop codon in 
the vwb gene were screened. RN4220, which contains an inactivating mutation in its 
vwb gene but has functional Coa activity (464) was used to help distinguish between 
those animal plasmas which are predominantly coagulated by Coa and those that are 
not. Results are shown in Table 5.2. S. aureus strains tested for their ability to coagulate 
plasma of different mammalian species. 
 
Table 5.2. S. aureus strains tested for their ability to coagulate plasma of different 
mammalian species 
Degree of clot formation after 24 hours incubation at 37 ᵒC. Clot formation was graded on a 
scale of 0 - 4: 0 = no coagulation, comparable appearance to negative control tubes; 1 = minimal 
coagulation; 2 = less than 50% of the plasma has coagulated; 3 = more than 50% of the plasma 
has coagulated; 4 = complete coagulation with no displacement of clot on tube inversion, 
comparable in appearance to strain 8_4 (positive control). RN4220 is the vwb negative control. 
Strains with (*) contain the premature stop codon. Strain 8_4 with (+) contains the SaPI 
associated vwb gene. 
 
 
Strain MLST Bovine Cuniculine Equine Human Ovine Porcine 
LGA251 425 0 0 0 0 0 0 
H102840444 425 0 4 3 1 0 3 
RN4220 8 0 4 3 4 0 3 
8_4+ 398 4 4 3 4 4 3 
KO 130 4 4 3 4 3 3 
76626 130 4 4 3 4 2 3 
H061860351 130 4 4 3 4 3 3 
70355* 130 1 4 3 4 2 3 
MRSA 1410 49 0 4 3 3 2 3 
10.1799.W* 1245 1 4 3 4 1 3 
41764 1943 0 4 3 3 1 3 
25044 599 0 4 2 2 3 3 
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The mecC positive strains that were tested against different animal plasmas were found 
to cause coagulation to a varying extent. All MRSA except LGA251, coagulated 
cuniculine, equine and porcine plasma within the 24 hour incubation period to some 
extent. RN4220 showed the ability to coagulate all of plasma types, except bovine and 
ovine, demonstrating the role for Coa in clot formation. Coa is known to be a weak 
coagulator of ruminant plasma (473) and so the grade 4 clots formed by strains 8_4, KO, 
76626 and H061860351 suggest that vWbp is likely to have been largely responsible for 
the coagulation observed. Strain 8_4 clotted bovine plasma after 2 hours incubation. It 
was the most efficient at coagulation, and the only strain that contains the SaPI 
associated vwb gene. Strains from CC130 demonstrate the ability to clot a broad range 
of hosts´ plasma including ruminant plasma, despite lacking ruminate SaPI vwb. With 
the exception of strain 8_4, all the other strains which coagulated bovine plasma 
belonged to clonal complex 130.  Of the CC130 strains tested, none of the strains giving 
grade 4 coagulation at 24 h contained the premature stop codon in vwb, while the two 
CC130 strains (70355 and 10.1799.W) which only inefficiently clotted the plasma 
possessed the premature stop codon (Table 5.2). 
After the initial screening of these strains, I carried out a more detailed investigation 
into the clotting ability of this novel vwb gene and the effect of the premature stop 
codon, in the work detailed below. 
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5.2 Materials and Methods 
Table 5.3. List of strains, plasmids and oligonucleotides used in this study 
Strain/Plasmid Description Reference 
S. aureus strains   
KO ST130, mecC clinical isolate, Denmark, nasal swab, bovine  This study 
KO∆vwb KO with vwb gene deletion This study 
KO∆vwb + pXBO1-vwb KO∆vwb complemented with pXB01-vwb This study 
KO∆vwb + pXBO1 KO∆vwb with empty plasmid pXB01 This study 
BCVA92 ST 398, mecA clinical isolate, human, nasal swab, UK (68) 
LGA254 
ST 425, mecC clinical isolate, 2007, bovine, bulk milk, 
Somerset, UK 
(67) 
76626 ST130, mecC clinical isolate, Denmark, human This study 
70355 
ST130, mecC clinical isolate, Denmark, human, containing 
the premature stop codon 
(67) 
51049 ST130, mecC clinical isolate, Denmark, human This study 
73415 ST130, mecC clinical isolate, Denmark, human This study 
C03 362 
ST1245, mecC isolate, England, bovine, containing the 
premature stop codon 
This study 
C03 365 
ST1245, mecC isolate, England, bovine, containing the 
premature stop codon 
This study 
RN4220 Restriction-defective derivative of NCTC8325-4 (395) 
Newman S. aureus reference strain  
LGA251 ST425, mecC reference strain  (67) 
PI 41/95 ST425, mecC isolate, Belgium, rabbit This study 
H093880936 ST425, mecC isolate, England, human This study 
M4A ST425, mecC isolate, England, bovine This study 
71277 ST130, mecC clinical isolate, Denmark, human, containing 
the premature stop codon 
This study 
L. lactis strains   
L. lactis cremoris 1363 Lactococcus lactis cremoris strain 1363 (474) 
L. lactis + pORI123 L. lactis containing pORI23 plasmid (475) 
L. lactis + pORI123-
vwb-KO 
L. lactis containing pORI23 plasmid vwb gene from KO This study 
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L. lactis + pORI123-
vwb-71277 
L. lactis containing pORI23 plasmid vwb gene from 71277 
containing the premature stop codon 
This study 
E. coli Strains   
DC10B Δdcm in the DH10B background; Dam methylation only  (396) 
Plasmids   
pXB01 
E. coli - S. aureus shuttle vector pRMC2 with bla deletion; 
CmR 
(404) 
pXBO1 vwb pXB01 with vwb gene from strain KO This study 
pIMAY pIMC5 with tetracycline inducible secY antisense from 
pKOR1; CmR  
(391) 
pIMAY∆vwb Modified pIMAY for deleting vwb gene This study 
pORI23-vwb-71277 Modified pORI23 with vwb gene from strain 71277 This study 
Primers   
vWBF A ATATGGTACCGCATGTGGTAGTGTTGGGTTA KpnI  
vWBF B AACATGTTGAATCAATATCCAGG  
vWBF C 
GGATATTGATTCAACATGTTCTTCCATATGTAATTTGAAGTAA
T 
 
vWBF D ATATGAGCTCGCATTGATGTCACTAATCTC SacI 
vWBF OUT FW GCTATGCACTTAATTACTGGTGTGA  
vWBF OUT RV GGATTTCTAGTGTATGAGTCGTTGAG  
vWBF COMP FW ATATGGTACCGGATATTGATTCAACATGTTTTGTAAAGC KpnI 
vWBF COMP RV ATATGAGCTCCTTCAAATTACATATGGAAGGTCG SacI 
IM151 TACATGTCAAGAATAAACTGCCAAAGC  (391) 
IM152 AATACCTGTGACGGAAGATCACTTCG  (391) 
5.2.1 Preparation of bacterial cultures  
Bacterial strains, plasmids and primers are listed in Table 5.3 For routine culture, 
Escherichia coli (E. coli) was grown in Lysogeny broth (LB) or on L-agar (Oxoid, UK) at 37 
°C. S. aureus from glycerol stocks were streaked onto Columbia blood agar plates (Oxoid, 
UK) or Tryptone Soy Agar (TSA) and grown overnight at 37oC.  L. lactis was grown at 30 
ᵒC in M17 medium (Oxoid) supplemented with 0.5% glucose (GM17). For the 
coagulation assay, bacteria were prepared as follows: single colonies of S. aureus were 
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used to inoculate 5 ml of Tryptic Soy Broth (TSB, Oxoid) and grown for 15 hours at 37 ⁰C 
with 200 rpm. L. lactis colonies were inoculated into GM17 broth and grown at 30 ᵒC, 
200 rpm overnight. The overnight cultures were centrifuged at 3000 rpm for 5 minutes 
and the supernatants discarded. The pellets were resuspended in 4 ml sterile phosphate 
buffered saline (PBS, Oxoid). 
Whenever appropriate, antibiotics were added to the media as follows: erythromycin at 
5 µg/ml for L. lactis and at 300 µg/ml for E. coli containing pORI23. S. aureus and E. coli 
were supplemented with 10 μg/ml chloramphenicol (Cm10) as appropriate.  
5.2.2 Generating vwb deletion mutant 
Oligonucleotides primer sequences are listed in Table 5.3. vwb deletion mutants in KO 
mecC-MRSA strain were generated by allelic exchange with the temperature-sensitive 
vector pIMAY, as previously described. Sequences upstream and downstream of vwb 
gene to be deleted were amplified with primers A/B or C/D using Phusion High Fidelity 
DNA Polymerase (ThermoFisher). PCR products AB and CD were used as templates to 
obtain deletion construct AD with primers A/D in a splicing overlap extension (SOE) PCR. 
For performing SOE-PCR, KOD Hot Start DNA Polymerase (Merck, UK) was used. 
Separate master mix A and B were prepared. Master mix A consisted of 5 μl KOD buffer 
(5X), 5 μl dNTPs, 3 μl MgSO4, 0.7 μl KOD enzyme and 26.3 μl Milli-Q water.  Master mix 
B consisted of 2.5 μl primer A and 2.5 μl primer D. Template DNA was prepared by mixing 
2.5 μl AB, 2.5 μl CD PCR product. Template DNA (5 μl) was added into master mix A and 
SOE-PCR was run for 10 cycles under the following conditions: 94°C for 5 min; 10 cycles 
of 94°C for 30s, 60°C for 1.5 min and 72°C for 2.5 min. An extra step of 10°C for 5 min 
was added in the program when adding master mix B in the reaction tube. SOE-PCR then 
was continued under the following conditions: 95°C for 2 min; then 35 cycles of 95°C for 
20s, 59°C for 10s and 70°C for 50s; and one final extension step of 70°C for 5 min. The 
SOE-PCR product of about 1.6 kb was isolated from agarose gel using YORBIO Gel/PCR 
DNA Purification Kit (YORBIO, UK). Product AD was digested with restriction enzymes 
KpnI and SacI (New England BioLabs) and ligated using T4 DNA Ligase (Life Technologies, 
UK) to pIMAY digested with the same enzymes. The resulting plasmids were designated 
pIMAY∆vwb. The plasmid was transformed into E. coli DC10B (a dcm deletion mutant of 
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DH10B, allowing the plasmid to be directly transferred into S. aureus strains) and 
plasmid DNA extracted using QIAprep Spin Miniprep Kit (Qiagen) from DC10B was then 
electroporated into S. aureus CC130 strain KO to create knockout mutants. Figure 5.4 
shows the vwb gene deletion in KO as an example. 
5.2.3 Complementation of deletion mutant 
For complement expression of vwb, the gene was cloned into expression plasmid pXB01, 
a derivative of the tetracycline-inducible expression vector pRMC2 with a deleted bla 
gene (404). The vwb gene was amplified from KO genome DNA with primers vwb COMP 
FW / vwb COMP RV. PCR products were digested with KpnI and SacI and ligated with the 
pXB01 plasmid cut with the same enzymes, generating plasmid pXB01vwb. The 
sequence was verified and the plasmid was transformed into E. coli DC10B. The plasmid 
DNA was then extracted and electroporated into mutant strains for complementation 
with expression, induced with 200 ng/ml anhydrotetracycline (Sigma-Aldrich, UK). 
5.2.4 Preparation of electrocompetent Lactococci    
100 ml of SGM17 media was inoculated with 1.5 ml of overnight L. lactis culture grown 
in SGM17 and incubated at 30 °C and 200 rpm. The culture was incubated until the 
OD595nm reached ~0.5 and centrifuged for 10 min, 5000 rpm at 4°C. The supernatant was 
removed and the pellets resuspended in 50 ml of ice cold 0.5M sucrose containing 10% 
glycerol, centrifuged again under the same conditions and the cell pellets resuspended 
in 25 ml of ice cold sucrose containing 10% glycerol, followed by another centrifugation 
and the cells resuspended in 1 ml of 0.5M sucrose containing 10% glycerol, stored at -
80 ᵒC in 40 μl aliquots.  
5.2.5 Electroporation of plasmid pORI23-vwb-71277 into L. lactis 
The plasmid pORI23 containing the vwb gene cloned from strain 71277 created during 
previous work on this study was extracted from E. coli cells using QIAprep Spin Miniprep 
Kit (Qiagen) and 5 µl was added to 40 µl of electrocompetent L. lactis cells in an 
electroporation cuvette and electroporated under the conditions of 25 μF, 200 Ω and 
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2.0 kV. 950 μl of SGM17MC medium were then added immediately and the cuvettes put 
back on ice for 5 min. The mixture was incubated at 30 °C for 2 h slightly rotating. 100 
μl of the culture and 10-1, 10-2, 10-3 dilutions were plated on streptococcus regeneration 
medium (SRM) with 5 μg/ml erythromycin and incubated at 30 °C for 48 h. The presence 
of the plasmid was confirmed by colony PCR with primers for the MCS for pORI23. 
5.2.6 Coagulation Assay 
Adapted from (464).  Cuniculine, bovine, human, equine, and ovine plasma were used 
for the coagulation assays. Blood from these animals was collected in 
ethylenediaminetetraacetic acid (EDTA) and centrifugation (3500 rpm at 4 ⁰C for 10 
minutes) was used to separate out the plasma from the other blood constituents. 
Plasma was either used fresh on the same day as collected or was stored at -20 and 
defrosted to room temperature when required. The coagulation assay was carried out 
by mixing 300 μl of plasma with 50 μl (1 x 108) of PBS-washed S. aureus from an overnight 
culture in a sealed glass test tube. The contents were mixed by gentle agitation and 
incubated at 37 ᵒC and the levels of coagulation was observed in comparison to controls 
by tilting the tubes at hourly intervals for four hours and then at 24 hours of incubation. 
For the negative control, 50 μl of PBS was added to the plasma. Positive controls were 
dependent on the plasma being used. For ruminant plasma strain BCVA92 (ST398) was 
used. Every strain was tested in triplicate and each assay was repeated at least twice. A 
positive result was obtained if a visible clot was formed in the contents of the tube at 
any one of these time points. They were scored as follows: minimal clotting apparent 
(1), less than 50% of the suspension has clotted (2) more than 50% of the liquid in the 
tube has clotted (3), and complete clot with no liquid on inversion (4).  
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5.3 Results 
5.3.1 Identification of stop codons in vwb gene in CC130 isolates 
Genomic analysis of CC130 isolates from humans and animals identified that the vwb 
genes in distinct clades, including a large clade from cattle, had an inactivating mutation 
in vwb, which should have no coagulation activity in cattle (Figure 5.2). This led to two 
hypotheses. Firstly, it could be that because the vwb gene was not required in cattle its 
loss was a random mutation. However, as this had happened on multiple occasions this 
seemed unlikely. Therefore the second hypothesis was that it actually functioned by 
promoting clotting in cattle and was being selected against. Thus the multiple 
inactivations were evolutionarily convergent due to a selective pressure.  
Figure 5.2 Phylogenetic tree showing the human and bovine CC130 isolates 
Maximum likelihood, midpoint rooted phylogeny based on core genome SNPs. Blue arrows and 
brackets indicate the strains containing the stop-codon within their chromosomal vwb gene. 
Colour of branches shows source of isolate: invasive disease (red), skin infection (yellow), human 
nasal carriage (orange), milk (blue), dog nasal swab (purple). Strain LGA251 included in the tree 
as a reference.  
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5.3.2 CC130 strains and the effect of the stop codon on coagulation of 
ruminant plasma  
A previous study on SaPI-encoded vwb has demonstrated that the ruminant coagulating 
activity conferred by vwb is not species specific (e.g. there is no difference between 
bovine or ovine plasma) (465). To confirm this, coagulation assays using bovine and 
ovine plasma were set up with a selection of CC130 strains along with the relevant 
controls (Table 5.4). CC130 strains containing the divergent vwb gene were able to clot 
bovine and ovine plasma after 24 hours. Comparison of five CC130 strains with the 
premature stop codon and five without, confirmed that the presence of the stop codon 
dramatically reduces the ability to coagulate bovine plasma (Table 5.4).  
 
 
 
 
 
 
 
Table 5.4. S. aureus CC130 strains ability to coagulate ruminant plasma 
To each tube of 300 µl of plasma, between 7 x108 – 9 x 109 CFU of S. aureus were added. Degree 
of clot formation at 24 hours incubation at 37 ᵒ C of S. aureus CC130 strains either with or without 
the presence of the vwb stop codon. Clot formation was graded on a scale of 0 - 4: 0= no 
coagulation, comparable appearance to negative control tubes; 1 = minimal coagulation; 2 = less 
than 50% of the plasma has coagulated; 3 = more than 50% of the plasma has coagulated; 4 = 
complete coagulation with no displacement of clot on tube inversion, comparable in appearance 
to strain BCVA92 (positive control for ruminant plasma). Strain RN4220 and PBS (negative 
control). Clotting assays were carried out in triplicate for each strain. N/A, this test was not done. 
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5.3.3 Evidence of host range of CC130 vwb in comparison to other 
lineages. 
5.3.3.1 Plasmid and deletion mutant construction 
In order to confirm the ability of the vwb gene to clot a variety of mammalian plasma in 
mecC CC130 strains, a vwb gene deletion mutant was constructed in strain KO that was 
isolated by nasal swab from a bovine host in Denmark. Strain KO has been shown to fully 
clot bovine plasma after 24 hours (Table 5.2) and does not contain the premature stop 
codon in the vwb gene that has been shown to reduce the ability to clot bovine plasma 
(Table 5.3). Figure 5.3 shows the construction of the vwb gene deletion in KO. 
 
Strain MLST Stop codon Bovine  Ovine  
KO 130 No 4 3 
MRSA 1410 130 No 4 3 
H061860351 130 No 4 3 
51049 130 No 4 3 
73415 1245 No 3 3 
C03 362 1245 No 1 3 
C03 365 1245 No 1 3 
C04 831 1245 Yes 0 N/A 
10.1799.W 1245 Yes 1 1 
70355 130 Yes 0 2 
RN4220 (-) N/A No 0 0 
BCVA92 (+) 398 No 4 4 
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Figure 5.3 Generating vwb gene deletion in S. aureus strain KO 
(A) PCR amplification of upstream fragment AB and downstream fragment CD of the vwb gene 
from KO genomic DNA using Phusion High Fidelity DNA Polymerase. Fragment AB and CD then 
were joined together using primer A/D in a Splice Overlap Extension (SOE) PCR, resulting in 
fragment AD. Plasmid pIMAY and fragment AD were both digested with SacI / KpnI and ligated 
together using T4 DNA ligase (Life Technologies, UK). Resulting construct, pIMAYΔvwb was 
transformed into E. coli DC10B. pIMAYΔvwb extracted from DC10B was electroporated into KO 
at 28 °C.  
(B, C) Single crossover integration was stimulated by growth at 37 °C on TSA (Cm10). Then loss 
of replicating plasmid was confirmed by colony PCR with MCS primers (IM151/152). Colonies 
negative for replicating plasmid were then screened for the side of integration with primers 
Δvwb_outF/D (AB side integration) and ΔvwbA/outR (CD side). A clone from either AB or CD 
integration event was grown at 28 °C in broth without antibiotic selection to stimulate rolling 
circle replication and then plated on TSA with 1 μg/ml ATc. Expression of the secY antisense RNA 
(a-secY) inhibits growth of cells maintaining the plasmid. If the plasmid integration event 
occured through the AB side, plasmid excision through the AB side recreates the wild-type locus, 
while CD excision yields a mutated gene. Figure 5.3B was sourced from (396).  
(D) Colony PCR screening of deletion mutants using primers Δvwb_outF/R, deletion mutants 
gave a PCR produce about 1.5 kb, while wild-type colonies gave a larger fragment. 
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To confirm if any change in coagulation ability is due to the loss of the vwb gene, a 
deletion complement was made using the plasmid pXB01 that expressed the KO vwb 
gene which had been deleted from the chromosome. The strains that were generated, 
along with mecA strain BCVA 92 (ST 398) which has shown to be very efficient at clotting 
bovine plasma, LGA251, LGA254 and 76626 were tested with the coagulation assay 
using bovine plasma. Results are shown in Table 5.5. 
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Table 5.5. Role of vwb in coagulation of bovine plasma in CC130 S. aureus. 
Strain BCVA92, positive control for ruminant plasma. PBS (negative control). 
 
 
 
 
 
 
 
 
 
 
As expected strain LGA254 and BCVA 92 were fully able to clot bovine plasma after 24 
hours, whereas strain LGA251 and the PBS control showed no clotting ability. The wild-
type strain KO and 76626, both mecC CC130 strains, were able to clot to grade 3 (more 
than 50% of the liquid in the tube has clotted), which were similar to previous results, 
but not to the full extent seen at 24 hours incubation. The deletion strain showed no 
clotting ability, and the strain containing the empty pXB01 plasmid showed grade 1 
clotting (very minimal clotting). The clotting ability was restored on complementation of 
the vwb mutant with the vwb containing plasmid pXB01. This data indicates that the 
vWbp is responsible for S. aureus strain KO ability to clot bovine plasma, and is not due 
to the activity of Coa. The clotting assay was not carried out with ovine plasma due to 
lack of available ovine plasma at the time. 
5.3.4 Expression of vwb CC130 in L. lactis 
To understand the ability of vWbp from CC130 strains to coagulate a broad range of 
animal plasma, and to eliminate the possibility that the native coa gene or other proteins 
expressed by S. aureus contributed to the results, the vwb genes were cloned into the 
E. coli pORI23 plasmid and expressed in Lactococcus lactis subsp. cremoris 1363. L. lactis 
Strain  Bovine clotting after 24 hours 
KO 3 
KO∆vwb 0 
KO∆vwb+pXB01 1 
KO∆vwb+pXB01vwb 3 
BCVA92 4 
LGA254 4 
LGA251 0 
76626 3 
PBS 0 
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was used as it has a well understood genetic background, and lacks other factors that 
could affect the clotting activity of vWbp, while being able to secrete S. aureus proteins. 
Also the pORI23 E. coli – L. lactis shuttle and expression plasmid has been used in other 
projects with ClfA (475). This experiment allows a way to study individual staphylococcal 
pathogenic factors, complementing the classical knockout mutagenesis strategy. The L. 
lactis strains containing the pORI23 plasmid which constituently expresses the vwb gene 
from CC130 strain KO were tested for their clotting ability. The strains were tested for 
the coagulation of bovine plasma at 1, 2, 3, 4 and 24 hours incubation at 30 ᵒC (Table 
5.6). No clotting was observed for any strains between 1-4 hours incubation (results not 
shown). L. lactis expressing the vwb gene from CC130 can fully clot bovine plasma by 24 
hours, whereas L. lactis, L. lactis containing the empty pORI23 plasmid and the PBC 
control were unable to clot bovine plasma suggesting that the vWbp produced by the 
chromosomally divergent vwb gene is solely responsible for the clotting of bovine 
plasma. In order to provide further evidence of this divergent vWbp’s ability to clot 
plasma from a broad host range and the effect of the stop codon, a strain of L. lactis was 
created containing the pORI23 plasmid expressing the vwb gene from strain 71277, 
which is known to contain the premature stop codon. 
 
Table 5.6. Coagulation of bovine plasma by L. lactis expressing the CC130 vwb gene 
L. lactis expressing vWbp clots bovine plasma. Strains were tested in triplicate and clotting was 
graded after incubation at 30 ᵒ C for 24 hours.  L. Lactis 1363, L. Lactis +pORI23, L. Lactis +pORI23-
vwb-71277 (contains stop codon) and PBS are the negative controls. 
 
 
 
 
 
 
Strains Bovine clotting after 24 hr 
L. Lactis 1363 0 
L. Lactis +pORI23  0 
L. Lactis +pORI23-vwb-KO  4 
L. Lactis +pORI23-vwb-71277 0 
PBS 0 
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Finally the KO strain and its vwb deletion mutants, along with the L. lactis strains 
containing the vwb gene, and control strains were tested against a broad panel of 
mammalian plasma to assess the full extent of the vwb gene of CC130 strains to 
coagulate plasma (Table 5.7).  
 
Table 5.7. Role of vwb in coagulation of plasma from a broad range of host species. 
Each strain tested in duplicate for each plasma. Results represent the outcome of three separate 
experiments. Between 3.35 x 107 – 2.75 x 108 CFU of S. aureus was added to 300 µl of plasma. 
Strain BCVA92 was the positive control for ruminant plasma. Strain RN4220, L. Lactis 1363, PBS 
and PBS + Atc were negative controls. Strains with (*) contain the premature stop codon in the 
vwb gene.  
 
Strain Bovine Human Ovine Porcine Cuniculine Equine Canine Feline 
KO 3 4 4 3 4 4 2 4 
KO∆vwb 1 4 4 3 4 4 2 4 
KO∆vwb+ 
pXB01vwb 
2 4 4 4 4 4 3 4 
KO∆vwb+pXB01 1 4 3 3 4 4 2 3 
L. Lactis 1363 0 0 0 0 0 0 0 0 
L. Lactis +pORI23  0 0 0 0 0 0 0 0 
L.Lactis+pORI23-
vwb-KO 
4 4 4 4 4 4 4 4 
L. Lactis+pORI23 -
vwb-71277* 
0 0 0 0 0 0 0 0 
RN4220 0 0 0 2 3 0 0 4 
Newman 0 1 3 3 4 4 0 1 
BCVA92 4 1 4 3 4 4 3 4 
LGA251 0 2 1 0 0 0 0 0 
71277* 0 4 4 3 4 4 1 3 
PBS+ Atc 0 0 0 0 0 0 0 0 
PBS 0 0 0 0 0 0 0 0 
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For each assay tested, none of the negative control tubes (either PBS+Atc or PBS in 
plasma) showed signs of coagulation after 24 h incubation. RN4220, which has been 
found to have an inactivating mutation in its chromosomal vwb gene, coagulated only 
cuniculine, porcine and feline plasma. Therefore, this clotting phenotype can be 
attributed to its Coa activity. CC130 strain KO showed the ability to clot plasma from all 
species tested. Human, ovine, cuniculine, equine and feline plasma all fully clotted. 
Bovine and porcine plasma clotted to grade 3 (more than 50%) and canine to grade 2 
(less than 50%). However, deletion of the vwb gene only reduced the clotting of bovine 
plasma to minimal clotting, and the other species tested clotted to the same extent as 
the wild-type. Complementation of the gene deletion by pXB01 expressing the vwb gene 
increased its ability to clot bovine and canine plasma compared to the deletion mutant. 
The deletion control strain containing the empty vector displayed the same clotting 
phenotype as the vwb deletion mutant. CC130 strain 71277, which contains the 
premature stop codon in its vwb gene, was unable to clot bovine plasma. It 
demonstrated the same clotting ability as strain KO for the other plasma tested, except 
for canine and feline, which has slightly reduced clotting ability. 
This suggested that the stop codon in this divergent vwb gene only affects the strains’ 
ability to coagulate bovine plasma. When strain LGA251 (ST425) was previously tested 
with a broad panel of animal plasma species, it was unable to form any clots. After it 
was retested, along with addition of canine and feline plasma, it displayed minimal 
clotting for human and ovine plasma, but no visible clots for the other plasmas. L. lactis 
strains containing either no vector (L. Lactis 1363), empty vector (L. Lactis +pORI23) or 
vector containing the vwb gene with the premature stop codon (L. Lactis +pORI23-vwb-
71277) did not clot plasma from any species tested. These results confirmed that L. lactis 
containing the pORI23-vwb-KO plasmid expressed a vwb protein able to fully clot plasma 
from all species tested.  
These results suggest that the divergent vwb is able to clot plasma from a wide variety 
of species, and the introduction of the stop codon renders the gene incapable of clotting 
any plasma, shown by the clotting phenotype of L. lactis expressing the vwb gene from 
strain 71277. 
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5.3.5 Screening of ST 425 strains 
The two ST 425 strains tested against a variety of mammalian plasma showed different 
coagulation abilities (Table 5.2). To determine if either of these strains showed a 
coagulation phenotype representative of ST 425, additional strains were tested for their 
ability to clot bovine, equine, ovine, porcine, cuniculine and human plasma (Table 5.8). 
These strains are interesting as they were isolated from a broad range of host species 
but also possess the ability to clot plasma of different species to varying degrees. 
 
Table 5.8. ST425 S. aureus strain’s tested for their ability to coagulate a broad range 
of host plasma.  
Between 1.5x108-3.5x108 CFU of S. aureus was added to each test tube. PBS was used as a 
negative control. 
Strain Host MLST Bovine Cuniculine Equine Human Ovine Porcine 
LGA251 Bovine 425 0 0 0 0 0 0 
LGA254 Bovine 425 4 4 3 3 4 3 
PI 41/95 Rabbit 425 0 4 3 2 0 3 
H093880936 Human 425 0 4 3 2 0 3 
H102840444 Human 425 0 4 3 1 0 3 
M4A Bovine 425 0 4 3 2 0 3 
 
Strain LGA251 was unable to coagulate any of the plasma tested. This may be due to a 
nonsense mutation at codon 240 in the coa gene. Strain LGA254 was found to have a 
distinct coagulation phenotype as it was able to rapidly coagulate all the plasma tested 
(Table 5.8) suggesting that this strain is a good producer of the S. aureus coagulases. 
Study of the LGA254 genome identified a second novel SaPI vwb allele. This may explain 
why LGA254 can clot plasma from diverse species, including equine. 
The other ST 425 strains are unable to clot ruminant plasma but clotted equine, porcine 
and cuniculine to the same extent as strain LGA254. They were also able to clot human 
plasma to a grade 2 clot (less than 50%).  
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5.4 Discussion 
When Bjerketorp et al (469) expressed the vwb gene from strain Newman and 8325-4, 
and tested their ability to coagulate plasma from many different animal species they 
found it did this with varying efficiency. The vWbp from human-adapted strains was a 
very efficient coagulator of human and porcine plasma, but a poor coagulator of goat, 
sheep, equine and bovine plasma (466). All S. aureus produce coagulase, which does not 
effectively induce clotting of ruminant plasma (473). This suggests the species-specific 
determinant is responsible for the difference in coagulation efficiency. Ruminant and 
equine isolates containing the additional SaPI encoded vwb gene that encodes a vWbp 
that can specifically clot ruminant and equine plasma (464), suggesting that the SaPI-
encoded vWbps may represent an important host adaption mechanism for S. aureus 
pathogenicity, and therefore that acquisition of vWbp-encoding SaPIs may be 
determinative for animal specificity.  
5.4.1 Identification of stop codons in vwb gene in CC130 isolates 
Whole genome sequencing of the mecC isolates in our collection from a broad range of 
host species revealed a unique vwb gene compared to other vwb genes characterised 
to date. S. aureus normally contains a highly conserved chromosomal vwb gene in 
addition to their coa gene (123). Basic screening showed that mecC CC130 strains 
isolated from human and bovine hosts, possessing the divergent vwb were able to 
coagulate bovine, cuniculine, equine, human, ovine and porcine plasma, unlike other 
mecA strains studied that have been shown to clot species specific plasma. These CC130 
strains could coagulate ruminant plasma, despite lacking the SaPI encoded vwb. While 
clear differences were observed in the ability of the strains to coagulate bovine plasma, 
there was little variation in the ability of the strains to coagulate porcine, equine and 
cuniculine plasma, despite the fact that they have a divergent vwb. This is probably due 
to this divergent vWbp having the ability to interact with a broad range of prothrombin 
from different species. Prothrombin is not well conserved between different animal 
species (464) and vWbp that interacts optimally with one animal prothrombin may be 
less able to interact with prothrombin from another species. A number of CC130 strains, 
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including bovine isolates, were found to have a premature stop codon mutation within 
their vwb gene, causing a loss of their ability to clot bovine plasma, but had little effect 
on their ability to clot ovine plasma.  
5.4.2 CC130 strains and the effect of the stop codon on coagulation of 
ruminant plasma  
These results provide preliminary evidence supporting a role for chromosomal vWbp in 
host species coagulation activity. The reason for this selection against the production of 
vWbp is not obvious and might be a sign of a host specialisation where the vWbp is not 
needed. One theory is that the ability to clot blood is largely redundant as a fitness factor 
in mammary gland infections. Therefore, the presence of this particular vwb allele within 
the CC130 lineage may not only reflect host adaptation but may also be an example of 
an adaptation for a particular ecological niche i.e. the bovine mammary gland.  
5.4.3 Knock out and complementation in S. aureus 
The presence of the divergent vWbp in the CC130 isolates was found to correlate with 
an ability to coagulate bovine plasma and its deletion from a bovine isolate was found 
to abolish the bovine plasma coagulation phenotype. Re-complementation of vwb into 
the deleted strain was found to restore the ability to coagulate bovine plasma, further 
supporting the conclusions that the vWbp is responsible for the species-specific 
coagulation activity. The deletion did not alter this strain’s ability to coagulate all the 
other species plasma, especially ovine and equine plasma which is normally associated 
with the SaPI encoded vwb, which this strain is lacking. But given that these strains can 
clot the other plasma maybe the coa gene is divergent as well.  
5.4.4 L. lactis confirms the divergent vWbp to coagulate a broad range of 
animal plasma and the effect of the stop codons. 
When testing these strains, it is possible that coagulation arising from Coa activity could 
mask any variation in coagulation capacity due to vWbp. It has been observed that 
purified Coa is more efficient at coagulating rabbit plasma than vWbp, but it is unknown 
whether both proteins are secreted by the bacterium to the same extent. The results of 
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this assay could not determine whether the difference in clotting was due to vWbp or 
Coa, as their activities could not be separated. coa expression could also be responsible 
for the difference in coagulation, especially in strains containing the stop codon in the 
vwb gene. This would compensate for vWbp not being produced, allowing these strains 
to coagulate ovine plasma.  
The ability to test S. aureus mutants of the vwb gene was limited as other factors might 
overcome and compensate for the function of the missing or mutated factor. To 
circumvent this problem, and to allow Coa activity to be distinguished from vWbp 
activity, I expressed the divergent S. aureus vwb gene, with and without the premature 
stop codon in a less virulent organism. These strains were tested for this specific 
determinant to clot plasma from a broad range of host species. I hypothesised that 
expression of vwb in Lactococci would result in their ability to clot plasma from a broad 
range of host species, even though staphylococcal knockout mutants are not defective 
in clotting. L. lactis is devoid of virulence factors and has a well characterised genetic 
background. This bacteria has already been used to express single staphylococcal 
surface proteins (127, 475). Genes are expressed when useful for the bacteria and 
downregulated when unnecessary. Therefore, expressing these factors constitutively in 
a surrogate bacterium might help discriminate between their intrinsic contribution 
when taken alone and the importance of their regulation in the staphylococcal context. 
The promoters of the pORI23 plasmid expressed the vwb gene constitutively, leading to 
the over expression of vWbp. L. lactis alone is unable to cause coagulation of any species 
plasma, therefore the expression of the CC130 vwb from pORI23 in L. lactis is responsible 
for the complete clotting of all plasma tested.  
5.4.5 Conclusions 
Mobile genetic elements play a central role in the adaption of S. aureus strains to 
different host species (467, 476). The chromosomal vwb and coa confers species specific 
coagulation activity. The SaPI vWbp confers the specific activation of ruminant and 
equine prothrombin. It has been suggested that the equine SaPI vwb gene evolved from 
an ancestral bovine or ovine SaPI vwb gene, maybe by recombination, to enhance its 
Investigation of a novel iron-uptake system and other genomic features in mecC 
Staphylococcus aureus 
198  Claire Raisen - January 2019 
adaption to an equine host (464). However, it has been shown that porcine isolates had 
only a weak clotting activity with porcine plasma (464). But in the case of mecC CC130 
strains, the vWbp seems responsible for clotting in a broad range of host species plasma. 
The divergent vwb chromosomal genes may have evolved from the human adapted 
strains by SNPs to allow this strain to infect different hosts. Overall, these divergent vwb 
genes encode host-specific functional activity likely to be important to S. aureus CC130 
host adaption.  
5.4.6 Future work 
Further work that could be carried out on this project would be to transfer the vwb 
genes, chromosomal and SaPI, from strains covering a variety of backgrounds, into L. 
lactis and test their coagulation activity for proof that the clotting of plasma in difference 
animal species is due to the CC130 vwb gene only and no other factors, such as 
coagulase.  
A possible strain to carry this out with is LGA251 (ST425), a bovine associated strain that 
has no clotting ability of the plasma tested, except very minimal clotting of human and 
ovine plasma, despite being cattle associated. It has been suggested that this may be 
due to a nonsense mutation at codon 240 in the coa gene, so any clotting activity would 
be due to its chromosomal vwb gene. Both the coa gene and the vwb gene could be 
cloned into L. lactis to assess their coagulation activity. Strain LGA254 (ST425) was found 
to have a distinct coagulation phenotype as it was able to rapidly coagulate all the 
plasma tested. This strain contains both the chromosomal and SaPI vwb genes. Both vwb 
genes could be cloned into L. lactis and their individual coagulation activity could be 
assessed. Other strains of interest would be Newman (human isolate), m-MR-6AA 
(ST133) which is ruminant-associated and C05 232 (ST151) which is bovine-associated. 
In this study, strain BCVA92 was the only isolate of human origin to effectively coagulate 
bovine plasma. It belongs to ST398, a sequence type that has a particularly diverse host 
range (477, 478). This may explain why this strain efficiently coagulated all the plasmas 
tested.  Work already carried out in our group has cloned vwb from strains 70355 
(CC130, human isolate), 41764 (human isolate), 10.4137.F (human isolate, ST22). These 
have already been cloned into pORI23 and can be transferred to L. lactis for expression. 
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Strain RN4220 has an inactivating mutation in its chromosomal vwb gene and has been 
shown to only coagulate cuniculine plasma and not ruminant through the activity of Coa. 
It would be of interest to create ∆coa, and ∆vwb/coa in strain KO to see the contribution 
of each coagulase to clotting ability of different animal plasmas, and to eliminate the 
possibility that the native coa gene contributed to this result. In this study, CC130 
isolates containing the divergent vwb gene isolated from humans and cows were tested 
for their ability to coagulate a broad range of animal plasma. Since these strains are not 
restricted to just human or bovine infections it would be interesting to study isolates 
from different species and investigate if the coagulation specificity is shifted towards the 
corresponding prothrombin. 
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6 GENERAL CONCLUSIONS AND 
FUTURE PERSPECTIVES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6: General conclusions and future perspectives 
 
Claire Raisen - January 2019   201 
6.1 Summary 
MRSA continues to be a significant cause of infections both in humans and animals. Since 
2011, mecC-carrying strains have been isolated from a broad range of host species, 
including humans, livestock, companion animals, and wildlife in more than 10 western 
European countries, presenting new challenges in MRSA diagnosis and treatment (59). 
The mecC isolates are capable of causing a wide variety of infections, including severe 
and fatal disease. mecC strains sequenced by our group have been shown to contain 
additional genetic features, such as the staphylobactin locus and the novel vwb gene, 
which may increase S. aureus ability to cause disease in a wide range of host species and 
niches.  
As detailed in Chapter 1, S. aureus possesses a multitude of mechanisms by which it can 
obtain iron from an iron-restricted host. It exploits multiple host iron sources by 
expressing a haem acquisition system (Isd), produces two α-hydroxycarboxylate-type 
siderophores, staphyloferrin A and staphyloferrin B which extract iron from host 
glycoproteins (197, 198, 203, 378, 479-481), and it expresses transporters for many 
other siderophores that it does not synthesise. The success of S. aureus as a pathogen is 
partly attributable to its numerous and often functionally redundant mechanisms for 
iron acquisition within the host (261).  
In Chapter 2 of this study, I have described the identification of the staphylobactin region 
in the genomes of mecC CC130 isolates, a non-host specific lineage, and investigated its 
possible role using sequence analysis. The novel locus encoding a siderophore-like non-
ribosomal peptide synthetase (NRPS) was found directly downstream of the SCCmec 
insertion site and is flanked by direct repeats, which suggest that staphylobactin could 
have been acquired by horizontal gene transfer. A homologous region was identified in 
Streptococcus equi, which encodes a NRPS termed ‘equibactin’ which is involved in iron 
acquisition (296).  The region has the same gene order and predicted functions as the 
equibactin locus, with stbE and stbG genes predicted to encode NRPSs, suggesting a 
possible role in iron acquisition. Of the 2,343 genomes that have been sequenced in our 
collection, 24% of these strains contained the staphylobactin region (97% belonging to 
CC130), covering a broad geographical and host range. The organisation of the stb 
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biosynthetic gene cluster is highly conserved in all CC130 S. aureus isolates. All these 
genomes contain the staphyloferrin B biosynthesis and transport genes, therefore 
staphylobactin was not acquired to compensate for lack of siderophore. When searching 
the genomes of other Staphylococcus spp., mainly CoNS, the staphylobactin locus was 
found in its entirety in all S. lugdunensis genomes searched and one S. hyicus isolate. 
Unlike the equibactin locus, the staphylobactin locus lacks a homolog for the iron-
dependent regulator EqbA. Instead, expression of this locus appears to be regulated by 
MntR, a DtxR-like regulator. A DtxR box upstream of stbB was identified. The substrate 
specificity of the two staphylobactin NRPS A-domains have conserved NRPS codes for 
cysteine and salicylate, suggesting that the staphylobactin cluster is likely to be 
functional. 
In Chapter 3, I discuss how I overcame barriers encountered to intrinsic restriction 
modification systems, low transduction frequency and low efficiency of recombination, 
when creating deletion mutants in bacteria which were extremely difficult to 
manipulate. I achieved this through developing and optimising a protocol, including an 
improved electroporation method, using the current tools and techniques available. This 
allowed the genetic manipulation of previously unmanipulated mecC strains, in order to 
study the function of genes. These staphylobactin and staphyloferrin mutants were used 
extensively throughout this thesis and will be indispensable for identifying the role of 
this gene cluster, assessing their role in pathogenicity and investigating how they can 
infect a broad range of host species. The protocols I developed have been used by Ba et 
al. (404) to study mecC strains. 
In Chapter 4, a number of assays were performed to access the possible function of the 
staphylobactin gene cluster in iron acquisition and their impact on virulence. Regulation 
and expression of siderophores in an iron-dependent manner were assessed using RT-
qPCR. MntR is possibly a positive regulator of the staphylobactin operon in an iron-
dependent manner. There was a slight increase in expression of staphylobactin NRPS in 
an iron deprivation-dependent fashion. Mutagenesis was performed to eliminate the 
siderophore biosynthetic loci from the S. aureus genome to dissect their individual and 
combined contributions toward growth in iron-restricted media, containing serum, 
transferrin, milk and metal ions. Deletion of the stb locus did not demonstrate any 
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detectable growth impairment in any of the conditions tested, unless introduced into a 
strain bearing the sbn deletion. Staphylobactin mutants were tested for sensitivity to 
streptonigrin to determine the contribution of the staphylobactin locus to intracellular 
iron accumulation. There was no difference detected between wild-type, staphylobactin 
biosynthetic and transport mutants in the conditions tested, suggesting that 
staphylobactin or its predicted ABC transporter does not contribute to intracellular iron 
accumulation. I evaluated whether staphylobactin could function as a NRPS antibiotic. 
The S. aureus CC130 strains seem to have the ability to kill other S. aureus isolates, which 
may contribute to their success. This doesn’t seem to be the role of the staphylobactin 
locus, as no loss of activity is seen in the ∆stb strain versus the wild-type. I determined 
whether mecC S. aureus produce siderophores using the CAS assay, and which 
siderophores they produce using LC-MS analysis of culture supernatants. There was only 
a small reduction detected in the siderophore output of the ∆sfa∆sbn∆stb mutant 
compared to ∆sfa∆sbn, however, this difference was statistically significant, providing 
some evidence that there is less siderophore produced and that staphylobactin may 
have iron-chelating activity. The slight difference suggests that if the concentration of 
staphylobactin in culture supernatant is low, it may not be produced in the conditions 
tested or the product of the stb cluster may have a low affinity for iron. Despite the 
changes in siderophore activity detected using the CAS assay and growth in minimal 
media being reduced for strains lacking the staphyloferrins, almost no difference was 
detected from culture supernatants between wild-type and mutants with or without 
iron in the medium using LC-MS. Staphylobactin and the staphyloferrins do not affect 
virulence in the wax larvae infection model. Although I was unable to generate definitive 
evidence revealing the biological role for the staphylobactin locus this study has 
generated valuable tools for further studies and thoroughly tested a number of 
hypotheses concerning its role in cation metabolism. 
In addition to the staphylobactin region, genomic sequence comparison revealed a 
novel vwb gene in the genomes of these isolates, which may explain how they have 
adapted to infect a broad range of host species. Strains from CC130 demonstrate the 
ability to clot a broad range of hosts´ plasma including ruminant plasma, despite lacking 
the ruminant and equine specific SaPI vwb. Identification of a stop codon in the vwb 
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gene of CC130 isolates from human and bovine hosts suggests convergent evolution. 
The presence of this stop codon affected coagulation of bovine plasma, but had little 
effect on ovine plasma. Knockout and complementation of the vwb gene in S. aureus 
CC130 strains showed that the loss of vwb affected the ability to clot plasma from a 
broad host range. L. lactis expressing the divergent vwb gene was used to confirm this 
in the absence of any other S. aureus proteins. mecC strains from ST425 were also tested 
for their ability to clot plasma. Strain LGA251 was unable to clot any plasma at all, due 
to an inactive coa gene. Other strains from ST425 were able to clot certain plasmas to 
varying degrees. However, strain LGA254 was efficient at clotting all plasma tested, 
including ruminant. This strain was found to contain both the chromosomal and SaPI 
vwb genes. 
6.2 Why more than one siderophore? 
The adaptive significance of S. aureus CC130 strains producing three siderophores, two 
of which are the α-hydroxycarboxylate-type staphyloferrins with redundant functions, 
is not clear. Many bacteria secrete multiple siderophores, such as uropathogenic strains 
of E. coli and Mycobacteria produce three siderophores (482), which may differ both in 
chemical properties and affinity for ferric iron. From my results using the CAS assay and 
growth in serum and transferrin, I know that both staphyloferrins are produced and 
functional in the strains containing the staphylobactin locus. So why would the mecC 
CC130 strains require more than one siderophore, in spite of the perceived costs of 
maintaining and expressing additional genes, gene products and metabolites? 
6.2.1 Siderocalin 
The production of more than one siderophore of different classes is an adaptive 
mechanism among pathogens and represents one mechanism by which the effects of 
siderocalin can be circumvented (483). To compensate for a siderocalin-susceptible 
siderophore (e.g. a catecholate), bacteria produce other siderocalin immune 
siderophores (e.g. a hydroxamate-based, citrate-based, or structurally modified 
siderophore). However, siderocalin evasion is not likely to have been a selective 
pressure influencing the acquisition of the staphylobactin locus by S. aureus, as neither 
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staphyloferrin incorporates catechol groups (267, 272) and staphylobactin is not a 
siderocalin-susceptible siderophore. 
6.2.2 The staphylobactin locus may be important in different host species 
In B. anthracis, petrobactin is the more biologically relevant siderophore in mammalian 
hosts, especially given its capacity to evade the activity of siderocalin (268). Bacillibactin 
facilitates uptake of iron from ferritin, which suggests that bacillibactin plays an 
important role in vivo, particularly in non-mammalian hosts which lack siderocalin (442). 
When S. aureus strains lacking the ability to synthesise staphyloferrin A, staphyloferrin 
B and/or staphylobactin where tested in the wax moth larvae infection assay. No 
difference in virulence was observed compared to the wild-type isolate. This suggests 
staphylobactin does not play the same role as bacillibactin and is not involved in iron 
acquisition from ferritin.  
The CC130 lineage is able to adapt to a multitude of unrelated hosts. As S. aureus 
possesses a highly conserved core genome, host-speciﬁc adaptations are likely to be 
carried by mobile genetic elements (MGEs). Staphylobactin may allow S. aureus to 
switch host speciﬁcities, playing a role in host adaption such as the ability to colonise a 
particular animal host or a role in its ability to cause disease. Factors influencing the 
adaption to a host will be determined by the physiological condition of the host, e.g. the 
immune system, as well as the environmental influences to which the bacteria are 
exposed, such as antibiotic treatment (21). Adaption mechanisms have already been 
shown for S. aureus isolates of bovine, ovine, equine, poultry, and laboratory mouse 
origin (464, 467, 476, 484, 485). 
6.2.3 The staphylobactin locus may be important during different stages 
of infection. 
In B. anthracis, production of petrobactin precedes that of bacillibactin by several hours 
during outgrowth, suggesting that petrobactin is the sole siderophore mediating iron 
acquisition during this early intracellular infection stage. Bacillibactin may facilitate iron 
acquisition late in the infectious process, during the transition from vegetative growth 
to sporulation (486).  
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In Mycobacterium smegmatis, exochelin can be detected in cell culture medium after 
16 hr, whereas carboxymycobactin and mycobactin cannot be detected before 40 hr 
and their levels only become appreciable after 64 hr. This shows a scavenging role for 
exochelins, but not carboxymycobactin (487). Whilst attempting to phenotype the 
staphylobactin locus, the expression of the NRPS genes stbE and stbG under iron 
restriction, was assessed using RT-qPCR during the mid-logarithmic phase. When 
carrying out quantification of siderophore output using the CAS assay, readings were 
taken at 24 and 48 hours. For detection of siderophores from culture supernatants using 
mass spectrometry, samples were taken for analysis post exponential phase 
(approximately 40 h). Although these experiments covered a range of time points, no 
significant amount of staphylobactin could be detected. Staphylobactin may be 
expressed very early or late during growth. 
6.2.4 The staphylobactin locus may be important in different host niches 
The production of multiple siderophores with differential expression within a given 
pathogen is not unusual, as with bacillibactin and petrobactin in B. anthracis, and may 
be a reflection of niche adaptation and virulence potential (195, 486, 488-491). 
Conditions that mimic those likely to be encountered within the host, specifically growth 
at 37 °C and in the presence of CO2/bicarbonate, constrain bacillibactin production while 
petrobactin secretion is unencumbered (486, 491).  
S. aureus siderophores steal iron from host proteins while the Isd system consumes host 
haem and releases iron. Both pathways are expressed within the iron-limited host 
environment. The functional redundancy built into staphylococcal iron acquisition 
systems guarantees that the pathogen obtains enough iron to successfully colonise a 
variety of diverse niches within the host. Sheldon and Heinrichs demonstrated that S. 
aureus strains that are unable to synthesise staphyloferrin A, produced smaller 
abscesses than both the wild-type and staphyloferrin B deficient strains (261). It was 
shown that the staphyloferrin A transporter in S. aureus contributes to bacterial fitness 
in abscesses and epithelial cells (492). This suggests that staphyloferrin A plays a 
prominent role in iron acquisition during skin colonisation and infection in both the 
coagulase-positive (CoPS) and CoNS. Whereas the staphyloferrin B biosynthetic and 
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transport genes are upregulated in the blood and serum, suggesting a more prominent 
role in severe and invasive staphylococcal infections (493, 494). Therefore, 
staphyloferrin A and B are likely to be expressed within specific host niches, and 
consequently impact the survival and pathogenicity of S. aureus within the host. 
Staphylobactin may be secreted under different environmental conditions encountered 
in the host. 
6.3 Characterising the contribution of staphylobactin in other host niches 
In this study the wax moth larvae infection model was used to characterise the 
contribution of staphylobactin and the staphyloferrins biosynthesis genes towards S. 
aureus virulence. Iron forms complexes with iron binding proteins such as haemoglobin, 
transferrin, lactoferrin and ferritin. High amounts of ferritin are found in the wax moth 
haemocoel (495), representing an easily accessible iron-concentrated source for 
extracellular pathogens. However, wild-type and mutant strains displayed no detectable 
difference in virulence, suggesting that staphylobactin does not contribute to iron 
acquisition from ferritin in this host. The ecology and pathology of S. aureus, however, 
is more expansive than could be described by the wax moth larvae infection model, and 
staphylobactin may play a prominent role in survival in other niches. Beyond 
colonisation of nares and skin, invasive S. aureus can target virtually every organ of the 
body. Further investigation is required to elucidate the respective roles of 
staphyloferrins and staphylobactin in staphylococcal pathogenicity within these 
microenvironments.  
S. equi is a host restricted pathogen which invades and causes abscessation of lymph 
nodes in horses. Deletion of the equibactin locus renders S. equi significantly less able 
to cause acute disease in the natural host (496).  S. equi is a host restricted pathogen so 
it is consequently easier to study the effect on virulence in its natural host. Strains 
containing staphylobactin infect a broad range of host species and cause a wide variety 
of infections. Identifying the right host species and infection model to use to study the 
effects of staphylobactin on virulence is made very difficult. In animals, S. aureus is the 
main causative agent of mastitis in cattle, sheep and goats (497, 498). A large proportion 
of strains in our strain collection containing the staphylobactin locus have been isolated 
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from bovine hosts. To study the effects of staphylobactin on virulence in the bovine 
udder, cows could be inoculated with these strains to induce intramammary infections 
and monitored for inflammation in the inoculated quarters. Mouse models are less 
costly than cows, however these strains naturally infect cattle and a mastitis model in 
cows could potentially be a good host to study the contribution of staphylobactin to 
virulence. Intracellular survival assays in bovine neutrophils or bovine mammary gland 
epithelial cells could be possible methods to study the involvement of staphylobactin in 
virulence.  
It might be more relevant to use an infection model that has shown a phenotype for the 
staphyloferrin siderophores. In the skin abscess model, S. aureus strains that are unable 
to synthesise staphyloferrin A are significantly impaired for abscess formation. 
Disruption of sstABCD did not significantly impact staphylococcal burden in the livers 
and kidneys of mice in a systemic infection model, but it did compromise bacterial 
survival in the heart (238), suggesting that there are specific niches in which SstABCD 
plays a role in staphylococcal pathogenesis. 
6.4 Siderophores: more than stealing iron 
Most of this study focused on the role of staphylobactin as an iron-chelating 
siderophore. However, recent studies have suggested additional roles for siderophores, 
including the acquisition of non-iron metals (265, 499) and modulation of host functions 
(500, 501).  
Staphylobactin’s ability to act as a chelator of other metals, including copper and zinc, 
was preliminarily tested by its ability to grow in Chelex-treated minimal media, 
supplemented with various metal ions. Only slightly reduced growth was observed when 
supplemented with manganese, and no difference in growth was observed when 
supplemented with zinc, copper, nickel or cobalt. The ability of staphylobactin to act as 
a chelator of other metals may be masked by the more dominant metal ion acquisition 
systems. Staphylobactin may facilitate the absorption of other metals in either the 
presence or absence of iron. Further analysis would need to be carried out to determine 
if staphylobactin is involved in the acquisition of non-iron metals. 
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In addition to numerous siderophores, NRPS enzymes also give rise to antimicrobial 
peptides (187) and peptide-based antibiotics such as penicillin (188), daptomycin (189), 
and vancomycin (182). The antimicrobial activity of staphylobactin containing isolates 
was determined against a variety of bacterial isolates. All strains, including 71277∆stb 
displayed a zone of inhibition around the paper disc, showing antimicrobial activity 
towards S. aureus strain Newman and RN4220. This activity could be attributed to 
bacteriocins identified during antiSMASH analysis in S. aureus isolates from our 
collection (360). 
6.5 Regulation 
Although not statistically significant, MntR is possibly a positive regulator of the 
staphylobactin operon in an iron-dependent manner. While carrying out antiSMASH 
analysis of the CC130 genomes, a region encoding an AraC family transcriptional 
regulator adjacent to the staphylobactin region was highlighted, representing a possible 
alternative promoter. During this project, from computational analysis, MntR is thought 
to be the regulator of the staphylobactin operon. Many siderophore systems are 
regulated at two different levels, therefore it would be of interest to carry out further 
work to see if stb is transcriptionally induced by AraC and if the region upstream of stbB 
contains an AraC-type DNA binding domain.  No other candidate regulation genes 
appear to be encoded on the S. aureus chromosome in the vicinity of any of the 
siderophores.  
6.6 Limitations 
My work focused primarily on the knockout made in the CC130 strain 71277, however 
there is some potential to provide more information about these genes if knockouts 
were generated in S. lugdunensis or in more divergent backgrounds. Generating deletion 
mutants within these strains crippled me in terms of time, allowing less time for a more 
thorough investigation into function of the staphylobactin locus. Initial studies to assign 
a function to staphylobactin were hampered by my inability to successfully demonstrate 
any activity by the gene products in the assays carried out so far. This is likely due to 
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staphylobactin not being produced, or produced in very small amounts that are 
undetectable in the conditions tested.  
6.7 Future work 
Although staphylobactin does not currently appear to be involved in iron acquisition in 
the conditions tested, further experimental work is necessary to characterise the 
contribution of the staphylobactin genes to iron acquisition and to assess for its role in 
staphylococcal survival and virulence.  
To ensure that these results were not specific to strain 71277, the experiments should 
be repeated using S. aureus strains from a broad host range and other staphylococcal 
species, such as S. lugdunensis, to see if the equivalent results are obtained. 
Elucidating the potential role of staphylobactin may be particularly relevant in CoNS, 
particularly S. lugdunensis, as the vast majority only express staphyloferrin A as a 
siderophore (210, 357), and while this species is a common constituent of the skin 
microbiota, it may act as an opportunistic pathogen (502).  
As sequence analysis of both the S. lugdunensis and S. aureus stb genes are predicted to 
be functionally analogous, it would be interesting to determine whether the S. aureus 
stb genes would complement the S. lugdunensis growth defect in serum and whether a 
siderophore would be made that could be transported. This has been previously carried 
out in S. lugdunensis, which does not produce staphyloferrin A or staphyloferrin B but 
expresses the transport systems for these siderophores. S. lugdunensis grows poorly in 
iron restricted growth media and the growth defect was complemented when the S. 
aureus staphyloferrin A gene cluster was introduced  into S. lugdunensis (334).  
Using the CAS assay for detection of siderophore and comparative metabolic profiling 
using LC-MS, Staphylobactin was not identified. This may be due to staphylobactin not 
being produced in the conditions tested or in small quantities that any difference was 
not detected. Complete genome sequencing has revealed that many bacteria have the 
potential to produce specialised metabolites, such as NRPSs and PKSs, however many of 
these biosynthetic gene clusters are not expressed in laboratory conditions.  Approaches 
to induce a change in staphylobactin expression, such as variation in growth conditions 
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e.g. temperature, pH, incubation time or other additives, could be carried out. Culture 
supernatants were tested for the presence of staphylobactin when grown in TMS 
minimal media. In an attempt to optimise siderophore production, a number of other 
growth media could be assessed, such as TSB with the addition of iron chelators 2,2’-
dipyridyl or EDDHA. Changes in the environment could induce changes in expression, 
though it is difficult to predict which variables will influence gene expression and 
activate biosynthesis. Phenotype MicroArrays using the Biolog system 
(http://www.biolog.com) could be used to provide thousands of growth conditions and 
allow a very rapid and easy way to look for optimal production conditions. However, I 
would need an assay for the detection of staphylobactin that could be used in 
conjunction with the Biolog system. Phenotypic differences between wild-type and ∆stb 
could be analysed using the Biolog system. 
The expression of the entire staphylobactin locus in a heterologous host, would simplify 
the identification of metabolites when the staphylobactin locus is expressed in a host 
with a limited natural metabolic profile. Reconstitution of the equibactin NRPS was 
carried out in E.coli to determine if all of the genes necessary for production of 
equibactin were present in the eqb locus, and to produce equibactin in a less complex 
media. However, despite effects on the streptonigrin sensitivity of strain ∆eqbAE in 
cross-feeding assays, LC-MS analysis of culture supernatants failed to identify equibactin 
(296). I attempted to use the same expression plasmids and E. coli strain to carry out the 
expression of staphylobactin. This has proved difficult with the staphylobactin locus as 
some genes are too large (stbE is 6018bp and stbG 2769bp) to use PCR with high fidelity 
polymerase, as to not introduce SNPs that could affect the function of the gene. Cloning 
has also proved difficult due to the start codon overlapping at the end of the previous 
gene within the staphylobactin gene cluster. 
Co-culture with other competing microorganisms may be an approach to induce 
staphylobactin expression as its expression is very low under standard laboratory 
conditions tested to date and may provide the chemical elicitor needed. 
Electrophoretic mobility shift assays were used to analyse recombinant EqbA binding to 
a DNA fragment containing the upstream region of the eqb operon (296). EqbA binds to 
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the eqbB promoter in a Fe2+, Zn2+ and Mn2+ responsive manner. Binding was not affected 
by Cu2+ or Fe3+. This assay has also been used to demonstrate that SbnI binds DNA 
upstream of a promoter within the sbnC coding region of the staphyloferrin B 
biosynthesis cluster (411). This procedure could be used to determine if MntR or the 
predicted AraC transcriptional regulator adjacent to the stb locus is capable of binding 
to DNA regions upstream of stbB in the presence of various cations. 
In S. aureus, reporter gene assays have been used to study promoters and analysis of 
gene expression in the following ways: to determine whether expression by the 
promoters of the mntABC and mntH genes were regulated by manganese or other metal 
ions and the characterisation of a zinc-responsive regulatory element (zur) (169, 290), 
to characterise the transcriptional regulation of the sbn operon, when grown in iron-
replete and iron deplete growth media (202),  to characterise fhuD1 and fhuD2, which 
are regulated by Fur and expressed under conditions of iron limitation (225). I have 
already made progress using the pMUTIN4 (503) plasmid to create transcriptional 
stb::lacZ fusions which can be tested using β-galactosidase assays. To allow inducible 
expression of the stb operon, a construct could be made by integrating the pMUTIN 
vector upstream of stbB, with transcription of the downstream genes placed under 
control of an IPTG-inducible promoter. Regulation could be monitored by attaching 
reporter gene to the predicted upstream regulatory sequence of the stb operon and 
growing these strains in minimal media supplemented with zinc, manganese, or iron or 
all three metals (metal-replete), and assessing expression by measuring fluorescence.  
Virulence was not notably influenced by staphylobactin in the wax moth larvae infection 
model. Wild-type and staphylobactin deficient strains of both CoPS and CoNS could be 
tested in a number of mouse models, including skin and nasal colonisation models, to 
ascertain if staphylobactin contributes to survival on the skin and in the nares. Other 
mouse models could be tested, including skin abscess and sepsis mouse model. These 
mouse infection models could be monitored with an in vivo imaging system (IVIS). The 
staphylococcal infections can be assessed non-invasively in real-time using strains 
labelled with either bioluminescence (e.g. lux) or fluorescence (e.g. red fluorescent 
protein) (504-506). 
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Using the mutants generated during this project, I hope to address the role of 
staphylobactin in iron acquisition in specific host reservoirs, niches, and stages of 
infection. 
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